var title_f18_45_19152="Acid fast stain biopsy answer";
var content_f18_45_19152=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F78871&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F78871&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Leprosy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 366px; height: 240px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADwAW4DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDsoXVy3UMMbgQQR+FSKOOepqEqpkEn8eCuc9s//W/WpQ4AxnJr88sdw8fePBxUTKD8rKGB7EZBqQHJIHH1pGZdvoaWoWFiLBiGJx16VN5mAd2eB/niqZnXdzj607z0II4HrVcrFdE0kishPB+tVHAYkEDn3qOacAEhhVJr0YOSOPerjB9CXJdStrdjG8DZXk9x2FcFqOjuCzR+vNd5d3okVQuOexPWsq6RGBDeua9LDVp0kctalCocVFLNB8jDKj8asQ6i0D5CkgDP+TWheWg3cc5NV/7P3MRuHrivR9pTkryRx8lSOkXoJb6y7SySOAu8DavccVZm1N2RUD/P3zVWS1htV3SEflzVdCsqbgvBPehQpvWKNPaTXxGxa35X7wGc8t1q42qggM2Ng7+tYkIBGDjp+NWPLVk2p1+lZTpK+p106sHpYfd3QmB8vdsznI61z15eII5HtnKN/q1BBJOeprp7GwG0s5yX61cm0KxCbikZZeahVIQdmdcKi7HGEyxMgm2fKBjJ60WWo3Et9svDGkacFlyc+groGs7eGVd1tGW67mGai3xGRlaKMAchgBgitFJPWwSrLYtQ3luAqLONnfmrjNEhWVHbnnFZF5PawEFFQO3IIFVZr9GUbnzngAHpRGhzao5alfl2Rt3GqbmHyg47is+61gqHCjBNZRvkDYQZNTQ2puPnZSB1rR0IwXvI54YjnehHaJbTXbT3G5jjgZrVZI3I2KETHQd6hhsNpwq4b6Vcj0q5fnDD8OtZznG97mznUkOiCxxbQfvcmszUQZY5I40O4dK2P7OnQDdzjmom2xplyo92OBTpTSd1qZVIt7mKqNCVMrLGqjBJNWxG00ZZQwA5yRjNSTiCY5UIzgEKykNg1YN0PLWJjlgME9MmtZVm+hnHCxav1Kiv+7OSMgcCqsM/73a35VLcwukxI+6armFxl0yW9u1bQ5X1OecXHoXiQcDOMc4p15bfaxCqcFWyfxBqKxtHlIaWRVHua0TEsCsVfe3TArCq0nZHRhudSu9CYxxxW8aMSSvt1qQzxrGQzAYHrWYHJb55ATjhcGs6V5C5MgI5PephRU+pWIqyg9SzqiLcbjuGPrVTSlRS6KQCc4PvVG5uAkLtlsD3qDTrvz8Sjdhf7w5/rXZKi+S1zloYiMaik0djpsv/ABL4vLI3kkOTz3rOvUJnfLgBu4qR7x1tR9mUZJHUdKqajPJvbCqcgDdnmuGFN8x7ixMV7xWlnht9ixujMT8+eMVYjvbcW5LNuOO3FYFxaETNKZhk9iKW3dlI3tvJ79hXYsNdXuZVcxglYvwsWnU+awRuAG6nntWosEjpnkIB3qgksEaLMdrOvQk4ArK1XxCFQxpJlm4AU/zpqjKWkUcFXFe0d5MvXWqx2shjUhmzjjtVa4vcAbmA9ya5y1jeWbzJAXc889qvPprFyzgsT69q6lQjH4mcsq6fwnulzqoVyA4CgenenQ6orANuBrjLm5BOcEn3NJDMwQljnvXzqwUWrnW8XJOyO6k1dV6sAetUJdbVm+V93PbpXLTXeBnjGOazzqChxtyQeuO1XTwMehM8VJnbpflx1IHapBengbq4ceIbePKs/wA47VG3ieLcnlYbJ5Bq/qM3siVXtuzsNWv3SzleLlgCcDvWPFqMk8EZJA3CoX1VJYQY15bviq0A3bc4GOnpVU6CiveRcq3MrI1423DLHBNSTSgxbT0xiq0WwJl2JI9KSeby1OOhOMk9/SocLspPQR2Gzjt2qpLdFRhDhfSntKDGwLqpHGCcfhUKwE57960jCPUmUmvhKE8rMSrqHPvSqpc45AxgACpZIMHOB9fSmGbYcA11J6e6Y6t+8Wre3VCDI2FHX3qy13CcIinPtVDa0oUDODViCyWGTdccKR3rCdt5M6KMXtEiub57VQyCR93A2ioIL/UbmeNVtpCDwee1dNaxpdooVEwmB3FbNjD5YT5E2AYOOtc068YL4dTvjTVtzkXWYyAyEkg4AIqndAqxVxwentXocsUbAHYoNc3f6duvm3gBW6e9KjiVJ6qxjUg46rU4rVCkpDIXV4/4iOBVC03eU/2j7wOOD1rq9XsI1jkReh7gc/nXDuZIZXjaQHDHA9K9rC2mtDy8TVkvdN7R7Zby/VAvA4rv4tPWKERqnOMVxngBt+pnzCB+lepBgHWONSST83sK8rM6so1eU68tpc0HIzoNOiQgyEgj05q+9qqwExMTVl1dd7RpuUnlTVaWVRGwWN0+XODXk3lJnpSSjHQy5xzlj0JrmdbWGRWAdlwecHB/PFbl47BucAeprmdbw44GK9bDU9Ty6szEhuba0uG3FiWJwWIyKtyTJ56ynDqOozyPpWVNaW7kmSNSc5yKbgRHMQwR3zmvUVGL1RjHEOCOkininXcG4Jq1HLCOAOCMVytvMyv8oH4Vq2rOCc1z1aHKa0q7kaIAjJYlOPugmka9be2wqQfaoJoBKuCSDjORVSUeSvyAuOgFRGlB77m0sTVtboTzag207cAjgDHUURZlYKxHzdc1mCO6d8lVUDt3rYtFZkALcgDqeM1vJKC0ONt1Je8iGSzVm2xfe9KLXTvKZyQoOeNoA/TFbEEUcSgg5lxlsdKhmmRUJGd3fNYOtKXuouNGMHzMp+UURiWAxWFdXLLIwDDcvOMdq0nLzSMWOAOcViXqETNJL+7XG0L3Irpox1sxu8lcrXWWbOTkc81U81kOSxJ9KvBTOcRrjio0tFeYjJZh3Jr0OeKWpwexqN6IrkvcJsYnaemOKauiiV1ZU3EdDknFbEOlyzqsKDMj9AD2rtbDw7MIgViEbbQCAciuOvjYU2jalhZNXZxWmaWYz84O4H9a6zTvD73al5MKO1b+neG2EmZAD6nNdHDZ+QgAAIryMXmPM/dZ2UMJbVnkY1IsclD+NRS6gQvAwazCs78Rc/Wnrb3BHzIGNewqcEeY5yuPn1FimOWNVTcSFcBSPxp8lvKDl0IzVqO0AUFiR61snCCM3zyMkoWLF15Pekt1SMjJBP61dujJu8u3RSehZugqCCxaRz5rMx744FV7VNGioT0udFp1yGiwVwoHWtOCeMjpjB61ztqkgQhTjtU9u1wpdZBuHG0nvXmVYpybR6mHpNwtI0ry9EAMjbinQY7nsB703TY5tRK3NzIyrnCIOmPb0HH41jam0l1HHbo2BuJwfXj/AOvXW2sYe23DEQVRhT6DpWNT3I3Z0umnoiSEwruUghepYClkvLMlRHJubHzGq9zDuQFyyA8DBqsdMUIS8jjIyK50ludMIRatIeZ7eRmUOp9ATzUS2cbsCpyPSqc9tEjIsbKhbqSa1LAi3h5AI7d/1ro5mo3RhXw8FszYsbOFCrOeAKguI2uLkzLFmBU+UsehHfFPF0rxABTtIwTUIuo1kXcflTkCuVRle7KjKMFYtQ3pt3j3ptTHUdR9a1bPUASAsZZs4D9ARXD3utOk5YsCnYYra0TVra4dUAwSOx4rOpRur2OzktG9jsvPVvvEe+Olc3qWoh70pCoKrwD6VZu7jzE2Q4RPUd6yJrZFnWVe/YGlh6UU7yOGtNtaGVq0kzzlirlemFFcvdadI+6Q8gknkdK7yV1fgvk54A7VQvkWO2kkZd2AQBjOT2FetRrciSscE6XM9GZfhO3eC480DKnoc9PevS7C4DsxHTIUH2rj9ItVsIYQzfvMZJ9zWgL4xN+76k5/GuPFRdefMjqoVY0KfKztJ54FQl1DduDVOREOGj3DIzgk4rBtL5zgyn5ehFX7i+7g/L6VxewcHYr2/MUNWQvIT5hA9q5rU3SNFRfX1rpbuWPaWY5GM1yt2BcSsVG1c8V6WGXc46snLRGPIRv5BCgU4RNMAI1+pq8bLeVQD5c81Pb+WizQbws/3RXXKsorQdLCyqvUp6ZBbR3JWeZAw7E5rbnNsAPL2tjuCKpNpEq2LSIkcpJJyOtc7IqwAl5GRyCd/UmsG/au9z06WChFWR0skpO4AYJ96zLm98skEAZ4FZsTXIiWQuTH3J60kUn2m4hEq7T1WrsogsHzSs3oTvrcaQFooXkcHBB4xRb6hqU0YljtAsWfXJP0qncywx3whER+bJ3IOta2mNLbX0QhJkjzkEjOKHtsbvD0qaNbTp7hUaK6iIk4bJHODVlo2djsTLntU1jFPdXEk0w2Bj+OK1yYYugA2jJNckqvLstThqQjKd1scbf2t3HukYsmeM9hWXc7DMqOdxVc57V118Tc2dw5IxnjPQVjWGkF4XLEOZMkmuqlUSi5SJlK1opGVcXC20YMKDc/G4jpSW677tJHkG3Byg/n+Fbl5okU2mws5+eEZbHcCotIhgvYSvkk24PLEfeNZ+2jZtHoRgnFaG74cjtjeCWQKoxtVieoru7e4gI8uLacDGRXmVlbWk90Y9wjfkIedtdLpNjNZEyNcx7MjIAJBrzcTTU3dsU6UYaI68SBWTB2qvUeufeh5Nrc5NZkd2C20EsDjDCllud+GUnAyCrL39v1/OvNnC25mkeHQ3VyjFSny9jWvaTvxuwW+tRmLe43qqg/xAc1sWNiFIYgYwCMd6+urVoqOqPnqWHlJ+69BI7Oa6GEjJ79cVYi0GdjmVQR6bq6fTlhjRTlCf7tbls6smEiHHGSK8epjJLRI9elh7I4h/DTPEAybVxzg81Cnh9hhVUgHqa9IaNdhyvX2qvcWqBAVxkdMVgsdPY09kcR/Y/l8Mo2j1qreaYBA+AOOetdmbUvy6E4P51ka0Le2tHedtoz0Bx+FaQrylJK46ceV7aHBIkkUxcDLH5V7Yrbs43CRb95PXd2zWe15bz3O1QcDrz1pbjXGjjkjtk+4OvXiu6SlKySOjRvTQvXc8iagsZwynBB7ZzVm9vgG8sleBwawrm6aaUOi7gVGGHaqTOZiySSE+h9KI0b7lpwsmXbiS0a4VWKyN0GTmtTS7GN9xi2gZBPJrA+zRuFKAKyc8dWrU0+4eOLGNinnDHHSqqJqNkxpKqro6r7GhBUZLYHI6AVRnsFDEFsg8DFUJ79rhC0BcRfdznvWlHdRwWW+5YAnhR74rmSlAxq0r6mBd6L5spGQV7ZqGLSjaSbgmO+Q3FdSWjeMOo4bpVG4XecKD1/Ct4TvozlnWqx0uNtblhgMQBj1zVl5VdQAQOKz0RieARyBVlECKS3OO1Eox3RzKU3uSJGF5yC2etLMRjI/IVHLdbDwKp3F4FVS2QpbGR2pxg3uF+kSywGOetOh2OQW4wfWoyoUA7t2f1qJ3YuqgDPrnpV7rQz5JXJWnZL0jP7s/pV25uDIpERG33rLUKASxzjqRT0ulVtgHPrnpRJLoVCjNll95Qlj1HAqhOSuCh3dyBV4q9xCVgnQSEHHeo7O2YXMf2oo4HUdqz5zvo4dLVmShuJIwzOFlZsKi9h71Xn0yWOE3AMg2E7n6nNdPfSWwjdERF54P0rGm1QyCVY8CM5HsaunzTfuo6ZV40lexQsvEdzp8GxAkgZvvdTim3C/wBqECaMoM5OOM+wqW3s4WmVjGo74x3rqtPhgSPdsUvjHTpVVeWlqlqZLGqo3yqyOcMLG3jRIykOcoCMk1VTTUUvJBcE3DZBz2FdfdmEJnaBxXKzRhbh5EYqh6CnRbqX6GFXFezVkP0vTdrhbpY3Uj72fmrRilisl8lFBB7nk1iyXsiKyhjio7a6Mky72JrZ4eUtZHBPGuWh1XnOId5YLH65pP7RsbqEoZ8HjoOvtWMFed/nkOw8Yrcs7CzSNWjVMjkEjoa46kIxV3+B10JxbM14rq/u3ST9zZw9h0x61qaNdWhMix5VFU/Mx4rNvHN5qLWpkKWqDnH8Rqrq1oYiDYsVVVwVB60Sh7RKL0OlShHWRdvFe4hfyJdsTE53HhvYVRtRe6WiExH5v4B8wIrKjupICC4ZwvAU9BUSazJCZpUDAsMeXu/lW7wdS1kroqnmFFPlua4N1qFwskcEcb9Bg9fwrstGsry8s2E52KFyCOM/hXnNr4gvvORcpjszcEV0lr4wms/LjuMzgj/WL/CPcVy16FW1oo6pVlUXuNHTQOyPshl5A6NwattOssSZcGQAbgTg59a52LxHHPH8uxsZw3U1AbsXCZSRVOepHauCph5PfQmUerRgNBLGkrT3CyBnJjCps2L2Xqc/WrdvefZVjEjt5R49cH39qppJ5+EkO0+9JNZyCEruDqeD9K9ucdOWR87hpRc+ZnUWl4ivhZgwPQjnNdRp86Mo3zjb9K8utbGW3H7pwyn1PQVs2c5IjaPKhl7nIJFcFXDKS0PWcktYSuj0ee/RFKxsOPftVGTVEaHghSo54rjbvU1CeW6lnx60wTh4usnbv0rGGBS1ZlOu1G9jpW1V1XAJC1yXjO/85Ig7fKMnmrDzOUIOQa5vxLIVtS0gyQw257muulhoqVyKNf3kZForXEq+bMAzdAOuBWhHAIEkigdtrjB3HNZ+kQOitI/zPjr6VeJbORgH616cYJozx2Kmp8q6FiKR4bXyF5Yc0yyi2rmZQX9F7VXMjbxuAzUkl0dpVcDiidPsc1LFtPUkguBBIpkfdH0U45X2NW57pXyR8wxkCsVG3BvMwCQQTn9aZbXboPs0sYcr91q5pUnc93DYiE9Vudho0ibJAU3MpwBj1FESp9peOcBnDcAnhawbK+miuEidQA3U1vJCjTIJJnKE8Kg/mawnDldzRzSk7l2eO9JAtpFCAfNkfyp8STMxDtuPcitC2QTIpXcEIwARjpUM8gt92MDFYKX2UclWfPpYhdfLBMh4FZlxf/NiNsIDgCs/UNSeZ2UHAzjOaqRLIVHGR1yK9CjhtOaZ5das07QRqT3YmBCjBHQVlXl/MyiJgu0NnrzVgnyULEDPTP8ASnW+jajqDkGJI4zwBjJpVHGD9Duy+i5e9PqSDVFeNUQEMoGW601L6MuFJcsTyxWpLjwte2cTkuoxySDTtOT5f3nJADHPes1ONrpndOhT5bxLks0cVsrFgwY4AHasm8d2IkGdjHaFReTWobEzTKMkg8kegrSgsJLhvOSMxJGnyx9yfWsedLU1jCFKKvqYNnctauZJE2YHrmq8ur+ZLu3MFPRh0NJrVoyz3A8xlMUe5Vz1auft9xmJk/1LphgOMNXVTpxlqTUk2nbQ2bzU2uWMTHynxhSw4NX9Lt96Rl9uQOAO1V9OsPPjUXI3FOjGtK4YW0ZigXJA4NaSkl7kTxqjvq9guZIbZgGIBzTzrEUYBUgN1yK5bU4Lqa4ySyrjOQatW1ky6eJZCS/PHoKaw8Gk5O5lOrOEfd0RdvNYaQk5wOuKoPqAuF3A4rDunl84RAncxwParEFuyoQASPU12xoQitDzpVpPcsSSPKwAPHetKzgEcYJHJ4qrZWZkkHpW+tttVdoyRxWOIqKNoo0w8HJOTG21hLcOME1uvZtBb7DIARVRLyGwTE5O72qvd63DKw8jJP0rzb1K0tNj0lTjTjfqTW+myzO0m8KF9qLq1kh+82R1qSyuJ5I+Ixzz1rThs7q5j+dcIeOKzlVcX7z0BRurJHF30bHJIAHSsC4jdZSQOnevUr3wdczTWzwHcBnerdxUNz4IeKcOu4x9xmuilmlKOjZnPL5T1R5qrq65kX5venw24nbqy+4NX9csG064MeQ0f97uKgNs4s1lVztau14inNadSqeCxNO0kSlZrJEaDYxJwxPpUr3V1OA8JSNOmKoWcn+keXkk4x9a17OAfOYXbk8huxriqWep69pQSU9zor7ToXfgAcdhVOTSpguRIcela6OHuVX27CrMseflxx0FcSrzhZXPHdOE23Y5gholxICT6moYEaOUGOU+XnOz0+lbtxbKRhhms2WL7PkjgV1QqKXqYycoKy2DyInm3vHlvU9quGVVACqMCqRuwF55yOlVbm+XH3trH1FUqbloQ6j7mm7JtJLDPpWNrBS4CxlQwVt1VjcHzgrlhn8jVswlSO59a2jTULNszc5X7EEELrCypHuJ/hPFVru0aFcvIXY88DgVrwHAIUHPrTbxFkA+X5qqM2p6jlPmh5nMbn3E/N+NNUNJk/pW0LPcOF61FJaNGenPqK6HUTOeCa1Mby5WfG1hj071qafHBDiS7dQQd23GSa0bGwLjcwNa2jaJby3LyzAMfeuWviILRnpYRST5jItImv5fPSzdIgcD1+tdDYWgiQsx+Ynt2q9dXVlZxmOMgtjoOlZcGqW7XAWT5c9NtcTqOotFoenyTa1NH7SIjgH5uwzWLq995SklWbnpWuyxE+YvfpmsG+uYnuXt7dA0inlj0FTTSvoi6VHW89jAjvY5biRZF2xjt6+9RvLJFOy20hCdQpOQfpUmoabKtxvY/u3PVKs2cdv5qRtkuo+ViOa9BVNNDZ4OHxG94Ojhu5BLfSokkZwu/oD+Neh2lqsOZFlLKR1xw1cFbWESW/JRg3LevtU9j4iksJDBMf3akqA3PFediKUqjbgTGPSLNnV7qKN5HlYbMY+Y8Cua0m1lmvZpWVlhACx5H3uc5qDVNQOpXca7Slqp3Enguf8ACtm21ILDI8xVRtwo9qapyhDTqaSso8pJZyvbX0xeN5Aw8tFxwPeul0uaJYFi+UsBgkjk1502uFborAGkkPOAK2tH1PUHmzceWidgOp/GprYZtXMJVOXSRB45VYJpLhIx83G2uU03TZbiQXN2SsQOVjA6n1rvtTt/7QiCuOKqpYAypGFO1T0rSjV9nC3UVWtzR5UO0rTLi8wqIUiHr3rqLfw/bxxHcAzgckirmmhI4QgG3jFWjOGJSM4z1NebUr1Jy00RhyxitdWcL4k0SASbgm3I6DiuK1K8+zsVyOOAK9jv7SN0O5QTjrXkHijTJGuzsAH07162AxSmuWRzVcK5O5zK3Ak1IMFBOMKPQ11dnpbJB5ztgYyd3SsKHR5rVvtEozjGKu3mpMQkUjlYl6Y7mu6pN1Go02aU8LCnHnmtDb3RW1skgUKxp9k7Ty9cjNczLfy3UiFjiPoBW/pLkxgrgConS5I67nBUrc07xVkdFfWlnLbI0qhfr1NMi0i2dt0EWQRwD3qO3RruRY2yVFdfZWhtrPzACCCOB6V5NWo6Csnqd1KUq78jK0/TpYxkptXsCK6vS0jaP5gFdT0PSn74lhiMjDLD7ppJTGoO2vLq1ZVdzsjBQGXmtWtlc+VMHBb7pA4P41NcThrdX2gFhng5rE1V4ZlIlwTjj1rnrm9ltIv3E7eRjIDDpWsMNzWtuXzRa0Kd2kIv5bmZFfDHarVxuqxzm4cW2WVmyFP3R9BVvU9UkaZtvDHq54/KsW5upLicmWXZEnYHk17dGk47m3M4pSNLT9MZpFeYhdvOf730rqrO3j2n5D9cda5/TriCaFAXkjHAGMbv1zW4b1cKtoxMYHPrmsqzd+WJlLmq6zLGnyqCWyQTWosqttXnOK5NZ3WRQtXlv24AX8aVSg27nh06nQ3JdpB6fSsa7kWSURIM5PJHanR3RJKkEmovt1sHdwuRnr71EE4M6lSdRaDorVA2MZz+tSNpsc5CtGCPWi1vreWRiSqAeprTMsSx7vMGMcYqpVJJ6GTw7h8SsZ3/AAj9s0wYFsf3SeKku7JY8IO3FaVi6yfdY89q0Ut1IywBrF4iUXqy3T9oci1ptOAppFt8t8wz7CupuoIkt2YqN3aqMbwxpu4J9K0jiXJaIzeGs9zNg0wt87jap70yK1hjZmxuUHr3q9d6irbWJG0HGwd65281EI5Eec54XPFaUva1fI1dOjSV3qzd3RBcCsO+v5SHWyGNpwWxwKSzvzOzq6kEdferRmjCYCKB6Gr9i4s0p14R1aOPmWWRyIZGlZuuSetT2cc9pIHkVlYdCK7G1sY5nVgqquP4RUVxpKSyMCCTycevFP2yjoz04V1VtZWOeubu6uoXILbUIBI9PWuq8PWNhBYpPJh9zZPfI71laQ5MDqyAPECpXruFWY2W1G0n9xyyg+/apqXacVoVG0nZFrxFrFgrrDaRbkUEbj2rjb8p5sMw+UZ5+lR3skkt/wDIpEQbr2pkzvPc+UmAFGMjvW9CkoWsaTfLBmguqzFv3UZ8pe7U25vZLpcOASD1xTltyVCs3P6mpIbEowTOA3Oa7lGCV7Hz9apUlK6ZSmuLkRgbuR3pJpXMUW/e0uMBa0vsoEpWP52ztBPb3rq/D3h8XBV5I8k4wxHX3rmxGIpwjdm1BVYO8mZHhbQpSDe3YO5xgKK6G2sHjf5lCgckntXb6fpMMCorKDgd6tX2nCSLEagGvCq4/nk10OtQ5neTOKJvGYLa2g2jgyS8Z/CrFjGwO+YDzAeStdE4YL5bIF2jH1rB1GVbediSFX17UoT5/dSFNWZM4k52H8KsWMTpGXk4J561HpVyJ4jnaeeDVnUJlS1YKwQcgHNZSbvyCjBN8zKcd6Lu4ki+6FOK53V7aI+IIVbGPILsB35OKt2dzDpxaaWQOx5xXPS6nNJdXV4It0kp2rk8KtdFODi21tY6YU3LYzr67/fzwP8A6sqSMdq5y9tB5DyI6uq87a1jbytfsZ33tIeg6AGqRspP7Va2BxGOMnoRXp0JKDujsrUoSpOPcq6fa/a12BsOffoa6SxtZrW3/fYIXjPrWPq1lJpZjli3AcZFW4Ne8yLyiRnHSulzlVV1seDWwkaautTqPD+oWscp+0uEc9Ae1dTH4ls2zFAxlJ4+UcV5ZcRfbUVjhe5xxmtS1u/sduEQAN6iuGvglN33ZMcRGCslY6271GQ6irOQqIMitL+1AYiCAOe9ee3WoyMCXJDnoc9PQ06K/nugYwT9ah4K9m9EgVdyVom7qeox7zl+R6ViXc4kj3ZJXGaf9ijiVpJn3Me2axNT1WG3bJYFR/COTW0YLanqddCi/iqOxj3wup3KxJnHUseazPsxhmBlc9eTnOK0bnVoUgMiBvOf3pumSFhxH5hbuecGurlnFXaOmOJot8ty/wCHW+0K7OchDjcOK2CksK7oskE9CeRWfhbG0CBeTyx6ZJqxaMzwBlfaOgHoK5Xq21sW3JlvzYSCVOcHHNWbcNMp2ADHc1SZFEQCjGDShpYlJQYUDkmrbjY+ep0pykuVXH31z5K+WH2t1Yj0rAe9LMqwyKsjHCozYLZ71baKS7kZRuLHkntU2n+GLA6i17czTvITlIeAN3ufQe1ClCJ7EKcqMfe1bEtNNuDN5088SpjATqc10Nnvb/Wt8gHGBjNa9jYiSMIY1U/r9a1IdDQfMw4x61xVMXH4WKrebba1Mq3Z4XDoAMjvV0X6KAZG/CrNzp/yHy8muevc2uTLlQOn1rKPLVZzKMloi5d33mj5jtXtWam+XJi+7msYTebOBJIctyFHpW3YYRCgcnHGPSutQUFoTVpuPxMrvExJLdBWfLEvJGNw6CtC8uWjjIPHJB9azrDYXZpfucjcetbwk7XJ+rq12QxPLtKqvOe4q7FBIqhrpkVc9BySKIovNkG0ADsTTxZNdTfvGYMBgY7/AEonU87G9LDxvaSNaydydsXCDk1amvYUAE0qZ+7x1rFLz2ahAuY26nv9KsWCxrmWQKVfnBPSuWUU9WdfsOXVFa5gUXDPYCRweT8wGapDTby9YiQALn7obHWuiD2cUp2ugLDj2qqumBrx545HKYyuxqqM0vI2U3FWIJdC8nTnV4tjx8kE5Dj2rmJLUwyh4V2hjgj0r0mC5VrV0cMRtIOe9cxNbwreoXjLEtnYp5NXRqyv7w4STTTOeSc2q/vkL/N97HatCXVUupjJHAkQVQihR1PrVo2ME8sj3cnyhsLGnf0FT6NozvqoaSHYit8invXTKumncyeGpx96xseFtE3p510NzuMhR2r0XT7QRKNqhccYFYnhtJIbkyXEY2jIyTwRXRTXaxQvKmAvTGa8HGVZTlYy5dbl2M4GCOR7U26uhBEWdhkDI5rnJtcuRGzMgA9a4XxLq76oPs7TOI1znZxn2rOhgZ1ZWexM6ipq8jo7/wARo9zNvddoyAc1xOo642o35g2FoweOO9c8bRBMSGcBT03GtOwjMcscFvGXnbkk/wAIr3oYSnQVzkjieeVonc2tzHbqkaOBLtwFqlqUjzylZLgjjoKij0uSP95MSWxisXVbn7JcIB0ziuSnSjKV0zrTadohfsUj2BXdvU9BUFvfw2RVZUM7egGQv1qlqd+rv8jck8g1T0q7MWoSQttK/pXVHDuUTrdRQWpqXV295dbrWJYWHB4xwabHZlJlZmy3fnmnI3nSOsZB53E1q2No8rYUZY8CiSVJHJLF82iM3UrgTyESjMYXk+1ZFlohlEl4ozED0HpXSTeGNQDzCU5jcE5z0PpWppFq8GltA3UqRiodeNNfu2Zxk5K0jkkKPiOHdxzz2qFpmZ9sZDAHk9qtRxyzb4JMRID87Z5wO1MlslWFfJyEP3QOta+1aNI4Sk3qVLy+iWRVkjJ2jGc8U231tImKLBIxLfLjpU0mi70IugVWQcE9agudKmtIw9tkhTlCaOaMtzsp4enFWiF7dXUysU2pkf8ALQ5rmdQl2nLOjE9dq81p3d00qkS/LIegqmlsWAdhk+gr0KfLFankVo1IvlMJnMjjKsfTitjRbiS3LLKw2jkHPSlFq725bAXOQoJxmsKKKRftG/IYdQDnFTKSkOnQdrNHaXNz56qCd23BCjua0I7V5Y1kICse2elcRpFzJ+7+b7p59xXf26zNAoiCY64NcdSHJselTq8sUi3YRPz5mwc/LhiePU8DB/OtSO0XBMozuORWBNPPboG8wBR0AWpbXVJCR5nmsOn3K5JxlLU5qVOMf4Zq38O2MCH92vc1naY0k96ITwAfvVrT38c1p5TRhCuPmI60aLBC8xkhRgAcHPes02o3Z1c7pxd9zq9Ds2VdxLEnjn0rpooAFBY549KzNNkVUwwxgcCtOK5RFGWA5rx60pTk2c6skSPbqyZC4Fct4ksIT6dK6K51GMRkBgce1c/qZeQGR8hew71ph1JSuyZy00OL+wJHKxHTpwKmiVoplYJ8mPSrBjkYEqvINNUljh+GA+le0npY8+c5SleQy4SO4nywGT37VYgtI4SWUbyezVGm1XGBknjitS2hjCh5m24PQ1E5qKsVFVJaFd7WaRPMWP8AdqM7V4zSQkyTov2cx4GMnjn0rXF9AFxGT149M1WZvLYSKMsTksRwtcylJ7o9Kk+SNuoTaYk6q4ZPMABKsMirFnp9uWPmwpuJBqp58rMXwQM9egx9Ks/aQGI7kZ6USjK25DqtvluVtY0O2Eb3EbojAbjk4rk21ZoVIhjYqD95Rx+da2pQid2d5XyT9wciqd5pUckcay7yhHPP6VvRi4r3nc7I1oxVp6j4PEFrJGqkOkmOccgmr9rYx3uXDnzG5yP4ah0fTbWzgkktbdd3vyT71oR3YST7m1yAWAHSrlbVQOOVazvEqDSYbOdQWae4H3Il7n1ree2EFvvldUzHh8dQ3tUH9pW9tmRyA3TOOaw9Qme9mXdduIwc4YYArLlnN6m8anPudJBq8dtbxxhgxztJzjJJ61DfX1x5Em1kWPOd2SSaxo9NluIw8bxyRnBG0nIp93JKqGGUNkHk+tEaUObQzqSSTUWZ9zqc+3y2nZxk5JrKkuF7t8x9KL6PzbhsBto6rWXdxSQFREp8w/xHsK9eCilpoeNOnKU97l4PBHMGnZVGQcDqa7Lwv9jGboKqLg8tXJaPpscqNNcKNq8knqaNV1MWgEVuNqgDAx3rlxC9r7iPQwuGa1O013V0X5Y8cjqT0rjb+5ilhmBZWbqPXNctc61NczDzHaRycYxxUyO5lj3kKjDmtaeFjTikF5qd1siOFllmJmYhh0FLDZSzzSvFuwe4rf07QorydW6+hrtoNDtNOi3PjgZJorYqFH3VqxKpKrrY4q2gmEMcTZjGeT613nh6OOGJT1I7tWdJao10smBt/hq2V+VVUYHauCvN1Y2YnKMfh3NPUZycojrkjisyNfIBy2WPzEgfpVpLYxRvNMzOQM4HWqtzcSAqJUVUkQ7B1aueKWyNIRbVzm9amjtrndIR5bnLADr7VnWl3NqE7GNfLTorDsPam67aOXzOd5LgKo6Vr21ullbgEbSRziu5WUO7OqVkkZc9tNhx58pIPXfmmWsklvasZ98ijJyx6CqkU73Go33lsdmcg/Sql/fyC325BRsqwI5rRRb0Z0wvy3MnVjJcXbNAp2kZJA9akD/ZNNY4Zm6BjXQQLCuirLMhLEYGK5y8uiSYnXET8jOOtbp83u9EZWbfMUpJzJYRDJHJ5qqqGW4jSLliMMR3FSMGkItoyAgOc1egsDboCh5xy4rRLlKlNSW2w3SLSAApk+YpzjHTmuogdpI1VDtVe5PWsvTrNIlExK7T0B6/WrnmTuuy3XGOd23rWVX3noYxlFbndW/hyVsB14HPJrdttFSFAGAUY5rpo0XOBjcACfakuoA0foa+YliZTeplFcq0OVk0aCY45POAOO/1/On22krZOSGZh0Ge1Wb2RrRCyYJPHFYs+szIrZXJ7ZPSuqnCpUXuvQxnX5dJnQoy7QCckdMVk6vdRRIDLcKoz0JrBTVneTDNgk9j1qysfnsC6h89yK3jhnTd5GPt1U0sWLXVzIVSyUPJ/wA9WHyr/ia1Dl7ZE8wsccs3VjWDeTtZeXBawebcSgleMKg9TS2KCBfOeUzXD/ecnp7Ch00/ejobNtRszTmt/lyCT7ZrCvm3PHKysmxuATya0pLgKAxbjv8A4VXv5Y3tpfkwwH3uv5VUHKLFThF7rQl0tbW7O8E7sZwD0qDULlt5CyDfnCriq1kY5bxo7NWD7QS3apZLdIWaWR98h/Ony3kdCcKCuVW1J7VS85woO1Ao5Zqq6ZeXZnnurqYxw44J4qeSc71JQYB4zT0ZLg4mA2Y6HpXWqaS0RxyxkZO0h7+I7N0SOzl8y4Py/dyBUhub67ILSBUHynjFVo4IbaM/Z41DE5yBVq0jkmIHIAo5IxV1+Jn9ZS0itSxbhbeLAZpJO7HpTbnz5fmVGYeg7Vt6Ppe+UlyCB2xXV2+nwpGoVBkeoriq4uNOWiuXCE6mrZ53bySxQ7gCcEgexpLO2ursfuVRmzufLYzXa6rZRiCdliUY7gVU0qzUQnaMEx4J9BnrULFXXMkd0KahG5m2ulXLIAbVd5+8SeM0+4tQjiEyiNI+H2qDub0FPvNTurDVUVSJUZThO5x3qteXkFvBEzKzuSXYDk5J6GkueTv/AF+JrHTU2hGs0SwoxjG35nXrWbr1lA0YMrFHHCkdTUEfiCGCAJBHI0revFZEd5PPdTz3pGR91SelVTpVFK70SMmkzPaG5SULhXiz16EVbjsy6t8vzHuaeLmEIzHBOeTWdJrcThhG2O3Nd15z0RzOlZ8zIr9JrU4X/VDrjvWNqcIeFp/+WmcBQauXWpl9yZBJ75rPaQscE8eldlOg95GUswcPdgjJhRYZcAL7tXU6XY2tw0ak5LEdfSqNvZqzFhgqo7rnNblimwo32eRUPG7bUVm1sddOtGpTv1Ohs7SK3jBjxzwMdKg8T3Pl6UsO/wDeSyAfgKlSc7VCHjGcVTvoY7qdDMTwOB6VwRjealLocrqKOiNGKRSsFtGMyCMMTUj4hwXI/OsyKMwTmRHPK7QaWRXZyxfK0nBPqQ7X0NuC+XYWdgFWs+1db+a5uZvliUbYs+lVpNiwNnnPaqUk0jIiR/LGvJxxURpaux0xlaJW1UiK7SRRvVOgJrI1DV5mkIZVJIwfata9nGxsbTgVxWoPM0hcZwa9CjR5lqKGJje7LhuIoYlET9ep9TWXqLl34BIAqusTswZmPNTNMu0kKW2jGfU1v7PlWh2xxCm0i7a6oZ4Y7fGVUbcD+KmXej3E8jE/Km0AAt39qpabGyTM7nDjnHcCup068ikiAIzUtOKvEipX5XZHH2ulPKrSGQqytg81uPFDDZpGzFm6lu1OXKXsgVcKSSfei6iMuMDjNbW1Vzz54rVpCWtyr8KnHb0rQiMpUbTUFhZhRmtq2ijVMECsqs4r4UcfNKTvJnrkMy7VznCjAzTLu+SNCoPzY9Kxrq7wvynAoEkWxSTuOOSa+VVFXuz1XN7IztUvgM72+grkNSvZGBIGF6Cuj1+2EqtInbk88Vw2o3TswjXgdK93BQg43POxCm5cq6lq0uE3gNy30rVS+kVdqnBrCsrZoo2kZTnjv+ta9natcopjQlmwfpXRWlDV9BQoTirdSzezzOkbRuA4GDmqtvqLIyjoc4PpVy5sryO4SLCGAgbj3BrWtNCXhyBtPUVxyqwirnoQoyUbSZjG9EmSRkBhlfUVG7Ou6At33x56Eela4s4Y52Lx438YA7etQ3Gm71CLIPMQ7ojn9KhVInR7PlsiklyzDMTeW7dcCtG2t/NQbjllHWqsFtPI+XjIIbb7ZrZ8uRFESfKSOSOSaJVEtjKrRvpcyrqwdVZmZVXr17VQs1NwWKgrEo+Vm6v+FdSulvNCdwyGG07jWdNZND8qBVA469quniHLS5zyw9KPxbkcVpIgUxbTn+92q3Dut0YybWY9Ao6VSlJhjRHkAhdtoVepNXL2ES2jJDlWUZGD0PanJt2uZKMYuyKmm+JmttQeKVCFBx0r0DStWgulDRnPavIL4yiYtcxhLlMFiOjiui0TfC6yRyrtwGII7ms8RhYyjzHY5xiux6FfSCS2nQdWUj6VmCaK0VULEFwETvkVTW/G4AMCxxkZqjdzS6k7xwAHyjyegz6ZrihQcdHsOFXnVhNQsQZEkg/1+CY3fkDNUHGoWKKjzRHe2cIla11OI4zNdOECKBgVzdxqK3F4Jmk2QpwpPeuqkpS31RpBtpmjcyxx7ZJFG/GTxXPy3H2q+MgQyKDgA8KPf3pt/qKXEjRhlYevoKi0jU7eO7lRjtgQbUY/xHua6403FXLimo+Zc1C1aWPEUPzkfMFrn7o+XG3mwlExyfrXfaXdW0jFo2+VRyfXFZ3iKdZWVo0jKScDA71NOs4ytYapOfuyPNJWZZSylmXPGD2pZNSwvcH3rohp0N60q42SR/3TiqNzoUryLgqFAxj0969SGIi9zzsRhFB6lvQL4yAFlOO5NdZBejy8JyO1cvp9tFbIY8kt3Na9vOkQAUDJ71hWhGbvY4lKSdkaQZse5p/RcnrioLfzGyTgZp84ZSADkd65ZNbG0aUpEnmAICxG30qRL23yVIPTAwKpmB5BliOPWobmUxIiBC7/AOyKycVLRHTCCjuT3l5HGhO0kdOlc7qWslYyIRjIx0rRm82dCJ1VE7KOtZlzDamLLbVcdq6KKinqOpCSV7FW3meW33M3DVHLIqRY64psCF3YRnCfXrUUzrGxA5NegkjyJ817FLDyyFVHBNWEgEYxtDMOR6Cnw736IOa0ra1fG4ryO9Ko7bm1Oq1sZFtp0yaqJXyY5V+b2yMH9a2rS3SEfKKknkaNMEYqJbh1i6DB4zWDcnuXKrfRD2ji8zjGT1qSC28yXaq1XSLdIMEjJ79a3rcpawLt+aRuhqJzsrR3Ml3kVvsRRwrcA1OyKBgZ49KHmLsCxJLHOBUpYRgbyqg9M1zvm6j50zSuZmaJ1LjOcimQXzYAIBPaq1whiBdzlz0AP6VUiEiuqs+Ac1hCEZROupJxkX7iaaaNivKjnrXNWunG81ECVsIo3ux6KOwroZryBEKpx2471n2oaWZ0tkGPvEHoW7Zqo80I9kdFGpFy03J5bUs6KjbQenuK3NMKWyDbtGxefWmW9j5cMc0pMlwR80nYfSqKs636gyYjPYdua53L2mh3QhHoyyZfNVSSQWb7wHQVvWsnlpsONgAG71rLsIBFEzSYxngY6VakdRArkcDIIz3rKdm7BLXQvPFDIQUfH0FMj04NKGMkbdxkciqVvdFsKEGCcDnkVq2KqpI2EOT94mspXijN80epD9iMIK44JzwKWyLPeuBgEDaM1syLlSDzxWDJL9m1JhztfDcDqaiMnUuiUzXmVRDsVwT0OKxbmA5bP/66vi4WWI/KQOxUkdKzZGeU5BYDPStKV1oYVKfNqZ1xppkvbSRR8kJZig7k1PcK3kkhcOemfWphO4ueoXjgVaZfNR95OcZGK6vaPRMx9k0rnGX9hHdROYZSZ48lkY1L4Z8yS2mRM7I+QxPQ+laVxbKkxdgFcjkjvWMk8EF1/o5fe52si9Pxrtg3OLiiZVFKNrF6Eg3LQQSFp5T8xz9weta1xaSQQollKURQN2P4j3JrKSNYJGlQ7SeWx3qOXUrjftj3HK8cVnOEpNOLHRq8ugX93O8bQzpluxPSuVunuJrkxIvTo54WuuEouIQ06bm6DPHNczq8MqRnDHbnr61UVZ2Z6+EqRnotDPdltN2873HJPdj6VX0xhPqCJMBtJB29gDVd3XzCnLAjLGr0MPlA3SY8tVxgda6Drkox0udzJpqw2XnWMqlRwQvrWHezubCJASDjIIHcGq9lqBUb/NZICnII68VRn8QWTQxx4YoowFPapp0J311POr1+VWLlhfCGctIQS5yc1NeXyP8AMJVUE4BJ4rM+228ygWycnrkZptrZRXEreaQw3ZHoK2lSlH3jjWIpTlyz0Lcd1Hgvu3n0HenXM17sH2OJdgGS+OlXGsBHhLXAVupxVsWRER86UrAg6DuPeueVW+rOqFOjD4dShoa3U0rSz3DLGOpPSr7ahb2p8m3k8xic5Y5xXP3t9dTKYLZG+yA/wd6y5rS8W2kmaGREHBc9qHG/xM6Y0ozbbO003Vzf3kVtbqJFJ2s3TmuimtI4eCd7sDtArzhL2PT9MhNrxIqZJHUGtqz1S4nsIZiSGPHH9ayqUW9VojCrSSs0RazY3lo4PmMGfJC/j0rDewkZwszOZWOSPQV0t3r2GjS4j8yRfugDvSW0e8vczJl3Hyr2FawlOK94h1oqNmjDNkyqEhZg2OlEdp9mzLcjdxW3uFvgmLLnjPanMBOjeavHbFae1lY4qtSDexj20rXUpSCLaOxI610Fvbnytr8H1xRp8NvbhWC9T+NXmYythFOaidRs5JTi9ImTeQKEAPQ96zFtt0zJEeDyDXVzae7RkMRz0HpVO0s1UyN3jbBHrWcsQlHQiNNuViG1syNjOOR+tWPKI3ZWrtyAGQABVAyAO1NOyTkfSpU21cUlrYht4gB83ORmo5ly/tjvV2QeWMngYGKgwMfMPpS5r6sXLbQjCrbw+ZPIXI45PWsi/vckBMAiq2tah9ouhDbEmNOrepqARk7iW+YjPNb0o296R3zoc0bdy7GCU3v07VveHcCQsVB7jNYFkjudsmcDHI9a3oROuIosIOprLESTVhUqDjKyNy9ulAAfjjoDWUY1vJChRTGww348YqSF0YAON2Dgk81ajkt45CSRjsori5eXRHdGool23UiF/MX75OCap34VkRXDHnovf3oudSAkROJCR9xfrSS3EbPjIBHQelTGEm7lOfJrIfbWiKwbeU7BSea1VujAn3wxXAUVgNPtCqgzI3JLHpUtlvaXdLIGOR8ucCidO+rJ9pz9To0uDsXBJ4y1Y+rSu7o0IGOtaLjEQ3nAPvWI7BwzbgqJnknAFRRir3MpqVm0WI7xjGyj5QeKilv0MQy+MdfSsuO7jZyIJVlXPJU9KshI5ol8wBlzkj1+tdTp8r2OaMk17zJLSf7TdebGmYAMM5q+2pxRkJtRc8CqFxfxW9s4G1Y1GTj/AArChSTUJzeSgxoo/cp/jV+y5ldrRFKcW7PY372RJxIY2yyNgn1NZEdtHaFzGPmc5LGmWrutumVIZuo980+RXlQ4JrphDk0voclSV21EuWiLKxDknI6VH5JjfaRkp90+ozUEe63IGSzHgYoacSFmZiDjByT2ocLyunoOnJqNrFzz1KhSueOo/lWJrQwhO07Rkk46Vpb412huWPSluLaO7i2OxRD1FQ1Y7sNU5JXaOES0e5u12cZBkYDsoq+9p9n04Bukxz17ZroRaWdks7JtAddpJ7Cuf127haMLEwJA2BV/nXRTvN2Wx2VcZFvQralKBbC3Xa8W3r3FYjQW8UkZJ+XrjvVmFbqcsy8RKAqD1Pc1XurScygbcsFySRwK6YclPVnJKU6/7uO5Zub9EgVIF2qeGOKtaZMRKkcfIbFYEDlZGVmLbT8ytXX+HdNadEuIV4PSnKtFRbMZYKUfiOxs7CRbYMwJY9BWD4yvDbWZtVwHcYbFdVZySwxAy9B61wPiRn1jWHMOdiHt3ryqKlOpd7I7qHLBaiaLciK02H1H4mtzU9Ss30SWDeDcvwqVg3EbadaKXwHPas3TpDNdySlcnGBXTKmpvmN4qL95MsNp221spt+Y3BEg96v6f56WAWCPcVarGkiMWawSjLE7ue1bsCpBFwFX14pybWjOGvjF8JgWmn3dzfiS6jEcK9D610MkyQldw/dqOTUcszOoPFY2qJcSlIoP9XnLn1+v+FQ4ue5wTrubLa3ZvpQyqBGDxinzRkJyRz2z2qKyQQRKpAGetTqfOc7lG0dff8KXNZ6bIwn7xLbIFVeNzenYVrWhKM0ZBBB6020t18pGAAJ59xUkk6whlJy2eMGuecnPRFxSgrsfPJtRi/8AOsJLpwHYNhQeR26/rU2o3SywFSSCeBjuajtrMNEW3AqRyvpRKKUbMcW3K6Jorj7SzbVIAqYBQq5bkHIOSPb+tMggEJPlj73GTQyurNnpnFVpsibO92SPITGCxByOcf0qpJckH5W56U+4cgE/gBVHySWyDkU0o2uyXduyK9ppDySh3xgdAO9a2maSlxdOJcgKdtbdrBHbgCQErtySRVaCRYp34YMGyc1zSrSkmkfQWu7o6Gz8P2KW67oyx65J4qpqNrbWkYlYMEZtoVFyTwSfpwK07XUPNgO0fKO5NXlWG6RRJGjx5yAy5Ga89zqRb5iF72pzP9lGPy5oiDCQDg8cEZqNxFESCFAPBJ711lxEPs7F2HOSa8+1y5dpjIuBGgAAPrXRQk6zsx8nN1Ks9xFbytHsGBnDDtVO3vmluvMYfL938RV6W2WeIlgNzDJxWTeNLbsoRBs6delerQjF6dTz8VUktEXpnZ7tTH0x19Kvw4SaMKzSS/ePtXMPdTeb5ls+dowUbpmt231cLaYXYJiMPgUVqUlFcpGGqe97xtC6lnAx/EnTPQ0i2QnV3vADBuKiLP3iO59q52wvmhuGZeULZ+ldHPNJJZuTnJHGRjJrhcXCVloerUfLHTVHNzyw2km22iWMOedvPAq/bXYe1O08kdfWsO+LJNskUJz69aUTvGoRRkduK9NU1OKPCrzlF3sXRLucq/IPrV/zMxoicKB0rHRv3ZbvRBfbGHmHktgU5xvqjGm29DajU8FhxTmdVIAGCabZX0RceYPlHWkmkjM5eNWAGTyetc0pO+x6NDC8zsxLlk2fO3Tp61nMSAMkMuMDtVC5uHlucoGMYyWOema1o7SKWDZISQORg85pu8T04YanDcry3AtUEkpLEHtUaeJ7KONzOsintxTbvTYwBKrONoAwfWsi9s4JTuxyOTt4FbUqXtNZGOKxGHpRcY7kGo6tDqlwI4mcRE9BxRFZo7jH0FMSAb9kaBR6ita1tSCrOdvueK7pONONkeD7SVSWjJ7GzjgRWlO1OgqprtpLMr3VmxaDgOvTJrorXRQ9mC67pd3G4kD8qsy+HoltiwlcMfvDPFeVLEJyu2e7RUKMbxep5jf2wZUmC7T0rsvAN26xGB1+QDiqWseHmBXynLKDyM1saNbizgC9DjHTmtZOM6bSKxOJjJGzfzsLaRIsFiOK4uxujaTyfaYGDM2AyiupDjqzcn1qnL84ZmiyucDilRXLdW3POlieVWMm7tF1MAIrqOp3dqn0rS4bYOJAMtV2KRzhI0Cgd6vW9kJSGeTk9q0nPlVmzBYmctImWbZRLuiGMVKqTP8Aez9a6GKyjGAqjHcnvS3kQjhOMADsO9YrEX0SIlBvWTMHyyqHcScVC5yMDnPXtitF13x4PBY5qBoiJgQBj09arm7kW00KxhzgYwvv1+laFrab154JHX+7UlrEGmJI9wKfd3ghDIMZz19awlzTfJE0VoLnkTuyxwkI4JPWuZvbhzKY8nB6e9TzXZydi8ms2SRmmG05B6120cPyLU46tbnlcetwDcRD5jtbGMVv+VgcEANjrWTaQOZAEQe9dJEENqi8lh2Nc+ISjJWOuhK8XcghgdZBgkqefpT7iE7wAasxFlAxyR603apRi5+Y+/SuXmd7m1r6GbNBubJwV71TKbMjPOe1atxGAPXoetZ0sYf5ixHNXFt7icUT/wBrzeaA4JVR19aqHVAbxmPyuezd60VsotoBYs5OeD2rD1uGNJwsP3iCeaiHI3ax9DFRcrI27e8UogDHnqqmus0u8BwCwGB0z0ry+C4khhXzEYSk444zXS6Dd+ZayuAfPXgljSxFFNXRzezlHdm9r2rqreXu3OAcYPSuE1O+8yOSPaScgHB45pdTuJZnBQHvu9TWPdvLHbrgHzGYg+5zitMPSjBI7IUdPU3dNu1VNrM20DGSap6rdrgJGeCeSaoqzi1UnPHyn3NUZXUSKzHdj+Inge1ehTgr3PGxVNuTY24u3h3fIQG4xVaG/dF+ZivoO5pkuoGa42RoGHTkcfWrjQwFgWjBYflmuhwujiVd0Xqjd0WV3jUN8wPPP1rrYGaZH53Z6c5xXIae3lgN1zXVWrssIyTk15mJpWZvTxPO7oyZ4FWcQ3a7QwO0t0pdPsbhLYyfZzNGpIDA84p3iBUmnsVlYj5+TmuwtzEtlEIAfLxx71m6koQTXU6qkotao4W6bzY3MUbxkfwkYNc5d+cGDKjZVsjFd7r8bSSxPbqNytg+4rJ1C3WNWYDDHqa7aVRSijgdqUuZGRaXjlgr5ZC3J71019ZPLagwlhhcDB/nXMKY49kk25S7CMbVLcn6Dp712Wn3Xl2oSQ78dO9Y4im004nXh8dZ3OLupTb4Ug7DwcD+dX4ZwLeGdJDkHlB6Vo3+mRai6hflJO7PTPvTLPQ47KYyXEwb/ZFJTVrM9KpjKU43T1LMky3NqCY+vf0rLt9InuJyRnbnjjtXSRG36IB5ZPGauwXdrEpVWUGhVpQVoI8WqoN3k9DLtdBjiHzkAgFiW4AA6/4/hV3Tkt5kLREMoPXH+e1Jqes2ZRoyd4b5Wx3rOttVtLeAQ267VLFj6sx7n8h+VRyVqivJGKqUobM3ZXRQduBis+7uTIgAJ5461SuL4lR6ZqKEmQjqcnmiNG2rKlXvohcMuSxznnmojcIr9PxNXpLdmiOemOKy7u3I27gBzya1U49TNxm1ctW6/aXznArRe2BRQp+UdfesqxkVGfBJAPArTDOYlIPB61MpXdyVexXlVEbagx2Y4qzG4AHt09aJzGQT0zxj1qAzBRwPmA9O1TbmQPQ0kmVTvbJP1qrdTmRyFztJ6moln83aWHHYU4urAjHTvS5eVjvzEMrKX9vQd6r3MxXG1SSPSpZQsTYJ5xVSaSOFgR99q0S6olvoyzbXZTLIckjHPaqd1OJpWA5OM5qzEgkyGz8wBNX7W0gIAKdOlSpxg72K9m5q1znWhcyE7vk+lXLew3ncO1bElpHg4Ufgad8sSkbVBxxkVUsS2tBQwyT1KKDyyOAO2K0bGIzA5UkZ6dsVXChzyQc/eIGMfhW1ajy4QoA+WuWtV0sjphTsRNbhCS3AHbtVK52KVAcb25GKk1K6GGQfjzWPCwS6EhJYnuadOnJrmZMpxvYuzNtDAtnHeqUtuGIJP4VbnlDHCjOapSSEYDkc81cLoJRUtj//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Acid fast stain of skin biopsy (x1000) from a patient with lepromatous leprosy shows numerous red acid-fast bacilli.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_45_19152=[""].join("\n");
var outline_f18_45_19152=null;
var title_f18_45_19153="Paracervical block OBS";
var content_f18_45_19153=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F51171&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F51171&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Paracervical block",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 419px; height: 366px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_45_19153=[""].join("\n");
var outline_f18_45_19153=null;
var title_f18_45_19154="Cromolyn sodium (ophthalmic): Pediatric drug information";
var content_f18_45_19154=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"9\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Cromolyn sodium (ophthalmic): Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?28/3/28723?source=see_link\">",
"    see \"Cromolyn sodium (ophthalmic): Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?16/46/17124?source=see_link\">",
"    see \"Cromolyn sodium (ophthalmic): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F8012001\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Opticrom&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F10579246\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?28/3/28723?source=see_link\">",
"      see \"Cromolyn sodium (ophthalmic): Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ophthalmic: Children &gt;4 years and Adults: Instill 1-2 drops 4-6 times/day",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F8012220\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, ophthalmic, as sodium [drops]: 4% (10 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F8012003\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F10579211\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Protect from light.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F10579206\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Vernal conjunctivitis, vernal keratoconjunctivitis, and vernal keratitis",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F8012106\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Conjunctival injection, dryness around the eye, edema, eye irritation, immediate hypersensitivity reactions, itchy eyes, puffy eyes, rash, styes, watery eyes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Dyspnea",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F10579207\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to cromolyn or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F10579209\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Patients should not wear contact lenses during treatment with ophthalmic solution.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299101\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F8012146\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F8043406\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F9770154\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were not observed in animal reproduction studies.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F10579244\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prevents the mast cell release of histamine, leukotrienes, and slow-reacting substance of anaphylaxis by inhibiting degranulation after contact with antigens",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F10579245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life: 80-90 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Elimination: Equally excreted unchanged in urine and feces (via bile)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15959 Version 21.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-89.218.100.194-DA315AB02B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_45_19154=[""].join("\n");
var outline_f18_45_19154=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8012001\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10579246\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8012220\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8012003\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10579211\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10579206\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8012106\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10579207\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10579209\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299101\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8012146\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8043406\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9770154\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10579244\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10579245\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/15959\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/15959|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?23/27/23987?source=related_link\">",
"      Cromolyn sodium (nasal): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?0/12/197?source=related_link\">",
"      Cromolyn sodium (nasal): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/24/35202?source=related_link\">",
"      Cromolyn sodium (nasal): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?28/3/28723?source=related_link\">",
"      Cromolyn sodium (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?16/46/17124?source=related_link\">",
"      Cromolyn sodium (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?17/12/17605?source=related_link\">",
"      Cromolyn sodium (systemic therapy and oral inhalation): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?28/53/29524?source=related_link\">",
"      Cromolyn sodium (systemic therapy and oral inhalation): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?27/63/28660?source=related_link\">",
"      Cromolyn sodium (systemic therapy and oral inhalation): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_45_19155="Ipratropium (nasal): Pediatric drug information";
var content_f18_45_19155=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Ipratropium (nasal): Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?21/7/21620?source=see_link\">",
"    see \"Ipratropium (nasal): Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?12/62/13284?source=see_link\">",
"    see \"Ipratropium (nasal): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9426949\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Atrovent&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F8120006\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Alti-Ipratropium;",
"     </li>",
"     <li>",
"      Apo-Ipravent&reg;;",
"     </li>",
"     <li>",
"      Atrovent&reg;;",
"     </li>",
"     <li>",
"      Mylan-Ipratropium Solution",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F10501612\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Anticholinergic Agent",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F10501618\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?21/7/21620?source=see_link\">",
"      see \"Ipratropium (nasal): Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children &gt;6 years and Adults: 0.03%: 2 sprays in each nostril 2-3 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children &gt;5 years and Adults: 0.06%: 2 sprays in each nostril 3-4 times/day",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F8120120\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, intranasal, as bromide [spray]: 0.03% (30 mL); 0.06% (15 mL) [delivers 42 mcg/spray; 165 sprays]; 0.06% (15 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Atrovent&reg;: 0.03% (30 mL) [contains benzalkonium chloride; delivers 21 mcg/spray; 345 sprays]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Atrovent&reg;: 0.06% (15 mL) [contains benzalkonium chloride; delivers 42 mcg/spray; 165 sprays]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F8120008\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F10501619\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Pump must be primed before usage by 7 actuations into the air away from the face; if not used for &gt;24 hours, pump must be reprimed with 2 actuations; if not used &gt;7 days, reprime with 7 actuations",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F10501616\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at room temperature.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F10501613\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Symptomatic relief of rhinorrhea associated with allergic and nonallergic rhinitis",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F8117605\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Atrovent&reg; may be confused with Alupent, Serevent&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Ipratropium may be confused with tiotropium",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F8120067\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Central nervous system: Headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea, nausea, taste perversion, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Respiratory: Epistaxis, pharyngitis, nasal congestion, nasal dryness, nasal irritation, upper respiratory tract infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Rare but important or life-threatening: Anaphylactic reaction, angioedema, blurred vision, conjunctivitis, cough, dizziness, hoarseness, laryngospasm, nasal burning, ocular irritation, palpitation, rash, tachycardia, thirst, tinnitus, urticaria",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F10501614\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to ipratropium, atropine, or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F10501615\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with narrow-angle glaucoma, bladder neck obstruction, or prostatic hypertrophy.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299540\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F8120070\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AbobotulinumtoxinA: Anticholinergic Agents may enhance the anticholinergic effect of AbobotulinumtoxinA.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): Anticholinergics may diminish the therapeutic effect of Acetylcholinesterase Inhibitors (Central). Acetylcholinesterase Inhibitors (Central) may diminish the therapeutic effect of Anticholinergics. If the anticholinergic action is a side effect of the agent, the result may be beneficial.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cannabinoids: Anticholinergic Agents may enhance the tachycardic effect of Cannabinoids.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirabegron: Anticholinergic Agents may enhance the therapeutic effect of Mirabegron. This may result in acute urinary retention.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     OnabotulinumtoxinA: Anticholinergic Agents may enhance the anticholinergic effect of OnabotulinumtoxinA.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Potassium Chloride: Anticholinergic Agents may enhance the ulcerogenic effect of Potassium Chloride.  Management: Patients on drugs with substantial anticholinergic effects should avoid using any solid oral dosage form of potassium chloride.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RimabotulinumtoxinB: Anticholinergic Agents may enhance the anticholinergic effect of RimabotulinumtoxinB.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Secretin: Anticholinergic Agents may diminish the therapeutic effect of Secretin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topiramate: Anticholinergic Agents may enhance the adverse/toxic effect of Topiramate. Specifically, the risk of oligohidrosis and hyperthermia may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F8119879\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F8119880\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal studies.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F10501617\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits secretions from the serous and seromucous glands lining the nasal mucosa",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F10501620\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?12/62/13284?source=see_link\">",
"      see \"Ipratropium (nasal): Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May cause dry mouth.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16002 Version 26.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-41.222.196.37-1E842E28B5-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_45_19155=[""].join("\n");
var outline_f18_45_19155=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9426949\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8120006\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10501612\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10501618\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8120120\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8120008\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10501619\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10501616\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10501613\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8117605\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8120067\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10501614\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10501615\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299540\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8120070\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8119879\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8119880\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10501617\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10501620\">",
"      Patient Information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/16002\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/16002|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?21/7/21620?source=related_link\">",
"      Ipratropium (nasal): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?12/62/13284?source=related_link\">",
"      Ipratropium (nasal): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?35/39/36469?source=related_link\">",
"      Ipratropium (oral inhalation): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?38/51/39732?source=related_link\">",
"      Ipratropium (oral inhalation): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?3/59/4021?source=related_link\">",
"      Ipratropium (oral inhalation): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_45_19156="Cornea vit A defic";
var content_f18_45_19156=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F72297&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F72297&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Xerosis of the cornea in vitamin A deficiency",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 376px; height: 541px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Corneal clouding from vitamin A deficiency in an unsupplemented child recovering from Kwashiorkor, taken at Instituto de Nutricion de Centroamerica y Panama (INCAP), Guatemala.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Interdepartmental Committee on Nutrition for National Defense (1963). Manual for Nutrition Surveys 2nd ed. Department of Health, Education and Welfare, Public Health Service, NIH, US Government Printing Office, Washington DC 1963.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_45_19156=[""].join("\n");
var outline_f18_45_19156=null;
var title_f18_45_19157="Developmental milestones 24 through 42 mos A";
var content_f18_45_19157=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F68086&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F68086&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 630px\">",
"   <div class=\"ttl\">",
"    Developmental milestones: 24 months through 3 years six months",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 610px; height: 652px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     &copy; 2007 Chris Johnson, MD, AAP Council on Children with Disabilities. Adapted with permission and contributions from: Frances Page Glascoe, PhD and Nicholas Robertshaw, authors of PEDS:Developmental Milestones; Franklin Trimm, MD, Vice Chair of Pediatrics, USA/APA Education Committee; the Center for Disease Control \"Act Early\" Initiative; the National Institute for Literacy/Reach Out and Read; and the Inventory of Early Development by Albert Brigance published by Curriculum Associates, Inc. Permission is granted to reproduce these pages on the condition that they are only used as guide to average development and not as a substitute for standardized validated screening for developmental-behavioral problems.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_45_19157=[""].join("\n");
var outline_f18_45_19157=null;
var title_f18_45_19158="Cross section of wrist";
var content_f18_45_19158=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F53265&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F53265&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 561px\">",
"   <div class=\"ttl\">",
"    Cross-sectional anatomy of the wrist",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 541px; height: 450px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This&nbsp;figure represents&nbsp;a cross sectional view of&nbsp;the right wrist.&nbsp;Tendons and median nerve may be compressed by inflammation or infection because they are encompassed by synovial sheath and flexor retinaculum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_45_19158=[""].join("\n");
var outline_f18_45_19158=null;
var title_f18_45_19159="Physiology and clinical course of asthma in pregnancy";
var content_f18_45_19159=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Physiology and clinical course of asthma in pregnancy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/45/19159/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/45/19159/contributors\">",
"     Steven E Weinberger, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/45/19159/contributors\">",
"     Michael Schatz, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/45/19159/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/45/19159/contributors\">",
"     Peter J Barnes, DM, DSc, FRCP, FRS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/45/19159/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/45/19159/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/45/19159/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/45/19159/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 8, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Asthma is the most common pulmonary disease encountered during pregnancy, occurring in 3 to 8 percent of pregnant women [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/1-8\">",
"     1-8",
"    </a>",
"    ]. Two questions about the interaction of asthma and pregnancy are raised by clinicians and patients alike:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      How does pregnancy affect asthma?",
"     </li>",
"     <li>",
"      How does asthma affect the outcomes of pregnancy?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The pathophysiology of asthma during pregnancy and the interrelationships of these two conditions will be reviewed here. The management of gestational asthma, the evaluation of dyspnea in pregnancy, and the changes in the respiratory system during pregnancy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29226?source=see_link\">",
"     \"Management of asthma during pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/33/39446?source=see_link\">",
"     \"Dyspnea during pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32340?source=see_link\">",
"     \"Respiratory tract changes during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     NORMAL PHYSIOLOGY DURING PREGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A review of maternal respiratory physiology during pregnancy is helpful in understanding the interrelationships between pregnancy and asthma. More detailed discussions of the normal physiologic changes in the cardiopulmonary system during pregnancy are presented separately. This review will emphasize those changes that directly impact or are influenced by co-existent asthma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32340?source=see_link\">",
"     \"Respiratory tract changes during pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/33/39446?source=see_link\">",
"     \"Dyspnea during pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20105?source=see_link\">",
"     \"Maternal cardiovascular and hemodynamic adaptations to pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Maternal pulmonary function",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spirometric evaluation of asthma in pregnant patients is similar to that of non-pregnant patients, as airway mechanics do not change significantly during pregnancy. Forced vital capacity (FVC), forced expiratory volume in one second (FEV",
"    <sub>",
"     1",
"    </sub>",
"    ),",
"    <span class=\"nowrap\">",
"     FEV",
"     <sub>",
"      1",
"     </sub>",
"     /FVC",
"    </span>",
"    ratio, and peak expiratory flow are stable to slightly increased in pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/9-14\">",
"     9-14",
"    </a>",
"    ]. As in non-pregnant patients, the diagnosis of asthma can be confirmed by demonstrating reversible airflow limitation before and after bronchodilator inhalation or before and after initiation of empiric treatment for asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/15\">",
"     15",
"    </a>",
"    ]. The diagnosis of asthma and the pharmacologic treatment of asthma during pregnancy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/1/19482?source=see_link\">",
"     \"Diagnosis of asthma in adolescents and adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/61/22487?source=see_link\">",
"     \"Use of pulmonary function testing in the diagnosis of asthma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29226?source=see_link\">",
"     \"Management of asthma during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although spirometry is minimally affected by pregnancy, some pulmonary function test measurements do change during pregnancy (",
"    <a class=\"graphic graphic_figure graphicRef80850 \" href=\"UTD.htm?17/37/18015\">",
"     figure 1",
"    </a>",
"    ). Vital capacity (VC) and total lung capacity (TLC) are usually preserved during pregnancy due to increased mobility and flaring of the ribs and unimpaired diaphragmatic excursion, although total lung capacity (TLC) may decrease slightly in the last trimester. In contrast, residual volume (RV) and functional residual capacity (FRC) normally decrease during gestation due to diaphragm elevation from the enlarging uterus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32340?source=see_link&amp;anchor=H5#H5\">",
"     \"Respiratory tract changes during pregnancy\", section on 'Functional changes in the respiratory tract during pregnancy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Maternal airway hyperresponsiveness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchoprovocation challenge is generally avoided during pregnancy, so limited data are available about maternal airway hyperresponsiveness during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/15\">",
"     15",
"    </a>",
"    ]. In a small prospective study of 16 asthmatic women, for example, the airways became less hyperreactive in most patients during pregnancy, as shown by measurements of the PC20 (ie, the dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/32/10756?source=see_link\">",
"     methacholine",
"    </a>",
"    needed to produce a 20 percent fall in FEV",
"    <sub>",
"     1",
"    </sub>",
"    ) (",
"    <a class=\"graphic graphic_figure graphicRef65099 \" href=\"UTD.htm?11/7/11389\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/16\">",
"     16",
"    </a>",
"    ]. These changes did not correspond to changes in the levels of estriol or progesterone. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/4/1098?source=see_link\">",
"     \"Bronchoprovocation testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Maternal arterial blood gases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Minute ventilation increases during pregnancy, presumably due to increased circulating levels of progesterone [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/17\">",
"     17",
"    </a>",
"    ]. The increase in minute ventilation, which exceeds metabolic demands, lowers alveolar and arterial tension of carbon dioxide (PaCO",
"    <sub>",
"     2",
"    </sub>",
"    ) while simultaneously increasing alveolar and arterial oxygen tension (PAO",
"    <sub>",
"     2",
"    </sub>",
"    and PaO",
"    <sub>",
"     2",
"    </sub>",
"    ). The resulting respiratory alkalosis induces secondary compensation through renal loss of bicarbonate. Thus, normal blood gases during pregnancy reveal a higher PaO",
"    <sub>",
"     2",
"    </sub>",
"    (100 to 106 mmHg [13.1 to 14.1 kPa]) and a lower PaCO",
"    <sub>",
"     2",
"    </sub>",
"    (28 to 30 mmHg [3.72 to 3.99 kPa]) than in the non-pregnant state, typically accompanied by a slightly alkalotic pH.",
"   </p>",
"   <p>",
"    During an acute asthma exacerbation, any associated changes in blood gases are superimposed on the \"normal\" respiratory alkalosis of pregnancy. Thus, a PaCO",
"    <sub>",
"     2",
"    </sub>",
"    &gt;35 mmHg (4.66 kPa) or a PaO",
"    <sub>",
"     2",
"    </sub>",
"    &lt;70 mmHg (9.31 kPa) associated with acute asthma represent more severe compromise during pregnancy than in the non-gravid state.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Fetal oxygenation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arterial oxygen tension PaO",
"    <sub>",
"     2",
"    </sub>",
"    in the fetus is only about one-third to one-fourth the PaO",
"    <sub>",
"     2",
"    </sub>",
"    in the adult [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/18\">",
"     18",
"    </a>",
"    ]. The fetus normally thrives at this low oxygen level due to a number of compensations, such as fetal hemoglobin and changes in the oxyhemoglobin dissociation curve. However, fetal oxygenation may be threatened in a number of ways that are potentially relevant to gestational asthma. First, maternal hypoxemia directly reduces oxygen supply to the fetus. Second, hypocapnia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    alkalosis itself may cause fetal hypoxia, although the exact mechanism is unclear. Finally, reduction in uterine blood flow (potentially due to exogenous or endogenous vasoconstrictors, dehydration, hypotension, or significant maternal alkalosis) may compromise fetal oxygenation.",
"   </p>",
"   <p>",
"    It appears that the fetus can compensate for hypoxemia in a number of ways, including redistribution of circulation to vital organs, decreased gross body movements, and increasing tissue oxygen extraction. The exact level and duration of fetal hypoxemia that exceed these compensatory mechanisms are not defined in humans. A common response to chronic hypoxia is deferment of growth needs in favor of vital functions, resulting in a small for gestational age fetus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     EFFECTS OF PREGNANCY ON ASTHMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical effect of pregnancy on asthma is variable [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/1,8,9,19,20\">",
"     1,8,9,19,20",
"    </a>",
"    ]. This was illustrated by a prospective study that followed 366 pregnancies in 330 asthmatic women [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/21\">",
"     21",
"    </a>",
"    ]. Asthma worsened during pregnancy in 35 percent, improved in 28 percent, and was unchanged in 33 percent; 4 percent were uncertain about a change.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     General trends",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most studies suggest that asthma severity prior to pregnancy is related to asthma severity during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/19,20,22-24\">",
"     19,20,22-24",
"    </a>",
"    ]. The following additional trends have been noted [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/21\">",
"     21",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Asthma was generally less severe during the last four weeks of pregnancy",
"     </li>",
"     <li>",
"      In women who improved, the improvement was gradual as pregnancy progressed",
"     </li>",
"     <li>",
"      In women whose asthma worsened, the increase in symptoms was most prominent between weeks 29 and 36 of gestation",
"     </li>",
"     <li>",
"      Substantial asthma symptoms were uncommon during labor and delivery",
"     </li>",
"     <li>",
"      The course of asthma in successive pregnancies in an individual patient tended to be similar",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Acute exacerbations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Asthma exacerbations occur in 20 to 36 percent of pregnant asthmatic patients [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/20,24\">",
"     20,24",
"    </a>",
"    ]. These exacerbations are not uniformly distributed over the course of pregnancy. In one observational study that followed 504 pregnant asthmatic patients, exacerbations occurred most frequently during weeks 17 through 24 of pregnancy (",
"    <a class=\"graphic graphic_figure graphicRef73070 \" href=\"UTD.htm?2/33/2590\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/25\">",
"     25",
"    </a>",
"    ]. A similar observational study of 146 patients revealed a peak incidence of severe asthma exacerbations during weeks 14 through 24 of pregnancy and a peak incidence of mild asthma exacerbations during weeks 25 through 32 of pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The reason for the unequal distribution of asthma exacerbations is unclear. It has been proposed that many women may decrease or stop taking their asthma medication shortly after becoming aware of the pregnancy, and this may lead to subsequent deterioration in asthma control [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/25\">",
"     25",
"    </a>",
"    ]. In particular, inadequate use of inhaled glucocorticoids may increase the risk of an asthma exacerbation. In one of the prospective studies mentioned above, only 4 percent of women taking inhaled glucocorticoids continuously from the start of pregnancy developed an acute attack, compared with 17 percent of women who were not [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     EFFECTS OF ASTHMA ON PREGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The available literature suggests that asthma may negatively impact various aspects of pregnancy, including perinatal mortality and several common complications of pregnancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Complications of pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of investigators have found that asthma during pregnancy is associated with an increased incidence of perinatal mortality and increased risks of hyperemesis, vaginal hemorrhage, preeclampsia, complicated labor, neonatal mortality, prematurity, hypertensive disorders, and low birthweight infants [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/26-38\">",
"     26-38",
"    </a>",
"    ]. However, such associations have not been found in all studies [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/35,39-41\">",
"     35,39-41",
"    </a>",
"    ]. The following large studies suggest a small but significant increase in the complications of pregnancy associated with asthma:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The largest study evaluated the outcome of 281,019 pregnancies: 37,585 pregnancies of women with asthma and 243,434 pregnancies of women without asthma [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/36\">",
"       36",
"      </a>",
"      ]. The pregnancies of women with asthma were more likely to be associated with miscarriage (OR 1.10, 95% CI 1.06-1.13), antepartum hemorrhage (OR 1.20, 95% CI 1.08-1.34), postpartum hemorrhage (OR 1.38, 95% CI 1.21-1.57), anemia (OR 1.06, 95% CI 1.01-1.12), depression (OR 1.52, 95% CI 1.36-1.69), or cesarean delivery (OR 1.11, 95% CI 1.07-1.16). There were no differences in stillbirths, therapeutic abortion, or most obstetrical complications (eg, placental abruption, preeclampsia, hypertension, diabetes). The outcomes of preterm births, low birth weight infants, and intrauterine growth retardation were not evaluated in this study.",
"     </li>",
"     <li>",
"      A retrospective cohort study examined the effect of asthma on 223,512 singleton pregnancies from 12 clinical centers in the United States [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/37\">",
"       37",
"      </a>",
"      ]. After adjusting for maternal age,",
"      <span class=\"nowrap\">",
"       race/ethnicity,",
"      </span>",
"      marital status, prepregnancy body mass index, smoking, alcohol use, comorbidities, and insurance status, women with asthma had higher odds of a number of complications of pregnancy, including preeclampsia (aOR 1.14, 95% CI 1.06-1.22), preterm birth (aOR, 1.17, 95% CI 1.12-1.23), and pulmonary embolism (aOR, 1.71, 95% CI 1.05-2.79).",
"     </li>",
"     <li>",
"      A study of 36,985 subjects found that asthmatic patients, on average, have a 15 to 20 percent increased risk of perinatal mortality, preeclampsia, preterm deliveries, or low birth weight infants compared to non-asthmatic women, and that patients with more severe asthma have a 30 to 100 percent increased risk (",
"      <a class=\"graphic graphic_table graphicRef59809 \" href=\"UTD.htm?19/27/19899\">",
"       table 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/38\">",
"       38",
"      </a>",
"      ]. No increased risk of congenital malformations was found in this study.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite these findings, neither the effect of pregnancy on asthma nor the effect of asthma on pregnancy should be considered a contraindication to pregnancy for patients with asthma. Furthermore, adequate therapy and good asthma control can probably minimize these complications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Possible causes of adverse outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three possible causes for these adverse pregnancy outcomes have been suggested [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/42\">",
"     42",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypoxia and other direct consequences of poorly controlled asthma &ndash; Direct consequences of asthma that could impair fetal oxygenation and uteroplacental blood flow include maternal hypoxemia, hypocapnia, and alkalosis, all of which can occur during an acute exacerbation of asthma. Diminished pulmonary function during pregnancy is associated with adverse perinatal outcomes, as observed in the following reports:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      An observational series of 2123 pregnant women with asthma demonstrated that decreased gestational maternal forced expiratory volume in one second (FEV",
"      <sub>",
"       1",
"      </sub>",
"      ) was associated with gestational hypertension and preterm birth compared to women with a normal FEV",
"      <sub>",
"       1",
"      </sub>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another series found a modest increased risk (OR 1.48, 95 % CI 1.04-2.09) of congenital malformations in the infants of asthmatic women experiencing an exacerbation during the first trimester of pregnancy compared to infants of asthmatic mothers not experiencing an exacerbation [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Factors related to both asthma and pregnancy &ndash; A factor associated with asthma that could influence pregnancy would be polymorphisms of the beta-2 adrenergic receptor, as these could contribute both to asthma and preterm labor. However, the clinical significance of this association is unclear [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/45\">",
"       45",
"      </a>",
"      ]. Links between bronchial hyperreactivity and uterine muscle hyperreactivity (preterm birth) and vascular hyperreactivity (preeclampsia) have been reported in women with asymptomatic airway hyperresponsiveness, but the clinical significance of these associations is also unclear [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19159/abstract/46,47\">",
"       46,47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Complications of asthma medications &mdash; Complications of medications used for the treatment of asthma are reviewed in detail elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29226?source=see_link\">",
"       \"Management of asthma during pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/21/18770?source=see_link\">",
"       \"Patient information: Asthma and pregnancy (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?38/63/39925?source=see_link\">",
"       \"Patient information: Asthma treatment in adolescents and adults (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?14/20/14660?source=see_link\">",
"       \"Patient information: Asthma and pregnancy (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?30/25/31124?source=see_link\">",
"       \"Patient information: Trigger avoidance in asthma (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?31/6/31841?source=see_link\">",
"       \"Patient information: How to use a peak flow meter (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?28/25/29075?source=see_link\">",
"       \"Patient information: Asthma inhaler techniques in adults (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H357491\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The forced vital capacity (FVC), forced expiratory volume in one second (FEV",
"      <sub>",
"       1",
"      </sub>",
"      ),",
"      <span class=\"nowrap\">",
"       FEV",
"       <sub>",
"        1",
"       </sub>",
"       /FVC",
"      </span>",
"      ratio, and peak expiratory flow do not change significantly during normal pregnancy. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Maternal pulmonary function'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Residual volume (RV) and functional residual capacity (FRC) decrease during pregnancy, while total lung capacity (TLC) decreases only slightly in the last trimester (",
"      <a class=\"graphic graphic_figure graphicRef80850 \" href=\"UTD.htm?17/37/18015\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Maternal pulmonary function'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Minute ventilation increases during pregnancy, associated with increased tidal volume, presumably due to increased circulating levels of progesterone. Thus, normal pregnancy is associated with a compensated respiratory alkalosis. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Maternal arterial blood gases'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Arterial blood gases obtained during pregnancy normally reveal a higher arterial oxygen tension (PaO",
"      <sub>",
"       2",
"      </sub>",
"      ) in the range of 100 to 106 mmHg (13.1 to 14.1 kPa) and a lower arterial carbon dioxide tension (PaCO",
"      <sub>",
"       2",
"      </sub>",
"      ) in the range of 28 to 30 mmHg (3.72 to 3.99 kPa), compared with the non-pregnant state. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Maternal arterial blood gases'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of asthma during pregnancy is based on the demonstration of reversible airflow obstruction by spirometry. However, bronchoprovocation challenge is usually avoided during pregnancy. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Maternal pulmonary function'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/1/19482?source=see_link\">",
"       \"Diagnosis of asthma in adolescents and adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/61/22487?source=see_link\">",
"       \"Use of pulmonary function testing in the diagnosis of asthma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In general, asthma worsens during pregnancy in a third of patients, improves in a third, and is unchanged in a third. However, other studies suggest that asthma severity prior to pregnancy is related to asthma severity during pregnancy. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Effects of pregnancy on asthma'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Asthma exacerbations affect 20 to 36 percent of pregnant asthmatic patients and tend to occur during the middle trimester. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Acute exacerbations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Gestational asthma is associated with a relatively small but statistically significant increase in pregnancy complications, such as perinatal mortality, preeclampsia, and preterm delivery. However, appropriate therapy and good asthma control probably minimize these complications. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Effects of asthma on pregnancy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29226?source=see_link\">",
"       \"Management of asthma during pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/1\">",
"      Murphy VE, Gibson PG, Smith R, Clifton VL. Asthma during pregnancy: mechanisms and treatment implications. Eur Respir J 2005; 25:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/2\">",
"      Namazy JA, Schatz M. Pregnancy and asthma: recent developments. Curr Opin Pulm Med 2005; 11:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/3\">",
"      Tan KS, Thomson NC. Asthma in pregnancy. Am J Med 2000; 109:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/4\">",
"      Alexander S, Dodds L, Armson BA. Perinatal outcomes in women with asthma during pregnancy. Obstet Gynecol 1998; 92:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/5\">",
"      Liccardi G, Cazzola M, Canonica GW, et al. General strategy for the management of bronchial asthma in pregnancy. Respir Med 2003; 97:778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/6\">",
"      Blaiss MS, Food and Drug Administration (U.S.), ACAAI-ACOG(American College of Allergy, Asthma, and Immunology and American College of Obstetricians and Gynecologists.). Management of rhinitis and asthma in pregnancy. Ann Allergy Asthma Immunol 2003; 90:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/7\">",
"      Demoly P, Piette V, Daures JP. Asthma therapy during pregnancy. Expert Opin Pharmacother 2003; 4:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/8\">",
"      Kwon HL, Belanger K, Bracken MB. Asthma prevalence among pregnant and childbearing-aged women in the United States: estimates from national health surveys. Ann Epidemiol 2003; 13:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/9\">",
"      Nelson-Piercy C. Asthma in pregnancy. Thorax 2001; 56:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/10\">",
"      Sroczyski T. [Evaluation of respiratory tract function in healthy women in the last month of uncomplicated pregnancy]. Ann Acad Med Stetin 2002; 48:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/11\">",
"      Grindheim G, Toska K, Estensen ME, Rosseland LA. Changes in pulmonary function during pregnancy: a longitudinal cohort study. BJOG 2012; 119:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/12\">",
"      Stenius-Aarniala B, Piiril&auml; P, Teramo K. Asthma and pregnancy: a prospective study of 198 pregnancies. Thorax 1988; 43:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/13\">",
"      Weinberger SE, Weiss ST, Cohen WR, et al. Pregnancy and the lung. Am Rev Respir Dis 1980; 121:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/14\">",
"      Milne JA, Mills RJ, Howie AD, Pack AI. Large airways function during normal pregnancy. Br J Obstet Gynaecol 1977; 84:448.",
"     </a>",
"    </li>",
"    <li>",
"     Management of asthma during pregnancy: Report of the Working Group on Asthma and Pregnancy NIH Publication No. 93-3279. National Asthma Education Program; National Institutes of Health, Bethesda, MD, 1993.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/16\">",
"      Juniper EF, Daniel EE, Roberts RS, et al. Improvement in airway responsiveness and asthma severity during pregnancy. A prospective study. Am Rev Respir Dis 1989; 140:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/17\">",
"      Wise RA, Polito AJ, Krishnan V. Respiratory physiologic changes in pregnancy. Immunol Allergy Clin North Am 2006; 26:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/18\">",
"      Cousins L. Fetal oxygenation, assessment of fetal well-being, and obstetric management of the pregnant patient with asthma. J Allergy Clin Immunol 1999; 103:S343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/19\">",
"      Gluck JC. The change of asthma course during pregnancy. Clin Rev Allergy Immunol 2004; 26:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/20\">",
"      Schatz M, Dombrowski MP, Wise R, et al. Asthma morbidity during pregnancy can be predicted by severity classification. J Allergy Clin Immunol 2003; 112:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/21\">",
"      Schatz M, Harden K, Forsythe A, et al. The course of asthma during pregnancy, post partum, and with successive pregnancies: a prospective analysis. J Allergy Clin Immunol 1988; 81:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/22\">",
"      Gluck JC, Gluck P. The effects of pregnancy on asthma: a prospective study. Ann Allergy 1976; 37:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/23\">",
"      Williams, DA. Asthma and pregnancy. Acta Allergol 1967; 22:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/24\">",
"      Murphy VE, Gibson P, Talbot PI, Clifton VL. Severe asthma exacerbations during pregnancy. Obstet Gynecol 2005; 106:1046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/25\">",
"      Stenius-Aarniala BS, Hedman J, Teramo KA. Acute asthma during pregnancy. Thorax 1996; 51:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/26\">",
"      Gordon M, Niswander KR, Berendes H, Kantor AG. Fetal morbidity following potentially anoxigenic obstetric conditions. VII. Bronchial asthma. Am J Obstet Gynecol 1970; 106:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/27\">",
"      Bahna SL, Bjerkedal T. The course and outcome of pregnancy in women with bronchial asthma. Acta Allergol 1972; 27:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/28\">",
"      Perlow JH, Montgomery D, Morgan MA, et al. Severity of asthma and perinatal outcome. Am J Obstet Gynecol 1992; 167:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/29\">",
"      Schatz M, Zeiger RS, Hoffman CP. Intrauterine growth is related to gestational pulmonary function in pregnant asthmatic women. Kaiser-Permanente Asthma and Pregnancy Study Group. Chest 1990; 98:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/30\">",
"      Lehrer S, Stone J, Lapinski R, et al. Association between pregnancy-induced hypertension and asthma during pregnancy. Am J Obstet Gynecol 1993; 168:1463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/31\">",
"      Triche EW, Saftlas AF, Belanger K, et al. Association of asthma diagnosis, severity, symptoms, and treatment with risk of preeclampsia. Obstet Gynecol 2004; 104:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/32\">",
"      Liu S, Wen SW, Demissie K, et al. Maternal asthma and pregnancy outcomes: a retrospective cohort study. Am J Obstet Gynecol 2001; 184:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/33\">",
"      Breton MC, Beauchesne MF, Lemi&egrave;re C, et al. Risk of perinatal mortality associated with asthma during pregnancy. Thorax 2009; 64:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/34\">",
"      Murphy VE, Namazy JA, Powell H, et al. A meta-analysis of adverse perinatal outcomes in women with asthma. BJOG 2011; 118:1314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/35\">",
"      Mihrshahi S, Belousova E, Marks GB, et al. Pregnancy and birth outcomes in families with asthma. J Asthma 2003; 40:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/36\">",
"      Tata LJ, Lewis SA, McKeever TM, et al. A comprehensive analysis of adverse obstetric and pediatric complications in women with asthma. Am J Respir Crit Care Med 2007; 175:991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/37\">",
"      Mendola P, Laughon SK, M&auml;nnist&ouml; TI, et al. Obstetric complications among US women with asthma. Am J Obstet Gynecol 2013; 208:127.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/38\">",
"      K&auml;ll&eacute;n B, Rydhstroem H, Aberg A. Asthma during pregnancy--a population based study. Eur J Epidemiol 2000; 16:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/39\">",
"      Dombrowski MP, Schatz M, Wise R, et al. Asthma during pregnancy. Obstet Gynecol 2004; 103:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/40\">",
"      Schatz M, Zeiger RS, Hoffman CP, et al. Perinatal outcomes in the pregnancies of asthmatic women: a prospective controlled analysis. Am J Respir Crit Care Med 1995; 151:1170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/41\">",
"      Minerbi-Codish I, Fraser D, Avnun L, et al. Influence of asthma in pregnancy on labor and the newborn. Respiration 1998; 65:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/42\">",
"      Schatz M. Asthma and pregnancy. Lancet 1999; 353:1202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/43\">",
"      Schatz M, Dombrowski MP, Wise R, et al. Spirometry is related to perinatal outcomes in pregnant women with asthma. Am J Obstet Gynecol 2006; 194:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/44\">",
"      Blais L, Forget A. Asthma exacerbations during the first trimester of pregnancy and the risk of congenital malformations among asthmatic women. J Allergy Clin Immunol 2008; 121:1379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/45\">",
"      Landau R, Xie HG, Dishy V, et al. beta2-Adrenergic receptor genotype and preterm delivery. Am J Obstet Gynecol 2002; 187:1294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/46\">",
"      Bertrand JM, Riley SP, Popkin J, Coates AL. The long-term pulmonary sequelae of prematurity: the role of familial airway hyperreactivity and the respiratory distress syndrome. N Engl J Med 1985; 312:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19159/abstract/47\">",
"      Siddiqui S, Goodman N, McKenna S, et al. Pre-eclampsia is associated with airway hyperresponsiveness. BJOG 2008; 115:520.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 555 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-61.234.146.186-239B17CE44-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_45_19159=[""].join("\n");
var outline_f18_45_19159=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H357491\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      NORMAL PHYSIOLOGY DURING PREGNANCY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Maternal pulmonary function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Maternal airway hyperresponsiveness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Maternal arterial blood gases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Fetal oxygenation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      EFFECTS OF PREGNANCY ON ASTHMA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      General trends",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Acute exacerbations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      EFFECTS OF ASTHMA ON PREGNANCY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Complications of pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Possible causes of adverse outcomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H357491\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/555\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/555|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/37/18015\" title=\"figure 1\">",
"      Pulmonary function in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/7/11389\" title=\"figure 2\">",
"      Methacholine test in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/33/2590\" title=\"figure 3\">",
"      Asthma attacks during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/555|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/27/19899\" title=\"table 1\">",
"      Eur study preg result asthma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/4/1098?source=related_link\">",
"      Bronchoprovocation testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/1/19482?source=related_link\">",
"      Diagnosis of asthma in adolescents and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/33/39446?source=related_link\">",
"      Dyspnea during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29226?source=related_link\">",
"      Management of asthma during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20105?source=related_link\">",
"      Maternal cardiovascular and hemodynamic adaptations to pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?14/20/14660?source=related_link\">",
"      Patient information: Asthma and pregnancy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/21/18770?source=related_link\">",
"      Patient information: Asthma and pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/25/29075?source=related_link\">",
"      Patient information: Asthma inhaler techniques in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/63/39925?source=related_link\">",
"      Patient information: Asthma treatment in adolescents and adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/6/31841?source=related_link\">",
"      Patient information: How to use a peak flow meter (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/25/31124?source=related_link\">",
"      Patient information: Trigger avoidance in asthma (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32340?source=related_link\">",
"      Respiratory tract changes during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/61/22487?source=related_link\">",
"      Use of pulmonary function testing in the diagnosis of asthma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_45_19160="Screening for cervical cancer in resource-limited settings";
var content_f18_45_19160=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Screening for cervical cancer in resource-limited settings",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/45/19160/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/45/19160/contributors\">",
"     Lynette Denny, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/45/19160/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/45/19160/contributors\">",
"     Barbara Goff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/45/19160/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/45/19160/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/45/19160/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cervical cancer is the most common malignancy among women in the developing world, and more than 85 percent of worldwide cervical cancer deaths occur in these settings [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/1\">",
"     1",
"    </a>",
"    ]. Effective strategies for cervical cancer screening and treatment of cervical intraepithelial neoplasia, a precursor to cancer, have been in place for more than 70 years and, where applied, have dramatically reduced the incidence of and mortality from this disease [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, standard strategies such as cervical cytology, human papillomavirus testing, and colposcopy, are often not possible in developing settings due to economic and other infrastructure issues. Health care resources and disease burden vary between and within countries, making it difficult to draw general conclusions regarding screening strategies for the entire developing world. Addressing individual countries is beyond the scope of this topic review. Therefore, cervical cancer screening in health care systems in which cytology or colposcopy are not feasible will be reviewed here.",
"   </p>",
"   <p>",
"    The general approach to and tests used for cervical cancer screening are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/16/38154?source=see_link\">",
"     \"Screening for cervical cancer: Rationale and recommendations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/32/35337?source=see_link\">",
"     \"Cervical cancer screening tests: Techniques and test characteristics of cervical cytology and human papillomavirus testing\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/36/25156?source=see_link\">",
"     \"Cervical cancer screening tests: Visual inspection methods\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among women worldwide, cervical cancer comprises 12 percent of all cancers and is the third most common cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/1\">",
"     1",
"    </a>",
"    ]. Over 85 percent of new cases are diagnosed in the developing world, and in these countries, it is the most common cancer in women. The following links provide global rates of cervical cancer in 2008 from the World Health Organization&rsquo;s GLOBOCAN database:",
"    <a class=\"external\" href=\"file://globocan.iarc.fr/map.asp?selection=4152&amp;title=Cervix+uteri&amp;sex=2&amp;type=0&amp;statistic=2&amp;map=5&amp;window=1&amp;size=1&amp;colour=1&amp;scale=0&amp;submit=&nbsp;Execute&nbsp;\">",
"     incidence",
"    </a>",
"    and",
"    <a class=\"external\" href=\"file://globocan.iarc.fr/map.asp?cancer=6162&amp;selection=4152&amp;title=Cervix+uteri&amp;sex=2&amp;type=1&amp;statistic=2&amp;map=5&amp;window=1&amp;size=1&amp;colour=1&amp;scale=0&amp;submit=&nbsp;Execute&nbsp;\">",
"     mortality",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    This difference in incidence in developed versus developing countries is illustrated in the relative rates of cervical and breast cancer. In 2000, international estimates of the number of diagnoses in the previous five years of cervical cancer was 1,401,400 compared with 3,860,300 breast cancer cases; of these diagnoses, the number in developing countries were 1,064,000 and 1,522,000, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     BARRIERS TO CERVICAL CANCER SCREENING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Barriers to implementing programs for cervical cancer prevention include competing health care demands, economic, social, and political issues.",
"   </p>",
"   <p>",
"    The principal health care issues that compete with cervical cancer prevention are maternal and infant mortality and infectious diseases (eg, tuberculosis, malaria, and human immunodeficiency virus [HIV]). The challenges facing health care systems worldwide are illustrated by the following. In 2002, there were 510,000 deaths (0.9 percent of the total deaths) attributed to maternal conditions, 2,464,000 deaths (4.3 percent of total deaths) due to perinatal conditions worldwide. Although cervical cancer is prevalent, it caused fewer deaths (239,000 deaths; 0.4 percent of total deaths) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/5\">",
"     5",
"    </a>",
"    ]. HIV infection is particularly important, since it is not only a competing health priority in some regions, but also exacerbates cervical neoplasia. In addition, with the scarcity of health care resources, existing health care services tend to focus on curative, rather than preventive, health care. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/4/36934?source=see_link\">",
"     \"Screening for cervical cancer in HIV infected women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Economic factors also present an obstacle to screening. Developing countries account for 84 percent of the global population, 90 percent of the disease burden, 20 percent of gross domestic product, but only 12 percent of health spending [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/6\">",
"     6",
"    </a>",
"    ]. The disparity in per capita expenditure on health in developed versus developing countries is stark. Yearly per capita expenditure on health in the United States in 2006 was $5711, $3809 in Switzerland, and $2389 in the United Kingdom. In contrast, in developing countries, annual per capita expenditures ranged from $14 in the Democratic Republic of Congo to $64 in Nepal [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/7\">",
"     7",
"    </a>",
"    ]. Standard cervical cancer screening methods, such as cytology or colposcopy, are costly.",
"   </p>",
"   <p>",
"    Social and political conditions in low resource settings often impede cervical cancer screening programs. Reliable and affordable modes of communication and transportation are often lacking. Therefore, women are often not able to travel to a screening site for an initial or follow-up visit or to receive results in a timely manner. Education and literacy also make an impact. Women in poor countries may be illiterate or may use a local dialect that differs from the national language. Thus, they may not be able to read written results. Also, women are likely to be uninformed about interventions such as cervical cancer screening, and thus there is no public demand and no political motivation to establish screening programs. War and civil strife are endemic in many poor countries and are another factor that may have devastating consequences for health care infrastructure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     APPROACH TO CERVICAL CANCER SCREENING",
"    </span>",
"    &nbsp;&mdash;&nbsp;In countries that have introduced successful cervical cancer screening programs, cervical cancer has become a relatively rare disease. In most developed countries, the Age Standardized Incidence Rate (ASIR) for cervical cancer is less than",
"    <span class=\"nowrap\">",
"     10/100,000,",
"    </span>",
"    whereas in developing countries, the ASIR of cervical cancer ranges from 25 to",
"    <span class=\"nowrap\">",
"     55/100,000",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cytologic screening with or without human papillomavirus (HPV) DNA testing has led to vast improvements in prevention and early detection of cervical cancer. Evidence of the effectiveness of this approach has led to the adoption of cervical cytology screening in all developed and some developing nations. The standard approach to cervical cancer screening in developed settings is to use cytology, typically in some combination with HPV testing, follow with colposcopy, and then treat based on the results of colposcopic results. This approach requires three visits with communication of test results after each step.",
"   </p>",
"   <p>",
"    Unfortunately, due to the barriers discussed in the preceding section, the success of the approach used in developing countries has not been replicated in developing countries. Cytology-based screening programs require a relatively sophisticated and costly infrastructure, including highly trained personnel, built-in quality control, ongoing training of staff, adequately equipped laboratories, and functional referral systems to communicate results of the test to women. HPV testing is costly, and when used as a triage test, adds an extra processing step to cervical cytology. Women, in turn, need to be able to return for further testing if indicated. Additionally, colposcopy requires a level of clinical expertise typically found only in tertiary health care facilities, if available at all, and histology requires a laboratory infrastructure and trained pathologists, all of which are in short supply in poor countries.",
"   </p>",
"   <p>",
"    A recent study estimated that 63 percent of women in developed countries receive cervical cancer screening, with an upper range of 80 to 90 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/9\">",
"     9",
"    </a>",
"    ]. The comparative figure in developing countries is 19 percent, ranging from 1 percent in Bangladesh, Ethiopia and Myanmar to 73 percent in Brazil.",
"   </p>",
"   <p>",
"    Human papillomavirus vaccines, another approach for cervical cancer prevention, are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/17/19738?source=see_link\">",
"     \"Recommendations for the use of human papillomavirus vaccines\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     General principles",
"    </span>",
"    &nbsp;&mdash;&nbsp;Creating a functional cervical cancer screening program in a low resource setting must include consideration of the screening test and its characteristics and also address the limitation of health care access and infrastructure. Ideal characteristics of a cervical cancer screening test used in a such settings include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Can be performed in a primary health care facility",
"     </li>",
"     <li>",
"      Can be performed by trained nurses or paramedical staff, particularly where there are few or no physicians",
"     </li>",
"     <li>",
"      Requires little technology and staff training to perform, process, and interpret",
"     </li>",
"     <li>",
"      Test result should be either immediate (eg, visual screening methods such as visual inspection with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/36/19011?source=see_link\">",
"       acetic acid",
"      </a>",
"      [VIA]) or be available within several hours (eg, rapid result HPV testing)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Performing screening and treatment at the same visit, thereby eliminating the intermediate steps of colposcopy and histological sampling, is another strategy that can avoid patient noncompliance with follow-up and reduce the overall costs of cervical cancer prevention (see",
"    <a class=\"local\" href=\"#H17\">",
"     'Screen and treat protocols'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Screening frequency and patient age",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women in developed countries are often screened for cervical cancer every one to three years. However, this screening frequency is not possible in most low resource settings. Decisions regarding screening frequency must be made based upon available resources. In programs in which women will receive screening only once or twice in a lifetime, screening should focus on the age range that will result in the largest reduction in cervical cancer incidence and mortality.",
"   </p>",
"   <p>",
"    The greatest impact on cervical cancer reduction appears to result from screening women aged 30 to 39 years. This is supported by a subgroup analysis from a randomized trial in which over 80,000 women aged 30 to 59 in India were assigned to either VIA screening or cervical cancer health education [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/10\">",
"     10",
"    </a>",
"    ]. At seven-year follow-up, women in the screening group showed a significant decrease in age-standardized rates of cervical cancer incidence (25 percent) and mortality (35 percent); these decreases were greater in women aged 30 to 39 (incidence: 38 percent and mortality: 66 percent) compared with other age ranges (40 to 49 years: 18 and 45 percent; 50 to 59 years: 24 and 1 percent).",
"   </p>",
"   <p>",
"    Optimal screening frequency and patient age have also been calculated using modeling studies, since longitudinal clinical data are not available. One such modeling study used clinical data from India, Thailand, Kenya, South Africa, and Peru to evaluate cervical cancer screening in women once in a lifetime at the age of 35 years [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/11\">",
"     11",
"    </a>",
"    ]. Within these parameters, screening with VIA or HPV testing would reduce the lifetime risk of cervical cancer by 25 to 36 percent and cost less than US $500 per year of life saved. Costs of the various protocols varied from country to country.",
"   </p>",
"   <p>",
"    By contrast, using cytology as the screening method in the United States, one study estimated that, compared with no screening, screening every three years costs $22,000 per year of life gained [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/12\">",
"     12",
"    </a>",
"    ]. Increasing the frequency of screening to every two years would cost $440,000 for every additional year of life gained, whereas annual screening would cost $1.8 million for each additional year.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Challenges to evaluating screening tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Determination of the performance of a screening test depends on the reference standard used. The gold standard typically used for cervical cancer screening tests is colposcopic-directed biopsy (biopsy of areas with suspicious colposcopic findings). Use of this standard tends to overestimate sensitivity, since false negative colposcopy will result in missing some cervical neoplasia. Few studies use random cervical biopsies as the reference standard [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     VISUAL INSPECTION METHODS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Historically, visual inspection of the cervix without magnification was the first method of screening of the cervix. It was introduced in the 1930s by Schiller, who used Lugol's iodine [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/14\">",
"     14",
"    </a>",
"    ]. It was, however, soon realized that this method of screening had a low specificity, and Schiller's test, as it was known, was rapidly replaced when cervical cytology became available.",
"   </p>",
"   <p>",
"    In contrast with colposcopy, visual inspection of the cervix is performed using the naked eye. Visual inspection is also referred to as direct visual inspection or cervicoscopy. This technique has reemerged as a screening tool for low resource settings because, despite its limited specificity, it is economical, requires little equipment, and provides immediate results [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/15\">",
"     15",
"    </a>",
"    ]. Visual inspection can be performed with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/36/19011?source=see_link\">",
"     acetic acid",
"    </a>",
"    or Lugol's iodine (VILI).",
"   </p>",
"   <p>",
"    Primary care clinicians or midlevel providers can be trained to perform visual inspection within a relatively short period of time; however, due to the subjective nature of the test, it is difficult to standardize quality control. The technique for performing these tests is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/36/25156?source=see_link\">",
"     \"Cervical cancer screening tests: Visual inspection methods\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Visual inspection with acetic acid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use of VIA screening followed by treatment reduces the rate of cervical cancer compared with no screening. This was best illustrated in the only randomized trial to address use of this test in a low resource setting. Clinics serving over 80,000 women aged 30 to 59 in India were assigned to either VIA screening or cervical cancer health education [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/10\">",
"     10",
"    </a>",
"    ]. Women with positive screening tests were further evaluated with colposcopy and directed biopsy, and those with CIN were treated with cryotherapy or excision. At seven-year follow-up, women in the screening group versus the health education group showed a significant decrease in age-standardized rates of cervical cancer incidence (75 versus 99 per 100,000 person-years) and mortality (40 versus 57 per 100,000 person-years).",
"   </p>",
"   <p>",
"    The sensitivity and specificity of VIA in developing countries for detection of CIN or cervical cancer has been evaluated in multiple observational studies [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/15-25\">",
"     15-25",
"    </a>",
"    ]. The highest quality data are reported in a meta-analysis of 11 studies with over 58,000 women aged 25 to 64 years in India and Africa. Each woman underwent VIA and one or more other screening tests; the reference standard was colposcopic-directed biopsy performed in all women [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/25\">",
"     25",
"    </a>",
"    ]. For detection of CIN 2 or a more severe abnormality (CIN2+), VIA had a sensitivity and specificity of 79 and 85 percent, respectively.",
"   </p>",
"   <p>",
"    Coexisting vaginal or cervical infection with Trichomonas vaginalis, Chlamydia trachomatis, or Neisseria gonorrhoeae did not alter the sensitivity or specificity of VIA for CIN2+ in a cross-sectional study of 2754 women in South Africa [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/23\">",
"     23",
"    </a>",
"    ]. However, there was a significant decrease in VIA specificity in women with HIV infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     VIA with magnification",
"    </span>",
"    &nbsp;&mdash;&nbsp;The addition of magnification to VIA (VIAM) does not improve the detection of CIN or cervical cancer over VIA with the naked eye. This was best illustrated by a meta-analysis of three studies that included over 18,000 women aged 25 to 65 years who were evaluated with both VIA and VIAM; colposcopy with directed cervical biopsy was used as the reference standard [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/26\">",
"     26",
"    </a>",
"    ]. For detection of CIN2+, there were no significant differences in the sensitivity and specificity for VIA (60 and 87 percent) versus VIAM (64 and 87 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Visual inspection with Lugol's iodine",
"    </span>",
"    &nbsp;&mdash;&nbsp;VILI is more sensitive than VIA, but equally specific. It is however, used less commonly than VIA [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/25,27\">",
"     25,27",
"    </a>",
"    ]. In our experience, VIA allows a more nuanced and more detailed analysis of the dysplastic area. In the meta-analysis of 11 studies described in a preceding section, women were evaluated with both VIA and VILI is 10 studies [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/25\">",
"     25",
"    </a>",
"    ]. For detection of CIN 2+ the sensitivity and specificity for VILI were 91 and 85 percent (compared with 79 and 85 percent for VIA) (see",
"    <a class=\"local\" href=\"#H9\">",
"     'Visual inspection with acetic acid'",
"    </a>",
"    above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     HPV TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;HPV testing used alone or in combination with VIA has the potential to improve cervical cancer screening in low resource settings. Unfortunately, it is not feasible to use the current HPV tests used in developed countries due to expense, the infrastructure required for processing, and waiting time for results. However, advances in HPV testing technology are under investigation with the goal of addressing these obstacles.",
"   </p>",
"   <p>",
"    This section will focus on the clinical utility of HPV DNA testing in low-resource settings. The general use of HPV DNA testing for cervical cancer screening is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/16/38154?source=see_link&amp;anchor=H11#H11\">",
"     \"Screening for cervical cancer: Rationale and recommendations\", section on 'HPV testing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    HPV testing reduces cervical cancer mortality in developing settings and is superior to VIA or cervical cytology. This was illustrated in a randomized trial of 131,746 women aged 30 to 59 years in rural India that compared a single lifetime screening with one of three screening modalities with standard care; the screening modalities were: HPV testing using the Hybrid Capture II test [HC2], cervical cytology, or VIA [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/28\">",
"     28",
"    </a>",
"    ]. At eight-year follow-up, women who received HPV testing versus standard care had a 50 percent reduction in stage II or higher cervical cancer (15 versus 33 per 100,000 person-year) and cervical cancer mortality (13 versus 26 per 100,000 person-year). For the groups screened by cytology or VIA, rates of stage II or higher cervical cancer (VIA: 32 per 100,000 person-year; cytology: 23 per 100,000 person-year) or cervical cancer mortality (VIA: 21 per 100,000 person-year; cytology: 21 per 100,000 person-year) did not differ significantly compared with standard care, but were significantly higher than women in the HPV testing group. This result for VIA differed from the finding of the trial in 80,000 women described above; the authors attributed this difference to a higher rate of treatment in that trial (see",
"    <a class=\"local\" href=\"#H9\">",
"     'Visual inspection with acetic acid'",
"    </a>",
"    above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Rapid result HPV test",
"    </span>",
"    &nbsp;&mdash;&nbsp;While these results are promising, the HPV tests (eg, HC2) used in developed countries are prohibitively expensive for low resource settings (in the United States the cost per test is approximately $50 to 100) and the waiting time for a result of one or more days [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/29\">",
"     29",
"    </a>",
"    ] is an additional impediment to patient follow-up. However, data are emerging regarding a new HPV test (careHPV) that is affordable, gives results quickly, and is portable. Each test will cost less than US $5, the processing kit has its own reagents and water supply and can be run using batteries, and the result is available within 2.5 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/30\">",
"     30",
"    </a>",
"    ]. The new test detects 14 high-risk types of HPV, similar to the 14 or 18 types detected by the tests used in developed countries. This test is not yet commercially available.",
"   </p>",
"   <p>",
"    The rapid result HPV test appears to perform as well for the detection of high grade cervical neoplasia as standard HPV testing, and to be superior to VIA. The single study that has evaluated the rapid result test was a cross-sectional study of 2388 women in China aged 30 to 54 [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/31\">",
"     31",
"    </a>",
"    ]. Each woman was assessed using with a self-collected vaginal specimen (for careHPV testing), VIA, and a provider-collected cervical specimen (for careHPV, HC2, and cervical cytology); colposcopic-directed biopsy was performed in all women and used as the reference standard. HC2 testing showed no significant difference in detection of CIN2+ versus provider-collected careHPV, but was superior to self-collected careHPV (sensitivity and specificity, HC2: 97 and 86 percent, provider-careHPV: 90 and 84 percent; self-careHPV: 81 and 82 percent). On the other hand, VIA was inferior to either a provider-collected or self-collected careHPV for detecting CIN2+ (sensitivity and specificity, VIA: 41 and 95 percent). Direct comparison of collection method for careHPV revealed no significant difference in CIN2+ detection between provider- and self-collected samples.",
"   </p>",
"   <p>",
"    These data are promising and indicate that rapid result HPV testing may be suitable for performing screening and treatment on the same day in low resource settings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Increasing HPV test specificity",
"    </span>",
"    &nbsp;&mdash;&nbsp;HPV testing has a high sensitivity, but a low specificity. Specificity takes on added importance in low resource settings whether follow-up for a positive test is further evaluation or immediate treatment. Additional costs are incurred when women with false positive screening tests are referred for a costly test like colposcopy. Also, where treatment is performed based on a screening test, low test specificity may result in large numbers of women being treated unnecessarily.",
"   </p>",
"   <p>",
"    One approach to the low specificity of HPV testing is to change the definition of a positive test. In the case of HPV testing, the definition of a positive test can be varied by changing the positivity threshold (expressed as the ratio of light emission, ie, relative light units [RLU] per positive control specimen [PC]). As for most tests, increasing the specificity results in a decrease in sensitivity. This was illustrated in a study of over 2900 women in South Africa in which detection of CIN2+ by HC2 at a threshold of &gt;1",
"    <span class=\"nowrap\">",
"     RLU/PC",
"    </span>",
"    (the typical standard) had a sensitivity of 88 percent and specificity of 82 percent, while a threshold of &gt;8",
"    <span class=\"nowrap\">",
"     RLU/PC",
"    </span>",
"    had a sensitivity of 79 percent and specificity of 90 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Self-collected samples",
"    </span>",
"    &nbsp;&mdash;&nbsp;For women who do not have access to a speculum examination or who are reluctant to undergo a pelvic examination, self-collected vaginal samples can be used for HPV testing [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/33\">",
"     33",
"    </a>",
"    ]. Women can collect samples from the vagina using a tampon, Dacron or cotton swab, cytobrush, or cervicovaginal lavage. Self-collection can be performed under supervision at a clinic or at home. If a women collects a sample at home, it is then placed in a collection tube with a transport medium and brought back to the clinic for processing.",
"   </p>",
"   <p>",
"    Self-collected samples were compared with clinician-collected sampled in a meta-analysis of 18 studies with 5441 women in which women collected vaginal samples for HPV testing [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/34\">",
"     34",
"    </a>",
"    ]. The analysis found a high concordance (0.87) between results of self- and physician-collected samples. Studies that evaluated acceptability reported that women preferred self- versus physician-sampling. A limitation of this analysis was that many of the included studies were conducted among a referral population of women with known or suspected cervical disease; therefore, a high HPV prevalence may impact the results.",
"   </p>",
"   <p>",
"    Further study is needed to determine the best method of self-collection (eg, swab, cervical brush, tampon). This question was addressed in an earlier meta-analysis, which included 12 of the same studies as the analysis described above and used physician-collected HPV samples as a reference standard [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/35\">",
"     35",
"    </a>",
"    ]. For seven studies that used a Dacron or cotton swab or a cytobrush, the pooled sensitivity and specificity for HPV detection were 78 and 90 percent. For three studies in which a tampon was used, the results are reported as a range of sensitivities (67 to 94 percent) and specificities (80 to 100 percent). These data do not allow comparison among the methods.",
"   </p>",
"   <p>",
"    Self-collected HPV testing (with a cervical brush) was compared with cervical cytology performed at a clinic in a randomized trial of 12,330 women in Mexico [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/36\">",
"     36",
"    </a>",
"    ]. The acceptability of self-collected HPV testing was high, 98 percent of women in the HPV testing group agreed to collect the sample and performed the testing, while 89 percent of those scheduled for a Pap test had the test performed. HPV testing had a higher sensitivity for detection of CIN2+ (relative sensitivity 2.9, 95% CI 2.0&ndash;4.1) and for invasive cancer (3.6, 95% CI 1.6-7.9). The disadvantage of HPV testing was that more women underwent colposcopy and ultimately had negative findings: 28 percent in the HPV testing group compared none in the cytology group. For CIN2+, the positive predictive value of HPV testing was 12.2 percent compared with 90.5 percent for cytology.",
"   </p>",
"   <p>",
"    Given these data, self-collection appears to be a useful method for HPV testing in women who do not have access to a speculum examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     COMBINING TWO SCREENING TESTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Combining two screening tests (eg, VIA and HPV testing) is one approach to balancing the strengths and weaknesses of each test. Two-test strategies can be either: additive, with screen positive defined as an abnormal result on either test considered screen positive; or sequential, in which only women with an abnormal result on the first test undergo a second test, and only those who are also positive on the second test would receive treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/37\">",
"     37",
"    </a>",
"    ]. The goal is to maximize screening performance by combining a test with high sensitivity (eg, VIA) with another test with high specificity (eg, HPV testing with use of a high threshold for positivity) (see",
"    <a class=\"local\" href=\"#H14\">",
"     'Increasing HPV test specificity'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    Use of a two-test approach to screening increased specificity, but decreased sensitivity in a prospective observational study of 1266 South African women aged 35 to 65 years. Each woman underwent screening with Hybrid Capture I HPV testing and VIA; VIAM, cervicography (a photograph of the cervix after application of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/36/19011?source=see_link\">",
"     acetic acid",
"    </a>",
"    ), and cytology were also performed. Women with abnormal results on any of the screening tests underwent colposcopy at a follow-up visit [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/38\">",
"     38",
"    </a>",
"    ]. Based on study results, use of VIA or HPV alone would result in a missed diagnosis of CIN2+ in 6 or 8 per 1000 women screened, respectively, while 180 or 131 per 1000 would receive unnecessary treatment. Sequential use of VIA followed by HPV would result in a missed CIN2+ diagnosis in 13 per 1000 women screened, while 41 per 1000 would receive unnecessary treatment.",
"   </p>",
"   <p>",
"    Given these results, it appears that it is preferable to use a combination of the two screening tests rather than either test alone. The number of missed diagnoses is notable, but does not outweigh the large decrease in the number women who would receive unnecessary treatment. Complications are rare with cryotherapy, the predominant method of treatment for CIN used in developing settings. However, unnecessary treatment also incurs costs, which may reduce the number of total women who can be screening within a particular program. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/19/44343?source=see_link\">",
"     \"Cervical intraepithelial neoplasia: Ablative therapies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SCREEN AND TREAT PROTOCOLS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A screening test followed in the same visit by treatment of women with positive results is referred to as a \"screen and treat\" protocol. This approach is only possible with screening tests that produce immediate results (eg, visual inspection, rapid result HPV testing). One-visit protocols eliminate communication difficulties involved in delivering and interpreting written results for patients as well as the issue of noncompliance with follow-up, in contrast with protocols that require two visits (screening followed by treatment) or three visits (screening followed by colposcopy followed by treatment).",
"   </p>",
"   <p>",
"    The ability of screen and treat protocols, specifically with use of HPV testing, to reduce the rate of high-grade CIN or cancer was demonstrated in a randomized trial of 6555 previously unscreened women in South Africa, aged 35 to 65 years [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/39\">",
"     39",
"    </a>",
"    ]. All women were screened with VIA, HC2 HPV testing, and cytology and were randomized to one of three groups: VIA screen positive followed by cryotherapy; HPV screen positive followed by cryotherapy; or no further evaluation or treatment for six months. All women also underwent HIV testing. At six-month follow-up, colposcopy with directed biopsy was performed in all women and CIN2+ was found in significantly fewer women in both the VIA and HPV screen and treat groups (2.2 and 0.8 percent, respectively) versus the delayed group (3.6 percent). This difference persisted in a subset of 2708 women who were evaluated at 12 months, with a rate of CIN2+ for VIA and HPV versus the delayed group of 2.9 and 1.4 percent versus 5.4 percent.",
"   </p>",
"   <p>",
"    Treatment based on results of screening tests with low specificity, such as VIA and HPV testing, will result in some women receiving unnecessary treatment. However, cryotherapy, the preferred treatment in developing setting, has a low complication rate [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/40\">",
"     40",
"    </a>",
"    ]. In this trial, adverse effects reported by women who underwent cryotherapy included vaginal discharge (78 percent), abdominal pain (30 percent), and abnormal bleeding (14 percent); only one woman had bleeding that required hospitalization [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/39\">",
"     39",
"    </a>",
"    ]. Women who underwent cryotherapy had more unscheduled visits during the study period than those who did not (1.0 versus 0.5 percent).",
"   </p>",
"   <p>",
"    This study is limited by the protocol used, since screening was followed two to six days later by treatment in the screen and treat groups, while a one-visit approach is generally an important component of screen and treat protocols. In fact, 82 women did not return after the initial screening visit.",
"   </p>",
"   <p>",
"    Cost-effectiveness is also likely to be improved with one-visit screen and treat protocols than those requiring two or more visits. The data regarding cost derives from studies based on mathematical modeling rather than clinical studies. In one such report, based on a theoretical cohort of previously unscreened 30 year-old black South African women, a single visit in which screen-positive VIA or HPV testing is coupled with cryotherapy would be more cost effective than two visit protocols with HPV or cytology (lifetime cost per woman US $39 to 41 versus $42 to 44) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19160/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cervical cancer is the most common malignancy among women in the developing world and more than 80 percent of worldwide cervical cancer deaths occur in these settings. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cervical cancer screening strategies such as cervical cytology and colposcopy are not feasible in many low resource setting due to economic, social, and political issues. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Barriers to cervical cancer screening'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Strategies for cervical cancer screening in low resource settings include use of tests that are performed in a primary care facility by trained nurses or paramedical staff, require little equipment, technology and staff training to perform, process, and interpret, and provide immediate results. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'General principles'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women in whom cervical cancer screening will be performed once in a lifetime, we suggest screening between the ages of 30 and 39 years rather than other age ranges (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Screening frequency and patient age'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women who are able to access a screening program that involves two or more visits, we suggest HPV testing in and visual inspection used in a sequential combination rather than either test alone (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). If one test is used, we suggest HPV testing rather than visual inspection (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Visual inspection methods'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'HPV testing'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16\">",
"       'Combining two screening tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Visual inspection is the only method available for women who are only able to access a screening program for one visit. A rapid result HPV test is under development not yet commercially available. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Visual inspection methods'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'HPV testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women screened using human papillomavirus (HPV) testing who do not have access to a speculum examination, we suggest self-collection of vaginal samples rather than clinician-collected samples (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). There is insufficient evidence regarding the best method for self-collection (eg, swab, cytobrush, cervicovaginal lavage). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Self-collected samples'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women screened using visual inspection, we suggest VIA rather than VILI (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We suggest visual inspection with the naked eye rather than with magnification (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Visual inspection with Lugol's iodine'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'VIA with magnification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Screen and treat protocols, in which a screening test is followed in the same visit by treatment of women with positive results, eliminate communication difficulties involved in delivering and interpreting written results for patients as well as the issue of noncompliance with follow-up. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Screen and treat protocols'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/1\">",
"      Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/2\">",
"      Quinn M, Babb P, Jones J, Allen E. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ 1999; 318:904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/3\">",
"      Willoughby BJ, Faulkner K, Stamp EC, Whitaker CJ. A descriptive study of the decline in cervical screening coverage rates in the North East and Yorkshire and the Humber regions of the UK from 1995 to 2005. J Public Health (Oxf) 2006; 28:355.",
"     </a>",
"    </li>",
"    <li>",
"     Ferlay J, et al. GLOBOCAN 2000. In: Cancer incidence, mortality and prevalence worldwide, IARC Cancer Base - No 5 (Ed), IARC Press, Lyon, France 2001. Vol Version 1.0.",
"    </li>",
"    <li>",
"     file://www.infoplease.com/ipa/A0933893.html (Accessed on April 21, 2011).",
"    </li>",
"    <li>",
"     The burden of disease and mortality by condition: Data, Methoda and Results for the year 2001 file://www.ncbi.nlm.nih.gov/books/NBK11808/ (Accessed on April 21, 2011).",
"    </li>",
"    <li>",
"     file://www.infoplease.com/science/health/expenditures-country-2006.html (Accessed on April 21, 2011).",
"    </li>",
"    <li>",
"     Cancer Incidence in Five Continents - Volume VIII. In: IARC Scientific Publications no. 155, DM Parkin, SL Whelan, J Ferlay, L Teppo, DB Thomas (Eds), International Agencey for Research on Cancer, Lyon, France 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/9\">",
"      Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med 2008; 5:e132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/10\">",
"      Sankaranarayanan R, Esmy PO, Rajkumar R, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet 2007; 370:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/11\">",
"      Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 2005; 353:2158.",
"     </a>",
"    </li>",
"    <li>",
"     Screening for cervical cancer. In: Common screening tests, Eddy DM (Ed), American College of Physicians, Philadelphia 1991. p.255.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/13\">",
"      Pretorius RG, Bao YP, Belinson JL, et al. Inappropriate gold standard bias in cervical cancer screening studies. Int J Cancer 2007; 121:2218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/14\">",
"      Schiller W. Leucoplakia, leucokeratosis, and carcinoma of the cervix. Am J Obstet Gynecol 1938; 35:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/15\">",
"      Sankaranarayanan R, Shyamalakumary B, Wesley R, et al. Visual inspection with acetic acid in the early detection of cervical cancer and precursors. Int J Cancer 1999; 80:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/16\">",
"      Cecchini S, Bonardi R, Mazzotta A, et al. Testing cervicography and cervicoscopy as screening tests for cervical cancer. Tumori 1993; 79:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/17\">",
"      Ottaviano M, La Torre P. Examination of the cervix with the naked eye using acetic acid test. Am J Obstet Gynecol 1982; 143:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/18\">",
"      Megevand E, Denny L, Dehaeck K, et al. Acetic acid visualization of the cervix: an alternative to cytologic screening. Obstet Gynecol 1996; 88:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/19\">",
"      Sankaranarayanan R, Wesley R, Somanathan T, et al. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors. Cancer 1998; 83:2150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/20\">",
"      Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary-care setting. University of Zimbabwe/JHPIEGO Cervical Cancer Project. Lancet 1999; 353:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/21\">",
"      Denny L, Kuhn L, Pollack A, et al. Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer 2000; 89:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/22\">",
"      Belinson JL, Pretorius RG, Zhang WH, et al. Cervical cancer screening by simple visual inspection after acetic acid. Obstet Gynecol 2001; 98:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/23\">",
"      Denny L, Kuhn L, Pollack A, Wright TC Jr. Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance. Cancer 2002; 94:1699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/24\">",
"      Cronj&eacute; HS, Parham GP, Cooreman BF, et al. A comparison of four screening methods for cervical neoplasia in a developing country. Am J Obstet Gynecol 2003; 188:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/25\">",
"      Arbyn M, Sankaranarayanan R, Muwonge R, et al. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer 2008; 123:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/26\">",
"      Sankaranarayanan R, Shastri SS, Basu P, et al. The role of low-level magnification in visual inspection with acetic acid for the early detection of cervical neoplasia. Cancer Detect Prev 2004; 28:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/27\">",
"      Sangwa-Lugoma G, Mahmud S, Nasr SH, et al. Visual inspection as a cervical cancer screening method in a primary health care setting in Africa. Int J Cancer 2006; 119:1389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/28\">",
"      Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009; 360:1385.",
"     </a>",
"    </li>",
"    <li>",
"     Crum C, Harvard University, 2009, personal communication.",
"    </li>",
"    <li>",
"     file://www1.qiagen.com/about/pressreleases/PressReleaseView.aspx?PressReleaseID=217 (Accessed on April 21, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/31\">",
"      Qiao YL, Sellors JW, Eder PS, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008; 9:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/32\">",
"      Kuhn L, Denny L, Pollack A, et al. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst 2000; 92:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/33\">",
"      G&ouml;k M, Heideman DA, van Kemenade FJ, et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ 2010; 340:c1040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/34\">",
"      Petignat P, Faltin DL, Bruchim I, et al. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol 2007; 105:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/35\">",
"      Ogilvie GS, Patrick DM, Schulzer M, et al. Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis. Sex Transm Infect 2005; 81:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/36\">",
"      Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet 2011; 378:1868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/37\">",
"      Goldie SJ, Kuhn L, Denny L, et al. Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. JAMA 2001; 285:3107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/38\">",
"      Denny L, Kuhn L, Risi L, et al. Two-stage cervical cancer screening: an alternative for resource-poor settings. Am J Obstet Gynecol 2000; 183:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/39\">",
"      Denny L, Kuhn L, De Souza M, et al. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA 2005; 294:2173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19160/abstract/40\">",
"      Gaffikin L, Blumenthal PD, Emerson M, et al. Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project. Lancet 2003; 361:814.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3202 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-FBD0C7583D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_45_19160=[""].join("\n");
var outline_f18_45_19160=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      BARRIERS TO CERVICAL CANCER SCREENING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      APPROACH TO CERVICAL CANCER SCREENING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      General principles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Screening frequency and patient age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Challenges to evaluating screening tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      VISUAL INSPECTION METHODS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Visual inspection with acetic acid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - VIA with magnification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Visual inspection with Lugol's iodine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      HPV TESTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Rapid result HPV test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Increasing HPV test specificity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Self-collected samples",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      COMBINING TWO SCREENING TESTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SCREEN AND TREAT PROTOCOLS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/32/35337?source=related_link\">",
"      Cervical cancer screening tests: Techniques and test characteristics of cervical cytology and human papillomavirus testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/36/25156?source=related_link\">",
"      Cervical cancer screening tests: Visual inspection methods",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/19/44343?source=related_link\">",
"      Cervical intraepithelial neoplasia: Ablative therapies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/17/19738?source=related_link\">",
"      Recommendations for the use of human papillomavirus vaccines",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/4/36934?source=related_link\">",
"      Screening for cervical cancer in HIV infected women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/16/38154?source=related_link\">",
"      Screening for cervical cancer: Rationale and recommendations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_45_19161="Approach to congenital malformations";
var content_f18_45_19161=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to congenital malformations",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/45/19161/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/45/19161/contributors\">",
"     Carlos A Bacino, MD, FACMG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/45/19161/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/45/19161/contributors\">",
"     Helen V Firth, DM, FRCP, DCH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/45/19161/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/45/19161/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/45/19161/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 9, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Major congenital malformations occur in approximately 3 to 4 percent of live births, although minor anomalies are more frequent. Birth defects can be isolated or present in a characteristic combination or pattern.",
"   </p>",
"   <p>",
"    The terminology related to congenital malformations and an approach to the evaluation of a child with a birth defect is reviewed here. The etiology of birth defects and principles of teratology are discussed in detail elsewhere (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/13/7386?source=see_link\">",
"     \"Genetic and environmental causes of birth defects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/7/19574?source=see_link\">",
"     \"Principles of teratology\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HISTORICAL BACKGROUND",
"    </span>",
"    &nbsp;&mdash;&nbsp;In ancient times, birth defects were believed to result from the action of supernatural forces [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/1\">",
"     1",
"    </a>",
"    ]. They were viewed as manifestations of evil, and sometimes as signs of God's warnings for impending disasters. Even though the perception of birth defects differs from culture to culture, it has been attributed mostly to negative forces. These concepts have evolved from ancient times until the present, although superstitions persist in many cultures.",
"   </p>",
"   <p>",
"    A more systematic study of birth defects began in the mid-twentieth century. This coincided with the recognition of the teratogenic effects of exposures to rubella infections and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?41/42/42664?source=see_link\">",
"     thalidomide",
"    </a>",
"    during pregnancy.",
"   </p>",
"   <p>",
"    The term dysmorphology was coined in the 1960s to define the study of abnormal features. This term is used to encompass the variability of normal physical traits, as well as pathologic features resulting from abnormal development. An individual with unusual physical features is said to be dysmorphic. Experts in dysmorphology are trained to describe patterns of abnormal traits and establish a diagnostic hypothesis based upon their appearance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     TERMINOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific terms are used to describe congenital abnormalities. The terms indicate how the anomalies were caused (",
"    <a class=\"graphic graphic_table graphicRef57394 \" href=\"UTD.htm?7/8/7307\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Malformations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malformations are defects of organs or body parts due to an intrinsically abnormal developmental process. In this process, a structure is not formed, is partially formed, or is formed in an abnormal fashion.",
"   </p>",
"   <p>",
"    Malformations often result from a defect in embryonic development. Thus, most occur prior to the eighth week after conception. However, malformations can also occur in body structures that form after this time, such as the central nervous system, external and internal genitalia, and teeth.",
"   </p>",
"   <p>",
"    Malformations can result from genetic or environmental forces. An example of the former is a mutation in HOXD13, a homeobox gene that causes a combination of syndactyly and polydactyly (synpolydactyly) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/2\">",
"     2",
"    </a>",
"    ]. An example of the latter is retinoic acid, which can cause anomalies, such as microtia and central nervous system defects, including polymicrogyria and hydrocephalus [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Major",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malformations can be classified as major and minor. Major malformations are those that have medical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    social implications. These often require surgical repair. As an example, the neural tube defects, such as meningomyelocele or orofacial clefting (cleft lip and palate), are common major malformations (",
"    <a class=\"graphic graphic_table graphicRef82547 \" href=\"UTD.htm?3/23/3453\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33767?source=see_link\">",
"     \"Pathophysiology and clinical manifestations of myelomeningocele (spina bifida)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/34/44581?source=see_link\">",
"     \"Facial clefts and holoprosencephaly\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The prevalence of major malformations depends upon the population surveyed and the method of ascertainment. In a report from the Mainz congenital birth defect monitoring system, standardized physical and sonographic examinations were performed in 30,940 liveborn and stillborn infants and abortions from 1990 to 1998 [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/4\">",
"     4",
"    </a>",
"    ]. Major malformations were identified in 2144 (6.9 percent).",
"   </p>",
"   <p>",
"    Diverse molecular mechanisms lead to major malformations. The defects may interfere with many normal processes, such as apoptosis (cell death), abnormal migration of neural cell crest derivatives, intracellular signaling, and chromatin modeling.",
"   </p>",
"   <p>",
"    The following are examples of genes and proteins involved in specific malformations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/13/7386?source=see_link\">",
"     \"Genetic and environmental causes of birth defects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Homeobox genes &mdash; Synpolydactyly (combinations of syndactyly and polydactyly), microphthalmia, holoprosencephaly",
"     </li>",
"     <li>",
"      Transcription factors &mdash; Conotruncal heart defects in DiGeorge syndrome, (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=see_link\">",
"       \"DiGeorge syndrome: Epidemiology and pathogenesis\"",
"      </a>",
"      ), campomelic dysplasia (a rare skeletal dysplasia caused by mutations in",
"      <em>",
"       SOX9",
"      </em>",
"      )",
"     </li>",
"     <li>",
"      Fibroblast growth factor receptors &mdash; Craniosynostoses, such as Pfeiffer syndrome, Crouzon syndrome, and Apert syndrome (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/18/8487?source=see_link\">",
"       \"Craniosynostosis syndromes\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Enzyme defects &mdash; Defects in cholesterol biosynthesis in Smith-Lemli-Opitz syndrome",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Minor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Minor malformations have mostly cosmetic significance. They rarely are medically significant or require surgical intervention. They represent part of the normal variation in the general population. Examples of minor anomalies include ear tags, clinodactyly (incurving of the fifth finger) (",
"    <a class=\"graphic graphic_picture graphicRef54831 \" href=\"UTD.htm?11/40/11904\">",
"     picture 1",
"    </a>",
"    ), and single transverse palmar creases (",
"    <a class=\"graphic graphic_table graphicRef78729 graphicRef55104 \" href=\"UTD.htm?31/9/31901\">",
"     table 3A-B",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Minor anomalies are common, although estimates of their prevalence vary with the population studied and the method of ascertainment. In the Mainz congenital birth defect monitoring survey noted above, mild errors of morphogenesis were diagnosed in 11,104 of 30,940 infants (35.8 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/4\">",
"     4",
"    </a>",
"    ]. In a study from 1964 limited to examination of newborn infants, 14 percent had a single minor anomaly; two and three or more minor malformations occurred in 0.8 and 0.5 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/5\">",
"     5",
"    </a>",
"    ]. Approximately 50 percent of minor anomalies are located in the head and neck [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Infants with three or more minor anomalies are at increased risk of having a major defect or syndrome. In two reports, a major malformation was present in 26 and 19.6 percent of infants with three or more minor anomalies [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Deformations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deformations are abnormalities of the position of body parts due to extrinsic intrauterine mechanical forces that modify a normally formed structure [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/9\">",
"     9",
"    </a>",
"    ]. Intrauterine forces, such as decreased amniotic fluid, uterine tumors, and uterine malformations (eg, bicornuate or septated uterus) can lead to fetal compression. Deformations can also occur with fetal crowding due to multiple gestations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/60/27594?source=see_link\">",
"     \"Neonatal outcome, complications, and management of multiple births\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Examples of common deformations include clubfoot, congenital dysplasia of the hip, and plagiocephaly (lopsided or flattened skull due to compression). These often can be corrected by physical therapy, casting, or the use of a special helmet to remodel the skull while the fontanelles are still open. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/37/10841?source=see_link&amp;anchor=H21#H21\">",
"     \"Overview of craniosynostosis\", section on 'Positional flattening (positional plagiocephaly)'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/23/33141?source=see_link&amp;anchor=H13#H13\">",
"     \"Prenatal diagnosis of talipes equinovarus (clubfoot)\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Disruptions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disruptions are defects of organs or body parts that result from destruction of or interference with normal development. Destruction can result from vascular, infection, or mechanical processes that lead to tissue compromise, such as compression, strangulation, hemorrhage, or thrombosis. Most cases of disruption are single events that are sporadic rather than inherited. Thus, their recurrence risk is very low.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Amniotic band sequence",
"    </span>",
"    &nbsp;&mdash;&nbsp;The amniotic band sequence (ABS) is a group of structural abnormalities that involve mostly the limbs, but also may affect the craniofacial region and trunk. ABS occurs in association with amniotic bands, but the mechanism of amniotic band formation and the pathogenesis of ABS are not firmly established. ABS is perhaps the most common example of intrauterine disruption. The specific malformations caused depend upon the time of the disruption. The typical appearance consists of amputations and malformations caused by the encircling constrictions of the limbs or other body structures, but the clinical spectrum is highly variable. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/2/36902?source=see_link\">",
"     \"Amniotic band sequence\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Dysplasias",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dysplasias refer to anomalies that result from the abnormal organization of cells into tissues. An example is abnormal growth of bone resulting in skeletal dysplasias, such as achondroplasia. This disorder is caused by mutations in the fibroblast growth factor receptor 3 gene, leading to abnormalities in endochondral ossification [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     PATTERNS OF DEFECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple malformations are often grouped in a recognizable pattern as follows (",
"    <a class=\"graphic graphic_table graphicRef75281 \" href=\"UTD.htm?6/33/6683\">",
"     table 4",
"    </a>",
"    ):",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;A syndrome is a pattern of anomalies that occur together and are pathogenetically related.",
"   </p>",
"   <p>",
"    Syndromes with a known cause include Turner syndrome or monosomy of the X chromosome. Patients with this disorder typically have short stature, neck webbing, shield-like chest, underdevelopment of the secondary sexual characteristics, and infertility. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/42/33449?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Syndromes with no known cause include Aicardi syndrome, for example. This is an X-linked dominant disorder characterized by a classical triad that includes agenesis of the corpus callosum, chorioretinal lacunae, and seizures. It is seen in females and lethal in males [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some syndromes are inherited, such as Marfan syndrome or achondroplasia. Other congenital malformation syndromes may appear to be nongenetic and have a very low recurrence risk. An example is Cornelia-de Lange syndrome (also called Brachman-de Lange syndrome), which is characterized by severe growth retardation, microcephaly, limb anomalies, distinctive dysmorphic features, and profound intellectual disability (mental retardation). Cornelia-de Lange syndrome is caused by mutations of the nipped-B-like (NIPBL) gene in approximately 50 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/12\">",
"     12",
"    </a>",
"    ]. This is an example of a sporadic disorder. Patients with Cornelia-de Lange syndrome do not reproduce; therefore the disorder falsely appears to be nongenetic even though it is caused by an autosomal dominant mutation. Similarly, other disorders that occur sporadically may represent new mutations of autosomal or even X-linked genes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Sequence",
"    </span>",
"    &nbsp;&mdash;&nbsp;A sequence is a pattern of anomalies in which a single known defect in development causes a cascade of subsequent abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Potter sequence is an example of this group of disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. This disorder is caused by oligohydramnios secondary to renal agenesis or other renal anomalies that reduce fetal urine output production. The decreased volume of amniotic fluid restricts fetal movements, resulting in characteristic anomalies. These include flat facies, depression of the nasal tip, abnormal ear folding, wrinkled skin, and malposition of the feet, including clubfoot deformities. Pulmonary hypoplasia is often associated with the external deformities. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16296?source=see_link\">",
"     \"Prenatal diagnosis of renal agenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another example is Prune-belly sequence, in which patients have severe abdominal defects due to lack of the major abdominal muscles. This disorder occurs in a male fetus when a urethral malformation or obstruction leads to a distended bladder that interferes with timely closure of the abdominal wall.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Developmental field defect",
"    </span>",
"    &nbsp;&mdash;&nbsp;A field defect is a pattern of anomalies caused by disturbance of a region of the embryo that develops in a contiguous physical space. This region is known as a developmental field [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Holoprosencephaly is a classic example of a developmental field defect. The clinical manifestations are variable. They range from very severe cases with almost absent forebrain to milder manifestations, such as a single central incisor. Although there are many etiologies for holoprosencephaly, the primary defect is the lack of normal induction by the prechordal mesoderm on the forebrain, resulting in abnormal cleavage of the embryonic forebrain. Craniofacial structures also are affected because the embryonic forebrain also influences mesodermal processes on the mid-face. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/34/44581?source=see_link\">",
"     \"Facial clefts and holoprosencephaly\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bladder exstrophy and cloacal exstrophy represent another developmental field defect. These conditions include urinary, genital, gastrointestinal, and orthopedic abnormalities. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/24/24966?source=see_link\">",
"     \"Clinical manifestations and initial management of infants with bladder exstrophy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Association",
"    </span>",
"    &nbsp;&mdash;&nbsp;An association is defined as two or more anomalies that are not pathogenetically related and occur together more frequently than expected by chance. In general, the etiology of associations is not defined. It is possible that some represent developmental field defects [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Examples of this pattern include the VATER or VACTERL association. These are acronyms for a group of typical associated anomalies. VACTERL association includes",
"    <strong>",
"     V",
"    </strong>",
"    ertebral anomalies,",
"    <strong>",
"     A",
"    </strong>",
"    nal atresia,",
"    <strong>",
"     C",
"    </strong>",
"    ardiac defects,",
"    <strong>",
"     TE",
"    </strong>",
"    fistula (tracheoesophageal fistula),",
"    <strong>",
"     R",
"    </strong>",
"    enal defects, and",
"    <strong>",
"     L",
"    </strong>",
"    imb defects [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/18\">",
"     18",
"    </a>",
"    ]. Because anomalies in these associations tend to occur together more frequently, the finding of one abnormality should prompt the clinician to look for related anomalies. For example, a child born with an imperforate anus should be evaluated for vertebral and renal anomalies that occur together in VACTERL association.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causes of congenital anomalies are genetic and nongenetic [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/1\">",
"     1",
"    </a>",
"    ]. Genetic abnormalities include chromosomal disorders (eg, Down syndrome); single gene (monogenic) disorders, including those that are autosomal recessive (eg, cystic fibrosis), autosomal dominant (eg, Marfan syndrome), or X-linked (eg, hemophilia); and multifactorial disorders that result from the interaction of multiple genes and environmental factors. The latter include cleft",
"    <span class=\"nowrap\">",
"     lip/palate,",
"    </span>",
"    congenital heart disease, and neural tube defects. Nongenetic etiologies include environmental factors, such as maternal phenylketonuria (PKU) or diabetes, teratogens (eg, alcohol, oral",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/33/19991?source=see_link\">",
"     isotretinoin",
"    </a>",
"    ), infections (CMV, rubella), and twinning. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/13/7386?source=see_link\">",
"     \"Genetic and environmental causes of birth defects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/60/27594?source=see_link\">",
"     \"Neonatal outcome, complications, and management of multiple births\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Frequency",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rate of various etiologies was identified in a report of surveillance for congenital malformations performed in 69,277 infants of gestational age &ge;20 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/19\">",
"     19",
"    </a>",
"    ]. The proportions of anomalies were",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Not known &mdash; 43.1 percent",
"     </li>",
"     <li>",
"      Multifactorial &mdash; 22.8 percent",
"     </li>",
"     <li>",
"      Familial &mdash; 14.4 percent",
"     </li>",
"     <li>",
"      Chromosomal &mdash; 10.1 percent",
"     </li>",
"     <li>",
"      Single gene &mdash; 4.1 percent",
"     </li>",
"     <li>",
"      Teratogen &mdash; 4.1 percent",
"     </li>",
"     <li>",
"      Uterine factors &mdash; 2.5 percent",
"     </li>",
"     <li>",
"      Twinning &mdash; 0.4 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     TERATOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Teratology refers to the study of congenital malformations caused by environmental or drug exposure. The term is derived from the Greek word \"teratos,\" which means monster. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/7/19574?source=see_link\">",
"     \"Principles of teratology\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Teratogens",
"    </span>",
"    &nbsp;&mdash;&nbsp;A teratogen is an agent that can cause abnormalities in the form or function of a developing fetus. It acts by producing cell death, altering normal growth of tissues, or interfering with normal cellular differentiation or other morphologic processes. The consequences of these actions can be fetal loss, fetal growth restriction, birth defects, or impaired neurologic performance. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/13/7386?source=see_link\">",
"     \"Genetic and environmental causes of birth defects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/7/19574?source=see_link\">",
"     \"Principles of teratology\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Approximately 4 to 6 percent of birth defects are caused by exposure to teratogens in the environment. These include maternal illnesses (eg, diabetes mellitus or PKU), infectious agents (eg, TORCH infections), physical agents (eg, radiation or heat exposure), and drugs (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?41/42/42664?source=see_link\">",
"     thalidomide",
"    </a>",
"    , antiepileptic drugs) and chemical agents (eg, mercury).",
"   </p>",
"   <p>",
"    Response to the teratogenic agent is highly individual and is influenced by multiple factors. These include maternal genotype, fetal genotype, the dose of the agent, route of exposure, timing of exposure, and concurrent exposures or illnesses during gestation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Timing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pattern and type of malformation depends in part upon the time of exposure",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the site of gene action. A brief review of human embryonic development indicates the system likely to be affected by a problem occurring at that time.",
"   </p>",
"   <p>",
"    Fertilization is the first step and occurs within 24 hours of ovulation. The following are other important milestones in development (",
"    <a class=\"graphic graphic_figure graphicRef65456 \" href=\"UTD.htm?10/40/10880\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Preimplantation and implantation on days 5 to 11",
"     </li>",
"     <li>",
"      Differentiation into three germ layers (ectoderm, mesoderm, and endoderm) by day 16",
"     </li>",
"     <li>",
"      Formation of the neural plate by day 19",
"     </li>",
"     <li>",
"      Closure of the neural tube by day 27",
"     </li>",
"     <li>",
"      Appearance of limb buds by day 30",
"     </li>",
"     <li>",
"      Formation of the branchial arches, clefts, pouches, and optic vesicle between weeks four and five",
"     </li>",
"     <li>",
"      Formation of the mature heart and kidneys by weeks five to seven",
"     </li>",
"     <li>",
"      Achievement of mature limb architecture by week eight",
"     </li>",
"     <li>",
"      Sexual differentiation of the internal and external genitalia between weeks 7 to 10",
"     </li>",
"     <li>",
"      Rotation of the intestines and return into the abdominal cavity in week 10",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A significant exposure that occurs during the first 10 to 14 days postconception may result in cell death. If enough cells die, spontaneous abortion may occur. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/23/19834?source=see_link\">",
"     \"Spontaneous abortion: Risk factors, etiology, clinical manifestations, and diagnostic evaluation\"",
"    </a>",
"    .) If only a few cells are damaged, then their roles may be compensated by other cells. This is known as the all-or-none theory. An example is an early significant exposure to radiation, which usually results in either pregnancy loss or no abnormalities.",
"   </p>",
"   <p>",
"    Some teratogens act within a narrow window. As an example, the teratogenic effect of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?41/42/42664?source=see_link\">",
"     thalidomide",
"    </a>",
"    is limited to 21 to 36 days postconception, when limb bud development begins.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Mechanisms of teratogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Teratogenesis is thought to occur after fertilization and results from many diverse mechanisms. These include cell death (eg, radiation), blocking of metabolic processes (eg, thioureas, iodides), and alterations in cellular growth and proliferation, migration, apoptosis (eg, fetal alcohol syndrome), and interactions between cells or between cells and tissues.",
"   </p>",
"   <p>",
"    Exposure prior to conception may cause genetic mutations, a process known as toxic mutagenesis, although this is controversial. The timing of this process differs in males and females. In females, DNA replication occurs during oogenesis in the fetus, many years before ovulation. Thus, genetic defects may follow fetal exposure. In contrast, continuing spermatogenesis makes males susceptible to mutations throughout their reproductive life.",
"   </p>",
"   <p>",
"    Although the Food and Drug Administration requires that all prescription drugs be tested, it can be extremely difficult to determine whether a particular substance is teratogenic. Animal studies may be helpful, although results may not always apply to humans. For example,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?41/42/42664?source=see_link\">",
"     thalidomide",
"    </a>",
"    is strongly teratogenic in humans, but weakly teratogenic in animals, while the opposite is true for",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/10/19624?source=see_link\">",
"     aspirin",
"    </a>",
"    . Data regarding the association of drugs or chemicals and birth defects come primarily from case reports of exposed patients. These do not always establish teratogenicity and often need validation by epidemiologic studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Specific teratogens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Numerous teratogens in the environment can lead to birth defects. Common agents are listed below (",
"    <a class=\"graphic graphic_table graphicRef59994 \" href=\"UTD.htm?14/42/15020\">",
"     table 5",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/13/7386?source=see_link\">",
"     \"Genetic and environmental causes of birth defects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Infectious agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exposure to infectious agents can result in a variety of problems in the fetus and neonate, including malformations, congenital infection, short- and long-term disability, and death. The pathogenesis of the fetal defects is usually direct invasion of fetal tissues leading to damage from inflammation and cell death. Agents known to be toxic to the fetus or embryo are toxoplasmosis, rubella, cytomegalovirus, herpes, and syphilis (the so-called TORCH infections), as well as varicella and parvovirus B19. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/24/28041?source=see_link&amp;anchor=H650131395#H650131395\">",
"     \"Overview of TORCH infections\", section on 'Clinical features of TORCH infections'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Maternal illnesses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several maternal illnesses are associated with birth defects. The mechanism is diffusion of a metabolite or antibody across the placenta that is toxic to the fetus.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Insulin-dependent diabetes mellitus is associated with a two- to threefold increase in risk of congenital anomalies, including congenital heart disease and spina bifida, and, less commonly, caudal regression and focal femoral hypoplasia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44809?source=see_link\">",
"       \"Infant of a diabetic mother\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Maternal phenylketonuria is associated with microcephaly, intellectual disability (mental retardation), and congenital heart disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/58/35753?source=see_link\">",
"       \"Overview of phenylketonuria\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Androgen-producing tumors of the adrenal glands or ovaries can produce virilization of female fetuses.",
"     </li>",
"     <li>",
"      Maternal antibodies present in autoimmune disorders can cross the placenta and cause toxicity in the fetus. Examples include myasthenia gravis leading to transient neonatal myasthenia, maternal Grave's disease causing fetal and neonatal thyrotoxicosis, idiopathic thrombocytopenic purpura resulting in fetal and neonatal thrombocytopenia, and systemic lupus erythematosus causing fetal heart block. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/57/7066?source=see_link\">",
"       \"Treatment of myasthenia gravis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/48/42760?source=see_link\">",
"       \"Hyperthyroidism during pregnancy: Treatment\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/56/38793?source=see_link\">",
"       \"Thrombocytopenia in pregnancy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/45/39641?source=see_link\">",
"       \"Pregnancy in women with systemic lupus erythematosus\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Physical agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical agents, such as heat and radiation have been implicated in the pathogenesis of birth defects. Elevation of maternal core temperature more than 1.5 degrees centigrade in the first trimester of pregnancy may be associated with an increased risk of neural tube defects [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. Heat exposure may be due to hot tub or sauna use or maternal fever. Other clinical findings associated with high maternal temperature include microcephaly, intellectual disability (mental retardation), hypertonia, hypotonia, and seizures.",
"   </p>",
"   <p>",
"    Excessive exposure to ionizing radiation has the potential to produce fetal death, growth disturbances, somatic abnormalities, mutation, chromosome fragmentation, and malignancy. In general, toxic levels are not achieved with diagnostic imaging (",
"    <a class=\"graphic graphic_table graphicRef75594 \" href=\"UTD.htm?23/2/23596\">",
"     table 6",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28120?source=see_link\">",
"     \"Diagnostic imaging procedures during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Drug exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maternal drug ingestion, both medical and recreational, can also cause adverse fetal and neonatal outcomes. Some common teratogenic medications include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Angiotensin converting enzyme inhibitors (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/32/1543?source=see_link\">",
"       \"Angiotensin converting enzyme inhibitors and receptor blockers in pregnancy\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Anticonvulsant agents (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/6/22633?source=see_link\">",
"       \"Risks associated with epilepsy and pregnancy\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Antineoplastic agents (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/51/17207?source=see_link\">",
"       \"Breast cancer during pregnancy and lactation: Epidemiology and diagnosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/31/12793?source=see_link\">",
"       \"Management of classical Hodgkin lymphoma during pregnancy\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?41/42/42664?source=see_link\">",
"       Thalidomide",
"      </a>",
"      , retinoic acid,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/61/20438?source=see_link\">",
"       methylene blue",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?17/31/17908?source=see_link\">",
"       misoprostol",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/26/6566?source=see_link\">",
"       penicillamine",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/43/26297?source=see_link\">",
"       fluconazole",
"      </a>",
"      , and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?1/38/1639?source=see_link\">",
"       lithium",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Androgenic agents, such as testosterone or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/11/5301?source=see_link\">",
"     danazol",
"    </a>",
"    , do not cause malformation, but can virilize a female fetus. Infants whose mothers consume alcohol during pregnancy can have fetal alcohol effects (FAE), alcohol-related birth defects (ARBD), fetal alcohol syndrome, or they may be normal [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/38/41575?source=see_link\">",
"     \"Alcohol intake and pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/12/6346?source=see_link\">",
"     \"Overview of illicit drug use in pregnant women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/31/22005?source=see_link\">",
"     Folic acid",
"    </a>",
"    antagonists (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/8/5255?source=see_link\">",
"     trimethoprim",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?1/1/1045?source=see_link\">",
"     triamterene",
"    </a>",
"    ) increase the risk of neural-tube defects and possibly cardiovascular defects, oral clefts, and urinary tract defects [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. Oral",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/33/19991?source=see_link\">",
"     isotretinoin",
"    </a>",
"    , used to treat severe acne, is associated with ear anomalies (microtia with or without atresia of the ear canal), central nervous system malformations, hydrocephalus, neuronal brain migration defects, cerebellum abnormalities, severe intellectual disability, seizures, and dysmorphic features [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. The widely used cholesterol lowering agents, such as statins (HMG-CoA reductase inhibitors) are completely contraindicated during pregnancy because they may cause severe birth defects including limb malformations, congenital heart disease, and CNS abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation of a child with congenital malformations includes a careful history and physical examination. This is followed by further testing as indicated. A general approach to evaluation is presented here. More detailed descriptions are included in the topic reviews of specific disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prenatal history may uncover specific exposures and etiologic factors. This should include medical and obstetric history, such as the duration of gestation, prenatal care, and maternal exposures (eg, alcohol, prescribed or illicit drugs, cigarettes, fevers, illnesses, chemicals, radiation). A history of stillbirths and miscarriages could be related to unbalanced chromosomal anomalies in the parents. Results of prenatal testing, including ultrasound examinations, should be obtained.",
"   </p>",
"   <p>",
"    A complete family history and pedigree should be obtained (for four generations, if possible). The age of the parents is important because the incidence of chromosome aneuploidies is increased in older mothers and fresh autosomal dominant mutations (achondroplasia, neurofibromatosis type I, etc) are more commonly seen with older fathers (advanced paternal age is defined as older than 45 years). The parents should be asked about consanguinity, which increases the incidence of autosomal recessive disorders.",
"   </p>",
"   <p>",
"    Ethnic origin may be helpful because some diseases are more prevalent in certain ethnic groups. Examples include sickle cell anemia in African-Americans and Tay-Sachs in the Ashkenazi Jewish population.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough physical examination should be performed. In addition to standard measurements of weight, length, and head circumference, measurements of specific structures may be helpful. These can be compared to standard measurements [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/30\">",
"     30",
"    </a>",
"    ]. In newborns and fetuses, the placenta and umbilical cord should also be examined.",
"   </p>",
"   <p>",
"    Examination of family members may assist with the evaluation of some abnormalities. One example is the child with holoprosencephaly; a parent might have a single incisor, representing a mild manifestation of the same disorder. Another example is Treacher-Collins syndrome, an autosomal dominant disorder in which a parent can have minimal microtia or mild underdevelopment of malar facial structures and mistakenly considered normal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Laboratory studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory evaluation depends in part upon the results of the history and physical examination. Unless a specific syndromic diagnosis is made on the examination, chromosome studies should be performed in children with:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One or more major anomalies (eg, congenital heart disease)",
"     </li>",
"     <li>",
"      Three or more minor anomalies",
"     </li>",
"     <li>",
"      Clinical findings suggestive of a chromosome disorder (eg, Down syndrome) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26874?source=see_link\">",
"       \"Clinical features and diagnosis of Down syndrome\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Unexplained intellectual disability, with or without dysmorphic features or other anomalies (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/8/5257?source=see_link\">",
"       \"Intellectual disability (mental retardation) in children: Evaluation\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Ambiguous genitalia (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/59/24506?source=see_link\">",
"       \"Evaluation of the infant with ambiguous genitalia\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Unexplained growth retardation or failure to thrive (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/60/18376?source=see_link\">",
"       \"Diagnostic approach to short stature\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/12/14538?source=see_link\">",
"       \"Etiology and evaluation of failure to thrive (undernutrition) in children younger than two years\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Any congenital anomaly and a family history of birth defects",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      multiple miscarriages",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional studies such as fluorescent in situ hybridization (FISH) or molecular analysis may be required. Molecular studies using array comparative genomic hybridization (aCGH) analysis (also known as chromosomal microarray assay) can detect small chromosome abnormalities and are equivalent to performing hundreds of FISH analyses simultaneously. aCGH is widely used clinically to diagnose conditions that are difficult to recognize clinically and cytogenetically (eg, microdeletions of the distal short arm of chromosome 1) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/31\">",
"     31",
"    </a>",
"    ]. In addition, aCGH has been helpful in identifying small chromosome duplications that cannot be detected by conventional cytogenetic techniques or even by most FISH studies (eg, duplications of the 22q11.2 critical region for velocardiofacial syndrome) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. Array CGH is quickly becoming the first line of testing in children with multiple anomalies and intellectual disabilities, displacing the use of chromosome and FISH studies. This technique increases the detection yield to 12 to 15 percent compared to conventional chromosome studies that have a detection yield of approximately 5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19161/abstract/34-37\">",
"     34-37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28536?source=see_link\">",
"     \"Cytogenetic and molecular genetic diagnostic tools\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Depending upon the dysmorphic features, biochemical studies, such as measurement of plasma amino acids, urine organic acids, peroxisomal studies, serum cholesterol precursors, and lactic acid and pyruvic acid, may be indicated. Imaging studies, such as brain CT and MRI scans, echocardiogram, and appropriate radiographs should be performed to help define abnormalities not apparent on physical examination. If an infant dies, postmortem pathology studies can be extremely important to establish a diagnosis and provide appropriate counseling. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/58/24489?source=see_link\">",
"     \"Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/0/10250?source=see_link\">",
"     \"Inborn errors of metabolism: Metabolic emergencies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?30/31/31218?source=see_link\">",
"       \"Patient information: Newborn appearance (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Specific terms are used to describe congenital anomalies (",
"      <a class=\"graphic graphic_table graphicRef57394 \" href=\"UTD.htm?7/8/7307\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Terminology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Multiple malformations are often grouped in a recognizable pattern (",
"      <a class=\"graphic graphic_table graphicRef75281 \" href=\"UTD.htm?6/33/6683\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Patterns of defects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Genetic causes of congenital anomalies include chromosomal disorders, single gene disorders, and disorders that result from the interaction of multiple genes and environmental factors (multifactorial disorders). (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Environmental causes of congenital anomalies include twinning and teratogens. A teratogen is an agent that can cause abnormalities in the form or function of a developing fetus (",
"      <a class=\"graphic graphic_table graphicRef59994 \" href=\"UTD.htm?14/42/15020\">",
"       table 5",
"      </a>",
"      ). The pattern and type of malformation depends in part upon the time of exposure",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the site of gene action. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Teratology'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Human malformations and related anomalies. In: Oxford monographs on medical genetics, Stevenson RE, Hall JG, Goodman RM (Eds), Oxford University Press, New York 1993. Vol 1.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/2\">",
"      Muragaki Y, Mundlos S, Upton J, Olsen BR. Altered growth and branching patterns in synpolydactyly caused by mutations in HOXD13. Science 1996; 272:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/3\">",
"      Lammer EJ, Chen DT, Hoar RM, et al. Retinoic acid embryopathy. N Engl J Med 1985; 313:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/4\">",
"      Queisser-Luft A, Stolz G, Wiesel A, et al. Malformations in newborn: results based on 30,940 infants and fetuses from the Mainz congenital birth defect monitoring system (1990-1998). Arch Gynecol Obstet 2002; 266:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/5\">",
"      MARDEN PM, SMITH DW, MCDONALD MJ. CONGENITAL ANOMALIES IN THE NEWBORN INFANT, INCLUDING MINOR VARIATIONS. A STUDY OF 4,412 BABIES BY SURFACE EXAMINATION FOR ANOMALIES AND BUCCAL SMEAR FOR SEX CHROMATIN. J Pediatr 1964; 64:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/6\">",
"      Myrianthopoulos NC, Chung CS. Congenital malformations in singletons: epidemiologic survey. Report from the Collaborative Perinatal project. Birth Defects Orig Artic Ser 1974; 10:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/7\">",
"      Leppig KA, Werler MM, Cann CI, et al. Predictive value of minor anomalies. I. Association with major malformations. J Pediatr 1987; 110:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/8\">",
"      M&eacute;hes K, Mesty&aacute;n J, Knoch V, Vincell&eacute;r M. Minor malformations in the neonate. Helv Paediatr Acta 1973; 28:477.",
"     </a>",
"    </li>",
"    <li>",
"     Graham JM. Clinical approach to deformation problems. In: Smith's recognizable patterns of human deformation, Elsevier Saunders, Philadelphia 2007. p.3.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/10\">",
"      Horton WA, Lunstrum GP. Fibroblast growth factor receptor 3 mutations in achondroplasia and related forms of dwarfism. Rev Endocr Metab Disord 2002; 3:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/11\">",
"      Aicardi J, Chevrie JJ, Rousselie F. [Spasma-in-flexion syndrome, callosal agenesis, chorioretinal abnormalities]. Arch Fr Pediatr 1969; 26:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/12\">",
"      Tonkin ET, Wang TJ, Lisgo S, et al. NIPBL, encoding a homolog of fungal Scc2-type sister chromatid cohesion proteins and fly Nipped-B, is mutated in Cornelia de Lange syndrome. Nat Genet 2004; 36:636.",
"     </a>",
"    </li>",
"    <li>",
"     Jones KL. Dysmorphology approach and classification. In: Smith's recognizable patterns of human malformation, 6th ed, Elsevier Saunders, Philadelphia 2006. p.1.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/14\">",
"      POTTER EL. Bilateral renal agenesis. J Pediatr 1946; 29:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/15\">",
"      Thomas IT, Smith DW. Oligohydramnios, cause of the nonrenal features of Potter's syndrome, including pulmonary hypoplasia. J Pediatr 1974; 84:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/16\">",
"      Opitz JM, Herrmann J, Pettersen JC, et al. Terminological, diagnostic, nosological, and anatomical-developmental aspects of developmental defects in man. Adv Hum Genet 1979; 9:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/17\">",
"      Hersh JH, Angle B, Fox TL, et al. Developmental field defects: coming together of associations and sequences during blastogenesis. Am J Med Genet 2002; 110:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/18\">",
"      Temtamy SA, Miller JD. Extending the scope of the VATER association: definition of the VATER syndrome. J Pediatr 1974; 85:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/19\">",
"      Nelson K, Holmes LB. Malformations due to presumed spontaneous mutations in newborn infants. N Engl J Med 1989; 320:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/20\">",
"      Milunsky A, Ulcickas M, Rothman KJ, et al. Maternal heat exposure and neural tube defects. JAMA 1992; 268:882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/21\">",
"      Chambers CD, Johnson KA, Dick LM, et al. Maternal fever and birth outcome: a prospective study. Teratology 1998; 58:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/22\">",
"      Pleet H, Graham JM Jr, Smith DW. Central nervous system and facial defects associated with maternal hyperthermia at four to 14 weeks' gestation. Pediatrics 1981; 67:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/23\">",
"      Mattson SN, Schoenfeld AM, Riley EP. Teratogenic effects of alcohol on brain and behavior. Alcohol Res Health 2001; 25:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/24\">",
"      Hern&aacute;ndez-D&iacute;az S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000; 343:1608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/25\">",
"      Hern&aacute;ndez-D&iacute;az S, Werler MM, Walker AM, Mitchell AA. Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol 2001; 153:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/26\">",
"      Hanson N, Leachman S. Safety issues in isotretinoin therapy. Semin Cutan Med Surg 2001; 20:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/27\">",
"      Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med 1998; 338:1128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/28\">",
"      Petersen EE, Mitchell AA, Carey JC, et al. Maternal exposure to statins and risk for birth defects: a case-series approach. Am J Med Genet A 2008; 146A:2701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/29\">",
"      Taguchi N, Rubin ET, Hosokawa A, et al. Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes. Reprod Toxicol 2008; 26:175.",
"     </a>",
"    </li>",
"    <li>",
"     Hall J, Froster-Iskenius UG, Allanson JE. Handbook of normal physical measurements, 1st ed, Oxford Medical Publications, Oxford University Press, 1989.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/31\">",
"      Cheung SW, Shaw CA, Yu W, et al. Development and validation of a CGH microarray for clinical cytogenetic diagnosis. Genet Med 2005; 7:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/32\">",
"      Yobb TM, Somerville MJ, Willatt L, et al. Microduplication and triplication of 22q11.2: a highly variable syndrome. Am J Hum Genet 2005; 76:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/33\">",
"      Shaffer LG, Kashork CD, Saleki R, et al. Targeted genomic microarray analysis for identification of chromosome abnormalities in 1500 consecutive clinical cases. J Pediatr 2006; 149:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/34\">",
"      Schoumans J, Ruivenkamp C, Holmberg E, et al. Detection of chromosomal imbalances in children with idiopathic mental retardation by array based comparative genomic hybridisation (array-CGH). J Med Genet 2005; 42:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/35\">",
"      Tyson C, Harvard C, Locker R, et al. Submicroscopic deletions and duplications in individuals with intellectual disability detected by array-CGH. Am J Med Genet A 2005; 139:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/36\">",
"      Stankiewicz P, Beaudet AL. Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation. Curr Opin Genet Dev 2007; 17:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19161/abstract/37\">",
"      Lu X, Shaw CA, Patel A, et al. Clinical implementation of chromosomal microarray analysis: summary of 2513 postnatal cases. PLoS One 2007; 2:e327.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2940 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-1AFF26D322-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_45_19161=[""].join("\n");
var outline_f18_45_19161=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H31\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HISTORICAL BACKGROUND",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Malformations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Major",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Minor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Deformations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Disruptions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Amniotic band sequence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Dysplasias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      PATTERNS OF DEFECTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Sequence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Developmental field defect",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Association",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Frequency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      TERATOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Teratogens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Timing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Mechanisms of teratogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Specific teratogens",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Infectious agents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Maternal illnesses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Physical agents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Drug exposure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Laboratory studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/2940\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/2940|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/40/10880\" title=\"figure 1\">",
"      Embryonic development",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/2940|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/40/11904\" title=\"picture 1\">",
"      Clinodactyly",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/2940|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/8/7307\" title=\"table 1\">",
"      Congenital anomaly terminology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/23/3453\" title=\"table 2\">",
"      Major congenital malformations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?34/9/34972\" title=\"table 3A\">",
"      Minor congenital malformations A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/14/12524\" title=\"table 3B\">",
"      Minor congenital malformations B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/33/6683\" title=\"table 4\">",
"      Congenital anomaly patterns",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/42/15020\" title=\"table 5\">",
"      Common teratogens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/2/23596\" title=\"table 6\">",
"      Fetal radiation exposure",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/38/41575?source=related_link\">",
"      Alcohol intake and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/2/36902?source=related_link\">",
"      Amniotic band sequence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/32/1543?source=related_link\">",
"      Angiotensin converting enzyme inhibitors and receptor blockers in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/51/17207?source=related_link\">",
"      Breast cancer during pregnancy and lactation: Epidemiology and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26874?source=related_link\">",
"      Clinical features and diagnosis of Down syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/42/33449?source=related_link\">",
"      Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/24/24966?source=related_link\">",
"      Clinical manifestations and initial management of infants with bladder exstrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/18/8487?source=related_link\">",
"      Craniosynostosis syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28536?source=related_link\">",
"      Cytogenetic and molecular genetic diagnostic tools",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=related_link\">",
"      DiGeorge syndrome: Epidemiology and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/60/18376?source=related_link\">",
"      Diagnostic approach to short stature",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28120?source=related_link\">",
"      Diagnostic imaging procedures during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/12/14538?source=related_link\">",
"      Etiology and evaluation of failure to thrive (undernutrition) in children younger than two years",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/59/24506?source=related_link\">",
"      Evaluation of the infant with ambiguous genitalia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/34/44581?source=related_link\">",
"      Facial clefts and holoprosencephaly",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/13/7386?source=related_link\">",
"      Genetic and environmental causes of birth defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/48/42760?source=related_link\">",
"      Hyperthyroidism during pregnancy: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/58/24489?source=related_link\">",
"      Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/0/10250?source=related_link\">",
"      Inborn errors of metabolism: Metabolic emergencies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44809?source=related_link\">",
"      Infant of a diabetic mother",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/8/5257?source=related_link\">",
"      Intellectual disability (mental retardation) in children: Evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/31/12793?source=related_link\">",
"      Management of classical Hodgkin lymphoma during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/60/27594?source=related_link\">",
"      Neonatal outcome, complications, and management of multiple births",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/24/28041?source=related_link\">",
"      Overview of TORCH infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/37/10841?source=related_link\">",
"      Overview of craniosynostosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/12/6346?source=related_link\">",
"      Overview of illicit drug use in pregnant women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/58/35753?source=related_link\">",
"      Overview of phenylketonuria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33767?source=related_link\">",
"      Pathophysiology and clinical manifestations of myelomeningocele (spina bifida)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?30/31/31218?source=related_link\">",
"      Patient information: Newborn appearance (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/45/39641?source=related_link\">",
"      Pregnancy in women with systemic lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16296?source=related_link\">",
"      Prenatal diagnosis of renal agenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/23/33141?source=related_link\">",
"      Prenatal diagnosis of talipes equinovarus (clubfoot)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/7/19574?source=related_link\">",
"      Principles of teratology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/6/22633?source=related_link\">",
"      Risks associated with epilepsy and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/23/19834?source=related_link\">",
"      Spontaneous abortion: Risk factors, etiology, clinical manifestations, and diagnostic evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/56/38793?source=related_link\">",
"      Thrombocytopenia in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/57/7066?source=related_link\">",
"      Treatment of myasthenia gravis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_45_19162="Back pain in children and adolescents: Overview of causes";
var content_f18_45_19162=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Back pain in children and adolescents: Overview of causes",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/45/19162/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/45/19162/contributors\">",
"     Peter A Nigrovic, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/45/19162/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/45/19162/contributors\">",
"     Jan E Drutz, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/45/19162/contributors\">",
"     William Phillips, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/45/19162/contributors\">",
"     Robert Sundel, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/45/19162/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/45/19162/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/45/19162/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 29, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causes of back pain in children and adolescents will be reviewed here. The epidemiology and evaluation of back pain in children are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/39/2679?source=see_link\">",
"     \"Evaluation of the child with back pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Benign musculoskeletal disease and trauma account for most cases of back pain in children and adolescents. Other causes, including congenital and acquired conditions such as trauma, infection, inflammatory disease, and neoplasm, which have different implications for treatment or prognosis, also must be considered (",
"    <a class=\"graphic graphic_table graphicRef54179 \" href=\"UTD.htm?12/40/12941\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef77360 \" href=\"UTD.htm?18/61/19422\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In most large published series, including those from referral centers, the majority of children with back pain receive no definitive diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. Nonspecific musculoskeletal pain accounts for at least 50 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/2-5\">",
"     2-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The frequency of specific causes depends upon the population studied. In a prospective series of 73 children presenting to a specialty hospital with back pain for more than three months, excluding children with a history of back surgery, only 13 patients (18 percent) received a definitive diagnosis: spondylolysis with or without spondylolisthesis (nine patients), Scheuermann kyphosis (two patients), osteoid osteoma (one patient), and lumbar disc herniation (one patient) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/4\">",
"     4",
"    </a>",
"    ]. Among children who present to the emergency department, common causes of back pain include trauma (25 percent), muscle strain (24 percent), sickle cell crisis (13 percent), idiopathic (13 percent), urinary tract infection (5 percent) and viral illness (4 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MUSCULOSKELETAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Musculoskeletal back pain may be related to muscles, bones, or discs, each with characteristic features [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Muscle-related pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most back pain in children, as in adults, is thought to arise from within the muscles [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/5\">",
"     5",
"    </a>",
"    ]. Muscle-related pain tends to be localized to the paraspinal muscles of the thoracic or lumbar area, rather than to the spine itself [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/6\">",
"     6",
"    </a>",
"    ]. It is often related to overuse, but there may be a history of acute injury. Muscle-related pain may be exacerbated by twisting or lifting.",
"   </p>",
"   <p>",
"    Contributing factors can include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A heavy backpack [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/7-11\">",
"       7-11",
"      </a>",
"      ]. The association between backpacks and back pain in children is inconsistent [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/12-14\">",
"       12-14",
"      </a>",
"      ]. The American Academy of Pediatrics recommends that a backpack weigh no more than 10 to 20 percent of the child's body weight [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/15,16\">",
"       15,16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Use of an especially soft mattress has been associated with back pain and stiffness in the morning [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Large breasts. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/37/3673?source=see_link&amp;anchor=H14#H14\">",
"       \"Overview of breast disorders in children and adolescents\", section on 'Juvenile breast hypertrophy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Sports equipment (eg, improper bicycle seat positioning, lack of cushioned insoles for running) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Depression, anxiety, and psychosocial distress [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/2,19,20\">",
"       2,19,20",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most children with muscular back pain do well. However, some develop prolonged and occasionally disabling pain similar to chronic back pain in adults.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Bone-related pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone-related pain tends to occur at the center of the spine. It is usually exacerbated by extension (backward bending) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/6\">",
"     6",
"    </a>",
"    ], though this finding is not specific. The most common causes of bone-related back pain in children and adolescents include spondylolysis and spondylolisthesis, scoliosis, and Scheuermann (juvenile) kyphosis, described in greater detail below.",
"   </p>",
"   <p>",
"    Less common causes of bone-related back pain include congenital absence of a lumbar pedicle [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/21\">",
"     21",
"    </a>",
"    ], idiopathic juvenile osteoporosis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/22,23\">",
"     22,23",
"    </a>",
"    ], aneurysmal bone cysts of the spine [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/24\">",
"     24",
"    </a>",
"    ], vertebral apophyseal fracture (more common in dancers and gymnasts) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/25,26\">",
"     25,26",
"    </a>",
"    ], and sacroiliac joint stress reaction related to sports training [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Spondylolysis and spondylolisthesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spondylolysis is a unilateral or bilateral defect (separation) in the vertebral pars interarticularis, usually in the lower lumbar vertebrae, particularly L5 (",
"    <a class=\"graphic graphic_figure graphicRef51634 \" href=\"UTD.htm?5/41/5781\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Spondylolisthesis occurs when bilateral defects permit the vertebral body to slip anteriorly.",
"   </p>",
"   <p>",
"    Spondylolysis (also known as &ldquo;pars defect&rdquo;) typically is acquired as the bone \"fatigues\" from recurrent microtrauma during excessive lumbar hyperextension or repeated lumbar flexion and extension. The most common spondylolytic defects occur at the isthmus [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Spondylolysis progresses to spondylolisthesis in approximately 15 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/31\">",
"     31",
"    </a>",
"    ]. Progression generally occurs during the growth spurt, with minimal change after 16 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/28,31\">",
"     28,31",
"    </a>",
"    ]. Progression to spondylolisthesis is correlated with persistent pain and lack of healing [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/29,32\">",
"     29,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Epidemiology &ndash; Spondylolysis is common, but high-grade spondylolisthesis is rare. The prevalence of spondylolysis in adolescents is approximately 6 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/31\">",
"       31",
"      </a>",
"      ]. It is increased in the Inuit population (as high as 25 percent), in whites compared with blacks, and in boys compared with girls, although girls progress to spondylolisthesis more often [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/33,34\">",
"       33,34",
"      </a>",
"      ]. Risk factors include a family history of spondylolysis, occult spina bifida at S1, and Scheuermann kyphosis [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/28,33,35,36\">",
"       28,33,35,36",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Scheuermann (juvenile) kyphosis'",
"      </a>",
"      below.)",
"      <br/>",
"      <br/>",
"      Spondylolysis is common in adolescent athletes with acute low back pain (accounting for 47 percent of cases in one orthopedic series) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/37\">",
"       37",
"      </a>",
"      ]. Athletes at particular risk include those who play sports that require repetitive",
"      <span class=\"nowrap\">",
"       flexion/extension",
"      </span>",
"      or hyperextension of the spine (eg, gymnastics, dance, diving, weight lifting, figure skating, volleyball, soccer, football (linemen), racquet sports, and throwing sports) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Clinical features &ndash; Spondylolysis usually presents in early adolescence. It may be asymptomatic but typically manifests as aching low back pain that is exacerbated by hyperextension and relieved by rest [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/5\">",
"       5",
"      </a>",
"      ]. The pain may extend into the buttocks and posterior thighs [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/38\">",
"       38",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Examination findings of spondylolysis may include [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/5,18,33,39\">",
"       5,18,33,39",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Lumbosacral tenderness, particularly with extension or lateral bending.",
"     </li>",
"     <li>",
"      A positive one-legged hyperextension test (also called the \"stork test\"): while standing on one leg and bending backward, pain is experienced in the ipsilateral back (",
"      <a class=\"graphic graphic_picture graphicRef78320 \" href=\"UTD.htm?42/14/43233\">",
"       picture 1",
"      </a>",
"      ). However, the one-legged hyperextension test is neither sensitive nor specific for spondylolysis [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hamstring tightness, manifest by limited passive straight-leg raising and forward bending.",
"     </li>",
"     <li>",
"      In patients with spondylolisthesis, a prominent spinous process may be palpable if there is significant slippage (",
"      <a class=\"graphic graphic_figure graphicRef70541 \" href=\"UTD.htm?10/6/10339\">",
"       figure 2",
"      </a>",
"      ). With increasing slippage, the sacrum becomes relatively more vertical, impairing hip extension and compelling the patient to walk with a knee-flexed, hip-flexed gait (Phalen-Dickson sign) (",
"      <a class=\"graphic graphic_figure graphicRef62049 \" href=\"UTD.htm?34/2/34850\">",
"       figure 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/40\">",
"       40",
"      </a>",
"      ]. Neurologic impairment rarely occurs because the vertebral body slips anteriorly away from the spinal cord and nerve roots.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Imaging &ndash; Imaging begins with lumbosacral plain radiographs, which may demonstrate a healing defect. Oblique views may demonstrate the classic \"Scotty dog\" sign with the crack (or collar) on the neck of the dog (",
"      <a class=\"graphic graphic_figure graphicRef51634 \" href=\"UTD.htm?5/41/5781\">",
"       figure 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/30\">",
"       30",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Early or incipient defects may escape detection on plain films, but they can be detected with magnetic resonance imaging (MRI) or bone scan [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/30,41-43\">",
"       30,41-43",
"      </a>",
"      ]. MRI may be helpful in identifying the edema that occurs before the fracture [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/41\">",
"       41",
"      </a>",
"      ]. Bone scan may distinguish whether the defect is new or old, which has implications for healing [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/44,45\">",
"       44,45",
"      </a>",
"      ]. CT scan with SPECT (single photon emission CT) is also sensitive for spondylolysis, but may be avoided to minimize radiation exposure [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/39,46\">",
"       39,46",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Plain radiographic findings of spondylolisthesis include (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef58784 \" href=\"UTD.htm?41/58/42917\">",
"       image 1",
"      </a>",
"      ):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Lateral view: Pars defects and anterior displacement of the lumbar vertebra",
"     </li>",
"     <li>",
"      Oblique view: Lucent collar and stepladder sign",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Treatment &ndash; Treatment of spondylolysis and spondylolisthesis is controversial. These conditions should be managed by an orthopedic specialist. Therapeutic modalities include rest and lumbar bracing to prevent hyperextension [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/47\">",
"       47",
"      </a>",
"      ]. Surgical fusion is indicated for intractable pain or slippage of greater than 50 percent in a child who is still growing and, therefore, at risk of progression, whether or not symptoms are present [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/28\">",
"       28",
"      </a>",
"      ]. Radiographic stage at the time of diagnosis is strongly predictive of the likelihood of healing [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/48\">",
"       48",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Scoliosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Scoliosis is an abnormal lateral curvature of the spine. It can be idiopathic or result from congenital spinal anomalies, muscular spasm or paralysis, infection, tumor, or other causes.",
"   </p>",
"   <p>",
"    Musculoskeletal back pain is more common among patients with scoliosis than among matched controls [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. However, back pain should not be attributed to scoliosis without excluding other causes of back pain (",
"    <a class=\"graphic graphic_table graphicRef54179 \" href=\"UTD.htm?12/40/12941\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical features, evaluation, diagnosis, and treatment of idiopathic scoliosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33770?source=see_link\">",
"     \"Clinical features; evaluation; and diagnosis of adolescent idiopathic scoliosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/12/37065?source=see_link\">",
"     \"Treatment and prognosis of adolescent idiopathic scoliosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Scheuermann (juvenile) kyphosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Scheuermann kyphosis is defined as anterior wedging of &ge;5&ordm; in at least three adjacent vertebral bodies, as measured on lateral spine radiographs (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef60638 \" href=\"UTD.htm?35/20/36175\">",
"     image 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The etiology of Scheuermann kyphosis remains undefined. A genetic component is suggested by increased concordance in monozygotic over dizygotic twins [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/52\">",
"     52",
"    </a>",
"    ]. The observation that a history of prolonged bed rest was more common among patients with Scheuermann kyphosis than controls suggests that in some cases, the wedging may reflect compression fractures associated with transient osteoporosis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/53\">",
"     53",
"    </a>",
"    ]. An association with sports or heavy lifting is controversial. Although these patients are generally taller than their peers, their sternal lengths have been found to be somewhat reduced, suggesting the possibility that sternal size may result in compressive stresses on the spine [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Epidemiology &ndash; The estimated prevalence of Scheuermann kyphosis ranges from 4 to 8 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/51,53\">",
"       51,53",
"      </a>",
"      ]. Scheuermann kyphosis is more common among boys than girls [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/53\">",
"       53",
"      </a>",
"      ]. Tall boys are at increased risk for severe disease.",
"     </li>",
"     <li>",
"      Clinical features &ndash; Scheuermann kyphosis typically occurs in early adolescence and affects the thoracic or thoracolumbar spine. It may be associated with spondylolysis [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/36\">",
"       36",
"      </a>",
"      ], and rarely, myelopathy [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/55-57\">",
"       55-57",
"      </a>",
"      ]. Pain generally is subacute without a clear episode of precipitating trauma. The pain is worse after activity and at the end of the day and improves with rest. It tends to improve with skeletal maturity. However, long-term follow-up suggests an increased prevalence of back pain in adulthood [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/58\">",
"       58",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Patients with Scheuermann kyphosis have a rigid kyphosis with a relatively sharp angulation when the child bends over, best viewed from the side of the patient (",
"      <a class=\"graphic graphic_figure graphicRef81479 \" href=\"UTD.htm?13/8/13440\">",
"       figure 4",
"      </a>",
"      ).The curvature does not flatten with forward bending, extension, or lying supine (in contrast to the curvature of poor posture) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/5,30\">",
"       5,30",
"      </a>",
"      ]. There may be a compensatory increase in lumbar lordosis and tightening of the hamstrings manifest by limited passive straight leg raising and forward bending. The physical examination is neither sensitive nor specific for Scheuermann kyphosis [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/53\">",
"       53",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Imaging &ndash; Standing lateral spine radiographs are necessary for the diagnosis (anterior wedging of &ge;5&ordm; in at least three adjacent vertebral bodies) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/51\">",
"       51",
"      </a>",
"      ]. Degeneration of the vertebral end plates also may be seen (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef60638 \" href=\"UTD.htm?35/20/36175\">",
"       image 2",
"      </a>",
"      ). In patients with lumbar pain, concomitant spondylolysis should be considered [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/36\">",
"       36",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Spondylolysis and spondylolisthesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment &ndash; Scheuermann kyphosis usually can be treated with conservative management: strengthening and stretching exercises, analgesics, and avoidance of precipitants. Bracing or other orthopedic interventions are required if pain is persistent or the kyphosis exceeds 60&ordm; [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/51,59,60\">",
"       51,59,60",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Disc-related pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disc-related pain is generally exacerbated by flexion (forward bending) and may radiate [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/6\">",
"     6",
"    </a>",
"    ]. Approximately 10 percent of persistent back pain in adolescents is disc related [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/37,61\">",
"     37,61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Disc herniation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vertebral bodies are separated by intervertebral discs, which provide support and mobility. The intervertebral disc is composed of a tough, ligamentous outer annulus and a gelatinous inner nucleus pulposus. The combination of intervertebral pressure and degeneration of the ligamentous fibers can lead to a tear in the annulus, allowing the nucleus pulposus to prolapse through the annulus. Radicular symptoms may ensue if the prolapsed material presses on a nerve root.",
"   </p>",
"   <p>",
"    Degenerative disc changes (with or without disc calcification) in the absence of overt prolapse are associated with pain in some adolescents and are an incidental finding in others [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/62-64\">",
"     62-64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Epidemiology &ndash; Herniation of the nucleus pulposus is less common in children and adolescents than in adults [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/65\">",
"       65",
"      </a>",
"      ]. Presentation before the age of 10 is rare. Risk factors include acute trauma, Scheuermann kyphosis, family history of disc herniation, and",
"      <span class=\"nowrap\">",
"       overweight/obesity",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/66-68\">",
"       66-68",
"      </a>",
"      ]. Sports associated with an increased risk of disc herniation include weight lifting, wrestling, gymnastics, and collision sports (",
"      <a class=\"graphic graphic_table graphicRef71147 \" href=\"UTD.htm?17/63/18427\">",
"       table 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/61\">",
"       61",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Clinical features and diagnosis &ndash; The presentation of degenerative disc disease in children is similar to that in adults. L4-L5 and L5-S1 are most frequently involved (",
"      <a class=\"graphic graphic_table graphicRef75974 \" href=\"UTD.htm?22/51/23355\">",
"       table 4",
"      </a>",
"      ). Clinical features include [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/66,69-71\">",
"       66,69-71",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Lumbar pain",
"     </li>",
"     <li>",
"      Sciatica (pain radiating below the knees)",
"     </li>",
"     <li>",
"      Limitation of spinal flexibility",
"     </li>",
"     <li>",
"      Limitation of passive straight-leg raising",
"      <br/>",
"      <br/>",
"      Severe midline disc herniations can compromise the cauda equina and result in bladder dysfunction, saddle-area anesthesia, and other findings, sometimes in the absence of compromised strength or reflexes. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18601?source=see_link\">",
"       \"Approach to the diagnosis and evaluation of low back pain in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/39/2679?source=see_link&amp;anchor=H11#H11\">",
"       \"Evaluation of the child with back pain\", section on 'Straight leg raising'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Disc herniation is usually confirmed with MRI after the onset of the clinical signs described above [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/72\">",
"       72",
"      </a>",
"      ]. However, the importance of imaging findings associated with disc degeneration remains unclear; herniated discs often are identified in MRI studies of patients without complaints of back pain. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18601?source=see_link\">",
"       \"Approach to the diagnosis and evaluation of low back pain in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Treatment &ndash; Initial treatment is conservative, although surgical therapy generally is successful if indicated for neurologic deficits or intractable pain [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/73\">",
"       73",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Disc calcification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intervertebral disc space calcification is an idiopathic, presumably postinflammatory condition that typically affects preadolescent children from infancy onward [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/74\">",
"     74",
"    </a>",
"    ]. It also may occur in patients with ochronosis (exogenously deposited or medication-induced pigmentation of the connective tissue).",
"   </p>",
"   <p>",
"    Intervertebral disc calcification generally involves the cervical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    thoracic discs. It may be an incidental imaging finding or associated with torticollis or back pain. Herniation occurs in one-quarter of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical course usually is benign. Spontaneous resolution is common [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     INFECTIOUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infectious causes of back pain in children and adolescents include discitis, vertebral osteomyelitis (including tuberculous osteomyelitis), sacroiliac joint infection, epidural abscess, and nonspinal infections (eg, paraspinous muscle abscess, pyelonephritis, pneumonia, pelvic inflammatory disease, endocarditis, and myalgia associated with viral illness).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Discitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Discitis refers to inflammation of the intervertebral disc. The etiology is controversial. Although disc biopsy is not necessary for diagnosis, as many as 60 percent of biopsied discs grow bacteria, usually",
"    <em>",
"     Staphylococcus aureus",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/76\">",
"     76",
"    </a>",
"    ]. However, children often recover without antibiotic therapy. The current consensus, backed by scant supportive evidence, is that discitis in children usually represents low-grade infection and is on one end of the spectrum of vertebral osteomyelitis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/76-78\">",
"     76-78",
"    </a>",
"    ]. In children younger than seven years, host defense systems usually are capable of overcoming the infection without assistance because the disc is richly vascularized [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/79,80\">",
"     79,80",
"    </a>",
"    ]. Occasionally, however, host defenses are overwhelmed, and complications such as abscess formation may result [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Epidemiology &ndash; Discitis is rare. At a single academic medical center, the incidence was one to two cases per 32,500 pediatric hospitalizations and clinic visits per year [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/79\">",
"       79",
"      </a>",
"      ]. However, given the mild and nonspecific presentation of discitis, it may be underdiagnosed.",
"      <br/>",
"      <br/>",
"      Discitis typically occurs in children younger than three to five years, but cases may occur through adolescence [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/77,81\">",
"       77,81",
"      </a>",
"      ]. In small case series, the mean age ranged from 2.8 to 4.5 years [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/77,78\">",
"       77,78",
"      </a>",
"      ]. The lower lumbar discs are affected most commonly, but any disc (and occasionally more than one) may be involved.",
"     </li>",
"     <li>",
"      Clinical features &ndash; Discitis typically presents with the gradual onset of irritability and back pain, limp, or refusal to crawl or walk, without systemic toxicity; fever usually is absent or low grade [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/77,82-84\">",
"       77,82-84",
"      </a>",
"      ]. In some patients, abdominal pain",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      vomiting may be the only complaints. Most patients have had symptoms for three or more weeks by the time discitis is diagnosed [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/77,78,82\">",
"       77,78,82",
"      </a>",
"      ]. Occasionally, the diagnosis is made incidentally on radiographs performed to exclude intraabdominal pathology [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/79\">",
"       79",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Examination findings may include [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/30,38,81,85\">",
"       30,38,81,85",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Refusal to bend forward",
"     </li>",
"     <li>",
"      Percussion tenderness over the involved spine",
"     </li>",
"     <li>",
"      Hip pain and stiffness",
"     </li>",
"     <li>",
"      Loss of lumbar lordosis",
"     </li>",
"     <li>",
"      Neurologic findings (eg, decreased muscle strength or reflexes)",
"     </li>",
"     <li>",
"      Ileus (with high lesions: T8-L1)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Laboratory features &ndash; Blood cultures usually are sterile, and the white blood cell count generally is normal [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/76,79\">",
"       76,79",
"      </a>",
"      ]. However, the erythrocyte sedimentation rate is elevated in more than 90 percent of patients.",
"     </li>",
"     <li>",
"      Imaging &ndash; Plain radiographs are normal at the start of the illness, but within two to three weeks they show narrowing of the intervertebral space [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/72,82\">",
"       72,82",
"      </a>",
"      ]. Narrowing of the joint space may be followed by destruction of the adjacent vertebral end-plates and herniation of the nucleus pulposus into the vertebral body. Spontaneous anterior fusion is common in older children. Rarely, vertebral body compression or wedging is noted.",
"      <br/>",
"      <br/>",
"      Diagnosis of discitis is best made by magnetic resonance imaging (MRI), which can define the inflammation and exclude alternative diagnoses such as vertebral osteomyelitis and tumor [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/83,86,87\">",
"       83,86,87",
"      </a>",
"      ]. MRI frequently documents involvement of the disc and both adjacent vertebral end plates, suggesting significant overlap between discitis and vertebral osteomyelitis [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/76\">",
"       76",
"      </a>",
"      ]. Bone scan also can localize the inflammation, but lack of specificity and imperfect sensitivity limit its utility [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/88\">",
"       88",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33289?source=see_link&amp;anchor=H6#H6\">",
"       \"Evaluation and diagnosis of hematogenous osteomyelitis in children\", section on 'Imaging'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Management &ndash; Management for discitis is not standardized. Aspiration of the affected disc for culture usually is not performed. Limited retrospective data suggest that initial treatment with intravenous antibiotics until the child shows clinical improvement, followed by oral antibiotics, is associated with a somewhat earlier response and fewer relapses than is treatment with oral antibiotics or analgesia alone [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/76\">",
"       76",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Empiric antibiotic therapy should be directed against",
"      <em>",
"       S. aureus",
"      </em>",
"      and",
"      <em>",
"       Kingella kingae",
"      </em>",
"      (eg, an antistaphylococcal agent",
"      <span class=\"nowrap\">",
"       [",
"       <a class=\"drug drug_pediatric\" href=\"UTD.htm?25/57/26519?source=see_link\">",
"        nafcillin",
"       </a>",
"       /",
"       <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/59/950?source=see_link\">",
"        oxacillin",
"       </a>",
"       ,",
"      </span>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/56/34688?source=see_link\">",
"       clindamycin",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"       vancomycin",
"      </a>",
"      ] and a third-generation cephalosporin [",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"       cefotaxime",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=see_link\">",
"       ceftriaxone",
"      </a>",
"      ]). Immobilization, either through bed rest or, occasionally, casting, may assist with pain control [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/79\">",
"       79",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The long-term outcome usually is good, although anomalies of the disc space and adjacent vertebrae (often asymptomatic) are common findings on long-term follow-up, occurring in 50 of 55 patients in two series [",
"      <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/89,90\">",
"       89,90",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Osteomyelitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vertebral osteomyelitis is most common among adolescents, but it may occur in any age group. In comparison to children with discitis, those with vertebral osteomyelitis are more likely to be febrile and ill appearing. Identification of a causal agent is crucial in selection of appropriate therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/39/20087?source=see_link\">",
"     \"Clinical features of hematogenous osteomyelitis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33289?source=see_link&amp;anchor=H14#H14\">",
"     \"Evaluation and diagnosis of hematogenous osteomyelitis in children\", section on 'Microbiology'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/9/24730?source=see_link&amp;anchor=H2#H2\">",
"     \"Treatment of hematogenous osteomyelitis in children\", section on 'Overview of treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Septic sacroiliitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bacterial arthritis of the sacroiliac joint usually occurs in late childhood. Clinical features include pain when pressure is applied over the sacrum or during a digital rectal examination and with maneuvers that twist the pelvis (ie, the FABERE test) (",
"    <a class=\"graphic graphic_figure graphicRef79475 \" href=\"UTD.htm?5/55/6015\">",
"     figure 5",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/30/14826?source=see_link\">",
"     \"Bacterial arthritis: Clinical features and diagnosis in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Noninfectious sacroiliitis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/31/8696?source=see_link&amp;anchor=H3#H3\">",
"     \"Spondyloarthropathy in children\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Epidural abscess",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidural abscess is a rare infection of the central nervous system that requires prompt recognition and proper management to avoid potentially disastrous complications. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17033?source=see_link&amp;anchor=H2#H2\">",
"     \"Epidural abscess\", section on 'Spinal epidural abscess'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The classic diagnostic triad consists of fever, spinal pain, and neurologic deficits, but only a few patients have all three components at presentation. Over time, an untreated epidural abscess is associated with a typical progression of symptoms from back pain (often focal and severe), to root pain (described as \"shooting\" or \"electric shocks\"), to neurologic deficits (motor weakness, sensory changes, and bowel and bladder dysfunction), and finally paralysis, which quickly may become irreversible.",
"   </p>",
"   <p>",
"    Considering epidural abscess is the key to diagnosis. MRI is the preferred imaging modality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Nonspinal infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonspinal infections that may present with back pain include pyomyositis, pyelonephritis, pneumonia, pelvic inflammatory disease (PID), endocarditis, and myalgia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Pyomyositis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Paraspinous muscle abscess (pyomyositis) is characterized by fever and muscle tenderness localized to a single muscle group. It is classically an infection of the tropics but is increasingly reported in temperate climates. Predisposing factors for pyomyositis include immunodeficiency, trauma, injection drug use, concurrent infection, and malnutrition. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32950?source=see_link&amp;anchor=H9#H9\">",
"     \"Pyomyositis\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Pyelonephritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms of urinary tract infection include fever, urinary symptoms (dysuria, urgency, frequency, incontinence, macroscopic hematuria), abdominal pain, and flank pain. Urinalysis and urine culture are necessary for diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/40/21129?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical features and diagnosis of urinary tract infections in infants and children older than one month\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumonia is suggested by fever, cough, and pleuritic chest pain, but these findings may be absent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38970?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical features and diagnosis of community-acquired pneumonia in children\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Pelvic inflammatory disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pelvic inflammatory disease (PID) is an acute infection of the upper genital tract structures (uterus, oviducts, ovaries) that may occur in sexually active females. Pelvic examination is necessary for diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=see_link\">",
"     \"Clinical features and diagnosis of pelvic inflammatory disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Endocarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endocarditis may be associated with vertebral osteomyelitis or discitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/52/18249?source=see_link&amp;anchor=H17#H17\">",
"     \"Complications and outcome of infective endocarditis\", section on 'Musculoskeletal complications'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/15/27896?source=see_link\">",
"     \"Infective endocarditis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Myalgia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mild to moderate diffuse myalgias occur frequently during the prodrome or early phase of any acute viral infection. The back is commonly involved. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/41/9879?source=see_link&amp;anchor=H2#H2\">",
"     \"Viral myositis\", section on 'Myalgias'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     INFLAMMATORY ARTHRITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A limited number of systemic inflammatory conditions can affect the spine and manifest as back pain, particularly ankylosing spondylitis, psoriatic arthritis, the arthritis of inflammatory bowel disease, and reactive arthritis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/31/8696?source=see_link\">",
"     \"Spondyloarthropathy in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/49/30488?source=see_link\">",
"     \"Clinical manifestations and diagnosis of psoriatic arthritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/34/4650?source=see_link\">",
"     \"Treatment of ulcerative colitis in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/7/24693?source=see_link\">",
"     \"Clinical manifestations of Crohn's disease in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/27/33210?source=see_link\">",
"     \"Reactive arthritis (formerly Reiter syndrome)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The hallmark of inflammatory disease is morning stiffness. After a night's rest, the patient awakes with axial discomfort and limited mobility that improves with a hot shower or bath and usual activity, and returns after periods of prolonged inactivity (\"gelling\"). Severe pain is most unusual.",
"   </p>",
"   <p>",
"    Family history of inflammatory spondylitis may be helpful, because inflammatory spondylitis often is HLA-B27 related. However, testing for HLA-B27 is of limited utility because it is common in the normal population and absent in some patients with spondylitis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/91,92\">",
"     91,92",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/39/2679?source=see_link&amp;anchor=H13#H13\">",
"     \"Evaluation of the child with back pain\", section on 'Rheumatologic assays'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On examination, sacroiliac joint tenderness may be present. Pain may be elicited by maneuvers that stress the sacroiliac joints. These maneuvers include application of simultaneous medial pressure on the anterior iliac spines and the FABERE test (",
"    <a class=\"graphic graphic_figure graphicRef79475 \" href=\"UTD.htm?5/55/6015\">",
"     figure 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/93\">",
"     93",
"    </a>",
"    ]. Pain from pelvic torque with the FABERE test in the absence of pain with passive motion of the hip joint suggests discomfort arising from the sacroiliac joint, but this test is neither sensitive nor specific. Full physical examination may reveal other clues to the presence of a spondyloarthropathy, such as arthritis in other joints, enthesitis (tenderness at sites of tendon insertions, most commonly at the Achilles tendon insertion), or findings suggestive of psoriasis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/31/8696?source=see_link&amp;anchor=H3#H3\">",
"     \"Spondyloarthropathy in children\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sacroiliac joint changes may be observed on plain radiographs, although MRI is far more sensitive for detection of early disease [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/94\">",
"     94",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     TUMORS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Osteoid osteoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common tumor that presents with back pain in children is osteoid osteoma, a benign tumor characterized by nocturnal pain and prompt relief with NSAIDs, although these features are variable. Ten to 20 percent of osteoid osteomas localize to the spine [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/95,96\">",
"     95,96",
"    </a>",
"    ]. Osteoid osteoma of the spine may be complicated by scoliosis secondary to bony deformity or muscle spasm. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/60/24522?source=see_link&amp;anchor=H13#H13\">",
"     \"Overview of benign bone tumors in children and adolescents\", section on 'Osteoid osteoma'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis of osteoid osteoma is made using plain film, CT, bone scan, or MRI. Radiographs demonstrate dense sclerotic areas obscuring the osteoid nidus [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Other tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other tumors that may affect the spine include leukemia, lymphoma, Ewing sarcoma, neuroblastoma, osteoblastoma, osteosarcoma, neurofibroma, and Langerhans cell histiocytosis (eosinophilic granuloma) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/59,97\">",
"     59,97",
"    </a>",
"    ]. (See appropriate topic reviews).",
"   </p>",
"   <p>",
"    A small series found that constant pain (unchanged by activity), nocturnal pain, and duration of pain less than three months were associated with tumors, although these characteristics were not specific [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/47/5882?source=see_link&amp;anchor=H13#H13\">",
"     \"Clinical assessment of the child with suspected cancer\", section on 'Bone and joint pain'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     MISCELLANEOUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Additional causes of back pain in children and adolescents may include sickle cell disease, syringomyelia, cholecystitis, pancreatitis, chronic recurrent multifocal osteomyelitis, renal stones, ureteropelvic junction obstruction, and chronic pain syndromes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Sickle cell disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sickle cell pain crisis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    collapse of vertebral bodies from avascular necrosis (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef68218 \" href=\"UTD.htm?12/51/13104\">",
"     image 3",
"    </a>",
"    ) may cause back pain in patients with sickle cell disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/4/18506?source=see_link\">",
"     \"Bone and joint complications in sickle cell disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Syringomyelia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Syringomyelia is a fluid-filled, gliosis-lined cavity within the spinal cord that may occur in the setting of congenital anomalies (eg, Arnold Chiari malformation type 1) or after spinal infection, inflammation, tumor, or trauma. Most lesions are between C2 and T9. Syringomyelia may be asymptomatic or associated with progressive central spinal cord deficits. It is diagnosed with MRI. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32426?source=see_link&amp;anchor=H33#H33\">",
"     \"Disorders affecting the spinal cord\", section on 'Syringomyelia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Cholecystitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical features of cholecystitis include steady and severe abdominal pain in the right upper quadrant or epigastrium that may radiate to the right shoulder or back; nausea; vomiting; and anorexia. Symptoms may be precipitated by ingestion of fatty food. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/33/29208?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of acute cholecystitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Pancreatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute pancreatitis is characterized by acute, steady upper abdominal pain. Approximately one-half of patients have band-like radiation to the back, and most have nausea and vomiting. Other features include restlessness, agitation, and relief on bending forward. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/5/20569?source=see_link\">",
"     \"Clinical manifestations and diagnosis of acute pancreatitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28616?source=see_link\">",
"     \"Clinical manifestations and diagnosis of chronic pancreatitis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Chronic recurrent multifocal osteomyelitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic recurrent multifocal osteomyelitis (CRMO) is thought to be an inflammatory disorder. The initial presentation is similar to that of osteomyelitis (eg, fever, localized pain, increased inflammatory markers). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33289?source=see_link&amp;anchor=H31#H31\">",
"     \"Evaluation and diagnosis of hematogenous osteomyelitis in children\", section on 'Chronic nonbacterial osteomyelitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Nephrolithiasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nephrolithiasis may cause flank pain in children and adolescents. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/19/13623?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical features and diagnosis of nephrolithiasis in children\", section on 'Pain'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     UPJ obstruction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with ureteropelvic junction obstruction may present with flank pain that increases during brisk diuresis (eg, after consumption of caffeine or alcohol). They also may have nausea and vomiting. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/3/26680?source=see_link\">",
"     \"Congenital ureteropelvic junction obstruction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Chronic pain syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic pain syndromes (or functional illness) comprise 10 to 15 percent of referrals to pediatric rheumatology practices [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/98-100\">",
"     98-100",
"    </a>",
"    ]. The majority of children with chronic pain are adolescents. Functional illness is rare before the age of seven to nine years [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/101\">",
"     101",
"    </a>",
"    ]. Complaints limited to the back are uncommon.",
"   </p>",
"   <p>",
"    Chronic pain syndrome is a diagnosis of exclusion. Hallmarks of functional illness include discordance between reported symptoms and physical findings, frequent school absences, and withdrawal from social activities with peers. Pain prolonged over the course of years is common. The parent may be inappropriately invested in the child's complaints, answering questions on his or her behalf [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/59\">",
"     59",
"    </a>",
"    ]. Chronic pain syndromes in children and adolescents have been associated with low parental education, psychosocial stresses, pending litigation, and a parental history of chronic pain [",
"    <a class=\"abstract\" href=\"UTD.htm?18/45/19162/abstract/2,102,103\">",
"     2,102,103",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/20/18754?source=see_link\">",
"       \"Patient information: Scoliosis (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?17/7/17521?source=see_link\">",
"       \"Patient information: Kyphosis in children (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?21/51/22320?source=see_link\">",
"       \"Patient information: Back pain in children and adolescents (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although benign musculoskeletal disease or trauma accounts for most cases of back pain in children and adolescents, congenital and acquired conditions such as infection, noninfectious inflammatory disease, and neoplasm must be excluded (",
"      <a class=\"graphic graphic_table graphicRef54179 \" href=\"UTD.htm?12/40/12941\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef77360 \" href=\"UTD.htm?18/61/19422\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Specific musculoskeletal causes of back pain include spondylolysis (",
"      <a class=\"graphic graphic_figure graphicRef51634 \" href=\"UTD.htm?5/41/5781\">",
"       figure 1",
"      </a>",
"      ) and spondylolisthesis (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef58784 \" href=\"UTD.htm?41/58/42917\">",
"       image 1",
"      </a>",
"      ); scoliosis; Scheuermann kyphosis (juvenile kyphosis) (",
"      <a class=\"graphic graphic_figure graphicRef81479 \" href=\"UTD.htm?13/8/13440\">",
"       figure 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef60638 \" href=\"UTD.htm?35/20/36175\">",
"       image 2",
"      </a>",
"      ); and intervertebral disc degeneration, herniation, or calcification. However, the large majority of pediatric musculoskeletal back pain has no specific identifiable source. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Musculoskeletal'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infectious causes of back pain include discitis, vertebral osteomyelitis (including tuberculous), epidural abscess, and bacterial infection of the sacroiliac joint. Nonspinal infections that can present with back pain include paraspinous muscle abscess (pyomyositis), pyelonephritis, pneumonia, pelvic inflammatory disease, endocarditis, and myalgia caused by viral illness. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Infectious'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Systemic inflammatory conditions that can affect the spine and manifest as back pain include ankylosing spondylitis, psoriatic arthritis, the arthritis of inflammatory bowel disease, and reactive arthritis. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Inflammatory arthritis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Osteoid osteoma is the most common tumor that presents with back pain in children. Other tumors that can present in the spine include leukemia, lymphoma, Ewing sarcoma, neuroblastoma, osteoblastoma, osteosarcoma, neurofibroma, and Langerhans cell histiocytosis (eosinophilic granuloma). (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Tumors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Additional causes of back pain include sickle cell pain crisis or vertebral body collapse, syringomyelia, cholecystitis, pancreatitis, chronic recurrent multifocal osteomyelitis, pyelonephritis, and chronic pain syndromes. (See",
"      <a class=\"local\" href=\"#H29\">",
"       'Miscellaneous'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/1\">",
"      Selbst SM, Lavelle JM, Soyupak SK, Markowitz RI. Back pain in children who present to the emergency department. Clin Pediatr (Phila) 1999; 38:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/2\">",
"      Combs JA, Caskey PM. Back pain in children and adolescents: a retrospective review of 648 patients. South Med J 1997; 90:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/3\">",
"      Feldman DS, Hedden DM, Wright JG. The use of bone scan to investigate back pain in children and adolescents. J Pediatr Orthop 2000; 20:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/4\">",
"      Bhatia NN, Chow G, Timon SJ, Watts HG. Diagnostic modalities for the evaluation of pediatric back pain: a prospective study. J Pediatr Orthop 2008; 28:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/5\">",
"      Kim HJ, Green DW. Adolescent back pain. Curr Opin Pediatr 2008; 20:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/6\">",
"      Metzl JD. Back pain in the adolescent. A user-friendly guide. Adolescent Health Update 2005; 17:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/7\">",
"      Macias BR, Murthy G, Chambers H, Hargens AR. Asymmetric loads and pain associated with backpack carrying by children. J Pediatr Orthop 2008; 28:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/8\">",
"      Skaggs DL, Early SD, D'Ambra P, et al. Back pain and backpacks in school children. J Pediatr Orthop 2006; 26:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/9\">",
"      Sheir-Neiss GI, Kruse RW, Rahman T, et al. The association of backpack use and back pain in adolescents. Spine (Phila Pa 1976) 2003; 28:922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/10\">",
"      Neuschwander TB, Cutrone J, Macias BR, et al. The effect of backpacks on the lumbar spine in children: a standing magnetic resonance imaging study. Spine (Phila Pa 1976) 2010; 35:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/11\">",
"      Rodr&iacute;guez-Oviedo P, Ruano-Ravina A, P&eacute;rez-R&iacute;os M, et al. School children's backpacks, back pain and back pathologies. Arch Dis Child 2012; 97:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/12\">",
"      Jones GT, Macfarlane GJ. Epidemiology of low back pain in children and adolescents. Arch Dis Child 2005; 90:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/13\">",
"      Jones GT, Watson KD, Silman AJ, et al. Predictors of low back pain in British schoolchildren: a population-based prospective cohort study. Pediatrics 2003; 111:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/14\">",
"      Reneman MF, Poels BJ, Geertzen JH, Dijkstra PU. Back pain and backpacks in children: biomedical or biopsychosocial model? Disabil Rehabil 2006; 28:1293.",
"     </a>",
"    </li>",
"    <li>",
"     Backpack safety. American Academy of Pediatrics. file://www.healthychildren.org/English/safety-prevention/at-play/Pages/Backpack-Safety.aspx (Accessed on October 25, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/16\">",
"      Moore MJ, White GL, Moore DL. Association of relative backpack weight with reported pain, pain sites, medical utilization, and lost school time in children and adolescents. J Sch Health 2007; 77:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/17\">",
"      Kovacs FM, Abraira V, Pe&ntilde;a A, et al. Effect of firmness of mattress on chronic non-specific low-back pain: randomised, double-blind, controlled, multicentre trial. Lancet 2003; 362:1599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/18\">",
"      Baker RJ, Patel D. Lower back pain in the athlete: common conditions and treatment. Prim Care 2005; 32:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/19\">",
"      Diepenmaat AC, van der Wal MF, de Vet HC, Hirasing RA. Neck/shoulder, low back, and arm pain in relation to computer use, physical activity, stress, and depression among Dutch adolescents. Pediatrics 2006; 117:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/20\">",
"      Mustard CA, Kalcevich C, Frank JW, Boyle M. Childhood and early adult predictors of risk of incident back pain: Ontario Child Health Study 2001 follow-up. Am J Epidemiol 2005; 162:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/21\">",
"      Polly DW Jr, Mason DE. Congenital absence of a lumbar pedicle presenting as back pain in children. J Pediatr Orthop 1991; 11:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/22\">",
"      Dimar JR 2nd, Campbell M, Glassman SD, et al. Idiopathic juvenile osteoporosis. An unusual cause of back pain in an adolescent. Am J Orthop (Belle Mead NJ) 1995; 24:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/23\">",
"      Smith R. Idiopathic juvenile osteoporosis: experience of twenty-one patients. Br J Rheumatol 1995; 34:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/24\">",
"      Codd PJ, Riesenburger RI, Klimo P Jr, et al. Vertebra plana due to an aneurysmal bone cyst of the lumbar spine. Case report and review of the literature. J Neurosurg 2006; 105:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/25\">",
"      Sovio OM, Bell HM, Beauchamp RD, Tredwell SJ. Fracture of the lumbar vertebral apophysis. J Pediatr Orthop 1985; 5:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/26\">",
"      Sw&auml;rd L, Hellstrom M, Jacobsson B, et al. Acute injury of the vertebral ring apophysis and intervertebral disc in adolescent gymnasts. Spine (Phila Pa 1976) 1990; 15:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/27\">",
"      Marymont JV, Lynch MA, Henning CE. Exercise-related stress reaction of the sacroiliac joint. An unusual cause of low back pain in athletes. Am J Sports Med 1986; 14:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/28\">",
"      Lonstein JE. Spondylolisthesis in children. Cause, natural history, and management. Spine (Phila Pa 1976) 1999; 24:2640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/29\">",
"      Morita T, Ikata T, Katoh S, Miyake R. Lumbar spondylolysis in children and adolescents. J Bone Joint Surg Br 1995; 77:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/30\">",
"      Ginsburg GM, Bassett GS. Back Pain in Children and Adolescents: Evaluation and Differential Diagnosis. J Am Acad Orthop Surg 1997; 5:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/31\">",
"      Fredrickson BE, Baker D, McHolick WJ, et al. The natural history of spondylolysis and spondylolisthesis. J Bone Joint Surg Am 1984; 66:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/32\">",
"      Pizzutillo PD, Hummer CD 3rd. Nonoperative treatment for painful adolescent spondylolysis or spondylolisthesis. J Pediatr Orthop 1989; 9:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/33\">",
"      Hu SS, Tribus CB, Diab M, Ghanayem AJ. Spondylolisthesis and spondylolysis. J Bone Joint Surg Am 2008; 90:656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/34\">",
"      STEWART TD. [The age incidence of neural-arch defects in Alaskan natives, considered from the standpoint of etiology]. J Bone Joint Surg Am 1953; 35-A:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/35\">",
"      Ota H. [Spondylolysis: familial occurrence and its genetic implications]. Nihon Seikeigeka Gakkai Zasshi 1967; 41:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/36\">",
"      Ogilvie JW, Sherman J. Spondylolysis in Scheuermann's disease. Spine (Phila Pa 1976) 1987; 12:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/37\">",
"      Micheli LJ, Wood R. Back pain in young athletes. Significant differences from adults in causes and patterns. Arch Pediatr Adolesc Med 1995; 149:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/38\">",
"      Sponseller PD. Evaluating the child with back pain. Am Fam Physician 1996; 54:1933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/39\">",
"      Masci L, Pike J, Malara F, et al. Use of the one-legged hyperextension test and magnetic resonance imaging in the diagnosis of active spondylolysis. Br J Sports Med 2006; 40:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/40\">",
"      Smith JA, Hu SS. Management of spondylolysis and spondylolisthesis in the pediatric and adolescent population. Orthop Clin North Am 1999; 30:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/41\">",
"      Leone A, Cianfoni A, Cerase A, et al. Lumbar spondylolysis: a review. Skeletal Radiol 2011; 40:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/42\">",
"      Campbell RS, Grainger AJ, Hide IG, et al. Juvenile spondylolysis: a comparative analysis of CT, SPECT and MRI. Skeletal Radiol 2005; 34:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/43\">",
"      Kobayashi A, Kobayashi T, Kato K, et al. Diagnosis of radiographically occult lumbar spondylolysis in young athletes by magnetic resonance imaging. Am J Sports Med 2013; 41:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/44\">",
"      Papanicolaou N, Wilkinson RH, Emans JB, et al. Bone scintigraphy and radiography in young athletes with low back pain. AJR Am J Roentgenol 1985; 145:1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/45\">",
"      van den Oever M, Merrick MV, Scott JH. Bone scintigraphy in symptomatic spondylolysis. J Bone Joint Surg Br 1987; 69:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/46\">",
"      Takemitsu M, El Rassi G, Woratanarat P, Shah SA. Low back pain in pediatric athletes with unilateral tracer uptake at the pars interarticularis on single photon emission computed tomography. Spine (Phila Pa 1976) 2006; 31:909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/47\">",
"      Klein G, Mehlman CT, McCarty M. Nonoperative treatment of spondylolysis and grade I spondylolisthesis in children and young adults: a meta-analysis of observational studies. J Pediatr Orthop 2009; 29:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/48\">",
"      Sairyo K, Sakai T, Yasui N. Conservative treatment of lumbar spondylolysis in childhood and adolescence: the radiological signs which predict healing. J Bone Joint Surg Br 2009; 91:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/49\">",
"      Mayo NE, Goldberg MS, Poitras B, et al. The Ste-Justine Adolescent Idiopathic Scoliosis Cohort Study. Part III: Back pain. Spine (Phila Pa 1976) 1994; 19:1573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/50\">",
"      Weinstein SL. Natural history. Spine (Phila Pa 1976) 1999; 24:2592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/51\">",
"      Lowe TG. Scheuermann's disease. Orthop Clin North Am 1999; 30:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/52\">",
"      Damborg F, Engell V, Andersen M, et al. Prevalence, concordance, and heritability of Scheuermann kyphosis based on a study of twins. J Bone Joint Surg Am 2006; 88:2133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/53\">",
"      Fisk JW, Baigent ML, Hill PD. Scheuermann's disease. Clinical and radiological survey of 17 and 18 year olds. Am J Phys Med 1984; 63:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/54\">",
"      Fotiadis E, Elias F, Grigoriadou A, et al. The role of sternum in the etiopathogenesis of Scheuermann disease of the thoracic spine. Spine (Phila Pa 1976) 2008; 33:E21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/55\">",
"      Jagtap SA, Manuel D, Kesavdas C, Nair MD. Scheuermann disease presenting as compressive myelopathy. Neurology 2012; 78:1279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/56\">",
"      Sariali E, Panier S, Glorion C. Mechanical spinal cord compression at the apex of a kyphosis: a propos of one case. Review of the literature. Eur Spine J 2009; 18 Suppl 2:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/57\">",
"      Ryan MD, Taylor TK. Acute spinal cord compression in Scheuermann's disease. J Bone Joint Surg Br 1982; 64:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/58\">",
"      Murray PM, Weinstein SL, Spratt KF. The natural history and long-term follow-up of Scheuermann kyphosis. J Bone Joint Surg Am 1993; 75:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/59\">",
"      Hollingworth P. Back pain in children. Br J Rheumatol 1996; 35:1022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/60\">",
"      Lowe TG, Line BG. Evidence based medicine: analysis of Scheuermann kyphosis. Spine (Phila Pa 1976) 2007; 32:S115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/61\">",
"      DePalma MJ, Bhargava A. Nonspondylolytic etiologies of lumbar pain in the young athlete. Curr Sports Med Rep 2006; 5:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/62\">",
"      Lee JY, Ernestus RI, Schr&ouml;der R, Klug N. Histological study of lumbar intervertebral disc herniation in adolescents. Acta Neurochir (Wien) 2000; 142:1107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/63\">",
"      Salminen JJ, Erkintalo MO, Pentti J, et al. Recurrent low back pain and early disc degeneration in the young. Spine (Phila Pa 1976) 1999; 24:1316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/64\">",
"      Tertti MO, Salminen JJ, Paajanen HE, et al. Low-back pain and disk degeneration in children: a case-control MR imaging study. Radiology 1991; 180:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/65\">",
"      Haidar R, Ghanem I, Saad S, Uthman I. Lumbar disc herniation in young children. Acta Paediatr 2010; 99:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/66\">",
"      Epstein JA, Epstein NE, Marc J, et al. Lumbar intervertebral disk herniation in teenage children: recognition and management of associated anomalies. Spine (Phila Pa 1976) 1984; 9:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/67\">",
"      Varlotta GP, Brown MD, Kelsey JL, Golden AL. Familial predisposition for herniation of a lumbar disc in patients who are less than twenty-one years old. J Bone Joint Surg Am 1991; 73:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/68\">",
"      Samartzis D, Karppinen J, Mok F, et al. A population-based study of juvenile disc degeneration and its association with overweight and obesity, low back pain, and diminished functional status. J Bone Joint Surg Am 2011; 93:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/69\">",
"      Mart&iacute;nez-Lage JF, Mart&iacute;nez Robledo A, L&oacute;pez F, Poza M. Disc protrusion in the child. Particular features and comparison with neoplasms. Childs Nerv Syst 1997; 13:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/70\">",
"      DeLuca PF, Mason DE, Weiand R, et al. Excision of herniated nucleus pulposus in children and adolescents. J Pediatr Orthop 1994; 14:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/71\">",
"      Frino J, McCarthy RE, Sparks CY, McCullough FL. Trends in adolescent lumbar disk herniation. J Pediatr Orthop 2006; 26:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/72\">",
"      Khoury NJ, Hourani MH, Arabi MM, et al. Imaging of back pain in children and adolescents. Curr Probl Diagn Radiol 2006; 35:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/73\">",
"      Durham SR, Sun PP, Sutton LN. Surgically treated lumbar disc disease in the pediatric population: an outcome study. J Neurosurg 2000; 92:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/74\">",
"      Girodias JB, Azouz EM, Marton D. Intervertebral disk space calcification. A report of 51 children with a review of the literature. Pediatr Radiol 1991; 21:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/75\">",
"      Dai LY, Ye H, Qian QR. The natural history of cervical disc calcification in children. J Bone Joint Surg Am 2004; 86-A:1467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/76\">",
"      Ring D, Johnston CE 2nd, Wenger DR. Pyogenic infectious spondylitis in children: the convergence of discitis and vertebral osteomyelitis. J Pediatr Orthop 1995; 15:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/77\">",
"      Fernandez M, Carrol CL, Baker CJ. Discitis and vertebral osteomyelitis in children: an 18-year review. Pediatrics 2000; 105:1299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/78\">",
"      Garron E, Viehweger E, Launay F, et al. Nontuberculous spondylodiscitis in children. J Pediatr Orthop 2002; 22:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/79\">",
"      Cushing AH. Diskitis in children. Clin Infect Dis 1993; 17:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/80\">",
"      Rudert M, Tillmann B. Lymph and blood supply of the human intervertebral disc. Cadaver study of correlations to discitis. Acta Orthop Scand 1993; 64:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/81\">",
"      Brown R, Hussain M, McHugh K, et al. Discitis in young children. J Bone Joint Surg Br 2001; 83:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/82\">",
"      Karabouta Z, Bisbinas I, Davidson A, Goldsworthy LL. Discitis in toddlers: a case series and review. Acta Paediatr 2005; 94:1516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/83\">",
"      Chandrasenan J, Klezl Z, Bommireddy R, Calthorpe D. Spondylodiscitis in children: a retrospective series. J Bone Joint Surg Br 2011; 93:1122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/84\">",
"      Spencer SJ, Wilson NI. Childhood discitis in a regional children's hospital. J Pediatr Orthop B 2012; 21:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/85\">",
"      Nussinovitch M, Sokolover N, Volovitz B, Amir J. Neurologic abnormalities in children presenting with diskitis. Arch Pediatr Adolesc Med 2002; 156:1052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/86\">",
"      Rothman SL. The diagnosis of infections of the spine by modern imaging techniques. Orthop Clin North Am 1996; 27:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/87\">",
"      Miller GM, Forbes GS, Onofrio BM. Magnetic resonance imaging of the spine. Mayo Clin Proc 1989; 64:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/88\">",
"      Szypryt EP, Hardy JG, Hinton CE, et al. A comparison between magnetic resonance imaging and scintigraphic bone imaging in the diagnosis of disc space infection in an animal model. Spine (Phila Pa 1976) 1988; 13:1042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/89\">",
"      Jansen BR, Hart W, Schreuder O. Discitis in childhood. 12-35-year follow-up of 35 patients. Acta Orthop Scand 1993; 64:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/90\">",
"      Kayser R, Mahlfeld K, Greulich M, Grasshoff H. Spondylodiscitis in childhood: results of a long-term study. Spine (Phila Pa 1976) 2005; 30:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/91\">",
"      Gran JT, Husby G. HLA-B27 and spondyloarthropathy: value for early diagnosis? J Med Genet 1995; 32:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/92\">",
"      Reveille JD. HLA-B27 and the seronegative spondyloarthropathies. Am J Med Sci 1998; 316:239.",
"     </a>",
"    </li>",
"    <li>",
"     Moder KG, Hunder GG. Examination of the joints. In: Textbook of Rheumatology, 5th, Kelley WN, Harris ED, Ruddy S, et al (Eds), WB Saunders, Philadelphia 1997. p.364.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/94\">",
"      Battafarano DF, West SG, Rak KM, et al. Comparison of bone scan, computed tomography, and magnetic resonance imaging in the diagnosis of active sacroiliitis. Semin Arthritis Rheum 1993; 23:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/95\">",
"      Cohen MD, Harrington TM, Ginsburg WW. Osteoid osteoma: 95 cases and a review of the literature. Semin Arthritis Rheum 1983; 12:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/96\">",
"      Azouz EM, Kozlowski K, Marton D, et al. Osteoid osteoma and osteoblastoma of the spine in children. Report of 22 cases with brief literature review. Pediatr Radiol 1986; 16:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/97\">",
"      Kriss VM. My aching back: a serious complaint in children. Curr Probl Diagn Radiol 2001; 30:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/98\">",
"      Bowyer S, Roettcher P. Pediatric rheumatology clinic populations in the United States: results of a 3 year survey. Pediatric Rheumatology Database Research Group. J Rheumatol 1996; 23:1968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/99\">",
"      Malleson PN, Fung MY, Rosenberg AM. The incidence of pediatric rheumatic diseases: results from the Canadian Pediatric Rheumatology Association Disease Registry. J Rheumatol 1996; 23:1981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/100\">",
"      Symmons DP, Jones M, Osborne J, et al. Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J Rheumatol 1996; 23:1975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/101\">",
"      Cassidy JT. Progress in diagnosis and understanding chronic pain syndromes in children and adolescents. Adolesc Med 1998; 9:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/102\">",
"      Flat&oslash; B, Aasland A, Vandvik IH, F&oslash;rre O. Outcome and predictive factors in children with chronic idiopathic musculoskeletal pain. Clin Exp Rheumatol 1997; 15:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/45/19162/abstract/103\">",
"      Balagu&eacute; F, Skovron ML, Nordin M, et al. Low back pain in schoolchildren. A study of familial and psychological factors. Spine (Phila Pa 1976) 1995; 20:1265.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2852 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-22DD962998-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_45_19162=[""].join("\n");
var outline_f18_45_19162=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H39\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MUSCULOSKELETAL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Muscle-related pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Bone-related pain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Spondylolysis and spondylolisthesis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Scoliosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Scheuermann (juvenile) kyphosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Disc-related pain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Disc herniation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Disc calcification",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      INFECTIOUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Discitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Osteomyelitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Septic sacroiliitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Epidural abscess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Nonspinal infections",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Pyomyositis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Pyelonephritis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Pneumonia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Pelvic inflammatory disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Endocarditis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Myalgia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      INFLAMMATORY ARTHRITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      TUMORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Osteoid osteoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Other tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      MISCELLANEOUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Syringomyelia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Cholecystitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Chronic recurrent multifocal osteomyelitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Nephrolithiasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      UPJ obstruction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Chronic pain syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/2852\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/2852|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?41/58/42917\" title=\"diagnostic image 1\">",
"      Spondylolisthesis imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?35/20/36175\" title=\"diagnostic image 2\">",
"      Scheuermann kyphosis x-ray",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?12/51/13104\" title=\"diagnostic image 3\">",
"      Vert collapse sickle cell",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/2852|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/41/5781\" title=\"figure 1\">",
"      Spondylolysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/6/10339\" title=\"figure 2\">",
"      Spondylolisthesis palpation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/2/34850\" title=\"figure 3\">",
"      Phalen-Dickson sign",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/8/13440\" title=\"figure 4\">",
"      Scheuermann kyphosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/55/6015\" title=\"figure 5\">",
"      FABERE test (Patrick test, \"figure of four\" test)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/2852|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/14/43233\" title=\"picture 1\">",
"      One-legged hyperextension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/2852|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/40/12941\" title=\"table 1\">",
"      Causes of back pain in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?18/61/19422\" title=\"table 2\">",
"      Back pain clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/63/18427\" title=\"table 3\">",
"      Contact collision sports",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/51/23355\" title=\"table 4\">",
"      Lumbosacral radiculopathies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18601?source=related_link\">",
"      Approach to the diagnosis and evaluation of low back pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/30/14826?source=related_link\">",
"      Bacterial arthritis: Clinical features and diagnosis in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/4/18506?source=related_link\">",
"      Bone and joint complications in sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/47/5882?source=related_link\">",
"      Clinical assessment of the child with suspected cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38970?source=related_link\">",
"      Clinical features and diagnosis of community-acquired pneumonia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/19/13623?source=related_link\">",
"      Clinical features and diagnosis of nephrolithiasis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=related_link\">",
"      Clinical features and diagnosis of pelvic inflammatory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/40/21129?source=related_link\">",
"      Clinical features and diagnosis of urinary tract infections in infants and children older than one month",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/39/20087?source=related_link\">",
"      Clinical features of hematogenous osteomyelitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33770?source=related_link\">",
"      Clinical features; evaluation; and diagnosis of adolescent idiopathic scoliosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/5/20569?source=related_link\">",
"      Clinical manifestations and diagnosis of acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28616?source=related_link\">",
"      Clinical manifestations and diagnosis of chronic pancreatitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/49/30488?source=related_link\">",
"      Clinical manifestations and diagnosis of psoriatic arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/7/24693?source=related_link\">",
"      Clinical manifestations of Crohn's disease in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/52/18249?source=related_link\">",
"      Complications and outcome of infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/3/26680?source=related_link\">",
"      Congenital ureteropelvic junction obstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32426?source=related_link\">",
"      Disorders affecting the spinal cord",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17033?source=related_link\">",
"      Epidural abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33289?source=related_link\">",
"      Evaluation and diagnosis of hematogenous osteomyelitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/39/2679?source=related_link\">",
"      Evaluation of the child with back pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/15/27896?source=related_link\">",
"      Infective endocarditis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/60/24522?source=related_link\">",
"      Overview of benign bone tumors in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/37/3673?source=related_link\">",
"      Overview of breast disorders in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/33/29208?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of acute cholecystitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/51/22320?source=related_link\">",
"      Patient information: Back pain in children and adolescents (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?17/7/17521?source=related_link\">",
"      Patient information: Kyphosis in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/20/18754?source=related_link\">",
"      Patient information: Scoliosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32950?source=related_link\">",
"      Pyomyositis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/27/33210?source=related_link\">",
"      Reactive arthritis (formerly Reiter syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/31/8696?source=related_link\">",
"      Spondyloarthropathy in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/12/37065?source=related_link\">",
"      Treatment and prognosis of adolescent idiopathic scoliosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/9/24730?source=related_link\">",
"      Treatment of hematogenous osteomyelitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/34/4650?source=related_link\">",
"      Treatment of ulcerative colitis in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/41/9879?source=related_link\">",
"      Viral myositis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_45_19163="Zoonoses from dogs C";
var content_f18_45_19163=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F67427&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F67427&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Zoonoses dogs, continued",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Transmission",
"       </td>",
"       <td class=\"subtitle1\">",
"        Organism",
"       </td>",
"       <td class=\"subtitle1\">",
"        Human symptoms",
"       </td>",
"       <td class=\"subtitle1\">",
"        Canine symptoms",
"       </td>",
"       <td class=\"subtitle1\">",
"        Geographic distribution",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Aerosol",
"       </td>",
"       <td>",
"        Bordetella bronchiseptica",
"       </td>",
"       <td>",
"        Asymptomatic to upper respiratory tract infections to pneumonia",
"       </td>",
"       <td>",
"        Kennel cough",
"       </td>",
"       <td>",
"        Worldwide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Coxiella burnetii",
"       </td>",
"       <td>",
"        Q fever, including A self-limited flu-like illness, +/- pneumonia, +/- hepatitis, +/- endocarditis",
"       </td>",
"       <td>",
"        Asymptomatic; infection may cause abortion or rapid death of newborn pups",
"       </td>",
"       <td>",
"        Worldwide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Urine",
"       </td>",
"       <td>",
"        Leptospira interrogans",
"       </td>",
"       <td>",
"        Leptosiprosis, subclinical to severe, potentially fatal illness",
"       </td>",
"       <td>",
"        Similar to human disease",
"       </td>",
"       <td>",
"        Worldwide",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_45_19163=[""].join("\n");
var outline_f18_45_19163=null;
var title_f18_45_19164="Classification of scleroderma";
var content_f18_45_19164=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F53984&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F53984&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Classification of scleroderma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Pre-scleroderma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Raynaud's phenomenon",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nailfold capillary changes and evidence of digital ischemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Specific circulating autoantibodies - anti-topoisomerase-I (Scl-70), anti-centromere (ACA), or anti-RNA polymerase-I, II, or III",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Many patients progress to systemic sclerosis within 3 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Scleroderma sine scleroderma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Presentation with pulmonary fibrosis or renal, cardiac, or gastrointestinal disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No skin involvement",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Raynaud's phenomenon may be present",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Antinuclear antibodies may be present - anti-Scl-70, ACA, or anti-RNA polymerase-I, II, or III",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Limited cutaneous scleroderma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Raynaud's phenomenon for years, occasionally decades",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Skin involvement limited to hands, face, feet, and forearms (acral distribution)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dilated nailfold capillary loops, usually without capillary drop-out",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        A significant (10 to 15 percent) late incidence of pulmonary hypertension, with or without skin calcification, gastrointestinal disease, telangiectasiae (CREST syndrome), or interstitial lung disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal disease rarely occurs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        ACA in 70 to 80 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anti-Scl-70 in 10 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Diffuse cutaneous scleroderma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Raynaud's phenomenon followed, within one year, by puffy or hidebound skin changes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Truncal and acral skin involvement; tendon friction rubs; myositis; arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nailfold capillary dilatation and capillary drop-out",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Early and significant incidence of renal, interstitial lung, diffuse gastrointestinal, and myocardial disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anti-Scl-70 (30 percent), anti-RNA polymerase-I, II, or III (12 to 25 percent), ACA (&lt;5 percent) antibodies",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_45_19164=[""].join("\n");
var outline_f18_45_19164=null;
var title_f18_45_19165="Symptoms of simple partial seizures";
var content_f18_45_19165=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F55996&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F55996&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Symptoms of simple partial seizures and auras",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td>",
"            Black Out",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Body size or weight alteration in perception",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Breathing difficulty",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Chewing movements",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Confusion",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Convulsion",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Deja-vu",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Dizziness",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Drooling",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Electric shock feeling",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Eyelid fluttering",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Eyes rolling up",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Falling down",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Foot stomping",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hand waving",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Heart racing",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Inability to move",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Incontinence",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Jamais vu",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lightheadedness",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lip smacking",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Loss of consciousness",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Making sounds",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Memory loss",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            One side of body different than other",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Out-of-body experience",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Oversensitivity to stimulation",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td>",
"            Psychic experience",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Racing thoughts",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Running",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Shaking",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Skin color changes",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sound perception distortion",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Spacial perception distortion",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Spacing out",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Spinning feeling",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Staring",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Stiffening",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Swallowing",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sweating",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Talking difficulty",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Teeth clenching/grinding",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tightness",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Time perception distortion",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tingling feeling",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tongue biting",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tremors",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Twitching movements",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Undressing",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Urge to urinate or defecate",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Visual distortion",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Visual loss or blurring",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Walking",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_45_19165=[""].join("\n");
var outline_f18_45_19165=null;
var title_f18_45_19166="Gail model accuracy";
var content_f18_45_19166=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F54619&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F54619&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 539px\">",
"   <div class=\"ttl\">",
"    Gail model accuracy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 519px; height: 278px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ability of the Gail breast cancer risk prediction model to discriminate among women who did and did not develop breast cancer in the Nurses' Health Study. Concordance statistics = 0.58 (95% Confidence Interval 0.56-0.60)*.",
"    <div class=\"footnotes\">",
"     * Reprinted with permission from B. Rockhill Levine (17).",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Elmore JG, Fletcher SW. The risk of cancer risk prediction: \"What is my risk of getting breast cancer?\" J Nat Cancer Inst 2006; 98:1673. Copyright &copy; 2006 Oxford University Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_45_19166=[""].join("\n");
var outline_f18_45_19166=null;
var title_f18_45_19167="Contents: Pediatric oncology";
var content_f18_45_19167=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Pediatric oncology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Pediatric oncology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Bone and soft tissue tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/51/37690\">",
"           Bone sarcomas: Preoperative evaluation, histologic classification, and principles of surgical management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/53/35673\">",
"           Bone tumors: Diagnosis and biopsy techniques",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/8/39050\">",
"           Chemotherapy and radiation therapy in the management of osteosarcoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/56/37769\">",
"           Clinical presentation, staging, and prognostic factors of the Ewing sarcoma family of tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/37/7770\">",
"           Epidemiology, pathology, and molecular genetics of the Ewing sarcoma family of tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/1/28694\">",
"           Intradural nerve sheath tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/50/32551\">",
"           Langerhans cell histiocytosis (eosinophilic granuloma) of bone in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/22/20842\">",
"           Osteosarcoma: Epidemiology, pathogenesis, clinical presentation, diagnosis, and histology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/47/25338\">",
"           Radiation therapy for Ewing sarcoma family of tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/63/16377\">",
"           Rhabdomyosarcoma and undifferentiated sarcoma in childhood and adolescence: Epidemiology, pathology, and molecular pathogenesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/50/14122\">",
"           Treatment of the Ewing sarcoma family of tumors",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cancer survivors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/16/38151\">",
"           ACTH deficiency in survivors of childhood cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/7/7286\">",
"           Endocrine surveillance in childhood cancer survivors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/14/7401\">",
"           Pubertal development and gonadal function in survivors of childhood cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Central nervous system tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/5/22618\">",
"           Clinical features, diagnosis, and management of von Hippel-Lindau disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/56/13192\">",
"           Clinical manifestations and diagnosis of central nervous system tumors in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/15/15609\">",
"           Clinical presentation, diagnosis, and staging evaluation of neuroblastoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/22/37226\">",
"           Complications of cranial irradiation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/60/24520\">",
"           Craniopharyngioma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/1/2071\">",
"           Diagnosis and classification of low-grade gliomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/50/1832\">",
"           Diffuse pontine glioma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/51/15161\">",
"           Ependymoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/21/38230\">",
"           Epidemiology of central nervous system tumors in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/15/14585\">",
"           Epidemiology, pathogenesis, and pathology of neuroblastoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/0/2058\">",
"           Epidemiology, treatment, and prognosis of medulloblastoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/40/40585\">",
"           Focal brainstem glioma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/43/695\">",
"           Hemangioblastoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/23/41332\">",
"           Histopathology and molecular pathogenesis of medulloblastoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/33/44568\">",
"           Management of low-grade glioma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/21/14678\">",
"           Molecular biology and pathogenesis of von Hippel-Lindau disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/16/39176\">",
"           Optic pathway glioma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/26/13736\">",
"           Overview of the management of central nervous system tumors in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/25/30105\">",
"           Pediatric intracranial germ cell tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/20/16714\">",
"           Pineal gland masses",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/42/8874\">",
"           Risk factors for brain tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/30/17894\">",
"           Sacrococcygeal germ cell tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/9/18586\">",
"           Treatment and prognosis of neuroblastoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/6/35946\">",
"           Uncommon brain tumors",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Complications of cancer and its therapy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/27/4538\">",
"           Bone problems in childhood cancer patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/46/41706\">",
"           Cardiotoxicity of anthracycline-like chemotherapy agents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/12/40138\">",
"           Cardiotoxicity of nonanthracycline cancer chemotherapy agents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/33/15898\">",
"           Fever in children with chemotherapy-induced neutropenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/55/31607\">",
"           Growth failure after childhood cancer: Role of growth hormone deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/19/39223\">",
"           Growth failure after childhood cancer: Role of hypothyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/37/30296\">",
"           Immunizations in patients with cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/25/28058\">",
"           Pediatric palliative care",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/18/39210\">",
"           Prevention and treatment of chemotherapy-induced nausea and vomiting",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/55/33658\">",
"           Therapeutic use and toxicity of high-dose methotrexate",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/12/41160\">",
"           Thromboembolism in children with cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/1/19481\">",
"           Tumor lysis syndrome: Definition, pathogenesis, clinical manifestations, etiology and risk factors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/20/3402\">",
"           Tumor lysis syndrome: Prevention and treatment",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Endocrine tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/14/38121\">",
"           Pheochromocytoma in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/51/40762\">",
"           Treatment of adrenocortical carcinoma",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Evaluation",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/47/5882\">",
"           Clinical assessment of the child with suspected cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/15/44280\">",
"           Evaluation and management of pain in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Genetic diseases",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/38/34410\">",
"           Tuberous sclerosis complex: Genetics, clinical features, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/36/32328\">",
"           Tuberous sclerosis complex: Management",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Genitourinary tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/37/5721\">",
"           Ovarian germ cell neoplasms: Pathology, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/12/2249\">",
"           Presentation, diagnosis, and staging of Wilms tumor",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/50/9002\">",
"           Treatment and prognosis of Wilms tumor",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/24/33162\">",
"           Treatment of malignant germ cell tumors of the ovary",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hematologic malignancies",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/53/21338\">",
"           Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/56/35720\">",
"           Epidemiology, clinical manifestations, pathologic features, and diagnosis of Burkitt lymphoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/6/32874\">",
"           Overview of Hodgkin lymphoma in children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/44/40649\">",
"           Overview of the outcome of acute lymphoblastic leukemia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/58/4009\">",
"           Overview of the presentation and classification of acute lymphoblastic leukemia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/6/31850\">",
"           Overview of the treatment of acute lymphoblastic leukemia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/53/32599\">",
"           Primary lymphoma of bone",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/55/37753\">",
"           Risk group stratification and prognosis for acute lymphoblastic leukemia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/23/36217\">",
"           Treatment of Burkitt leukemia/lymphoma in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/45/34520\">",
"           Treatment of nodular lymphocyte-predominant Hodgkin lymphoma",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neuroblastoma",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/15/15609\">",
"           Clinical presentation, diagnosis, and staging evaluation of neuroblastoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/15/14585\">",
"           Epidemiology, pathogenesis, and pathology of neuroblastoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/9/18586\">",
"           Treatment and prognosis of neuroblastoma",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Treatment",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/10/41129\">",
"           Emergencies in pediatric cancer patients",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Tumors of the eye and orbit",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/24/27018\">",
"           Overview of retinoblastoma",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-3C1CDFF056-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f18_45_19167=[""].join("\n");
var outline_f18_45_19167=null;
